{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T18:34:39Z","timestamp":1794681279063,"version":"4.9.1"},"reference-count":696,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100010722","name":"Harbin Medical University","doi-asserted-by":"publisher","award":["2023-KYYWF-0202"],"award-info":[{"award-number":["2023-KYYWF-0202"]}],"id":[{"id":"10.13039\/100010722","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-024-02165-x","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T07:54:25Z","timestamp":1732175665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":286,"title":["Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Shan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingda","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingpu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangjie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"2165_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2165_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1158\/2159-8290.CD-22-0475","volume":"13","author":"SS Onkar","year":"2023","unstructured":"Onkar SS, et al. The great Immune escape: understanding the Divergent Immune response in breast Cancer subtypes. Cancer Discov. 2023;13:23\u201340.","journal-title":"Cancer Discov"},{"key":"2165_CR3","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1002\/mco2.218","volume":"4","author":"S Nong","year":"2023","unstructured":"Nong S, et al. Metabolic reprogramming in cancer: mechanisms and therapeutics. MedComm (2020). 2023;4:e218.","journal-title":"MedComm (2020)"},{"key":"2165_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","volume":"5","author":"MZ Jin","year":"2020","unstructured":"Jin MZ, Jin WL. The updated landscape of tumor microenvironment and drug repurposing. Signal Transduct Target Ther. 2020;5:166.","journal-title":"Signal Transduct Target Ther"},{"key":"2165_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia L, et al. The cancer metabolic reprogramming and immune response. Mol Cancer. 2021;20:28.","journal-title":"Mol Cancer"},{"key":"2165_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2018.03.001","volume":"38","author":"P Icard","year":"2018","unstructured":"Icard P, et al. How the Warburg effect supports aggressiveness and drug resistance of cancer cells? Drug Resist Updat. 2018;38:1\u201311.","journal-title":"Drug Resist Updat"},{"key":"2165_CR7","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.cmet.2018.09.018","volume":"28","author":"J Van den Bossche","year":"2018","unstructured":"Van den Bossche J, van der Windt GJW. Fatty acid oxidation in macrophages and T cells: time for reassessment? Cell Metab. 2018;28:538\u201340.","journal-title":"Cell Metab"},{"key":"2165_CR8","doi-asserted-by":"publisher","first-page":"103627","DOI":"10.1016\/j.ebiom.2021.103627","volume":"73","author":"ZH Wang","year":"2021","unstructured":"Wang ZH, Peng WB, Zhang P, Yang XP, Zhou Q. Lactate in the tumour microenvironment: from immune modulation to therapy. EBioMedicine. 2021;73:103627.","journal-title":"EBioMedicine"},{"key":"2165_CR9","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423\u201337.","journal-title":"Nat Med"},{"key":"2165_CR10","first-page":"370","volume":"1826","author":"JQ Chen","year":"2012","unstructured":"Chen JQ, Russo J. Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. Biochim Biophys Acta. 2012;1826:370\u201384.","journal-title":"Biochim Biophys Acta"},{"key":"2165_CR11","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1111\/cas.15722","volume":"114","author":"R Nakahara","year":"2023","unstructured":"Nakahara R, Maeda K, Aki S, Osawa T. Metabolic adaptations of cancer in extreme tumor microenvironments. Cancer Sci. 2023;114:1200\u20137.","journal-title":"Cancer Sci"},{"key":"2165_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of Cancer: New dimensions. Cancer Discov. 2022;12:31\u201346.","journal-title":"Cancer Discov"},{"key":"2165_CR13","doi-asserted-by":"publisher","first-page":"11677","DOI":"10.18632\/oncotarget.24433","volume":"9","author":"F Tayyari","year":"2018","unstructured":"Tayyari F, et al. Metabolic profiles of triple-negative and luminal A breast cancer subtypes in African-American identify key metabolic differences. Oncotarget. 2018;9:11677\u201390.","journal-title":"Oncotarget"},{"key":"2165_CR14","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.18632\/oncotarget.23626","volume":"9","author":"TH More","year":"2018","unstructured":"More TH, et al. Metabolomic alterations in invasive ductal carcinoma of breast: a comprehensive metabolomic study using tissue and serum samples. Oncotarget. 2018;9:2678\u201396.","journal-title":"Oncotarget"},{"key":"2165_CR15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/1471-2164-13-334","volume":"13","author":"J Budczies","year":"2012","unstructured":"Budczies J, et al. Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue - a GC-TOFMS based metabolomics study. BMC Genomics. 2012;13:334.","journal-title":"BMC Genomics"},{"key":"2165_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ejca.2019.09.002","volume":"121","author":"AS Dias","year":"2019","unstructured":"Dias AS, Almeida CR, Helguero LA, Duarte IF. Metabolic crosstalk in the breast cancer microenvironment. Eur J Cancer. 2019;121:154\u201371.","journal-title":"Eur J Cancer"},{"key":"2165_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova NN, Zhu J, Thompson CB. The hallmarks of cancer metabolism: still emerging. Cell Metab. 2022;34:355\u201377.","journal-title":"Cell Metab"},{"key":"2165_CR18","doi-asserted-by":"crossref","unstructured":"Chandel NS. Glycolysis. Cold Spring Harb Perspect Biol. 2021;13(5):a040535.","DOI":"10.1101\/cshperspect.a040535"},{"key":"2165_CR19","doi-asserted-by":"publisher","first-page":"1054233","DOI":"10.3389\/fonc.2022.1054233","volume":"12","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, et al. When cancer drug resistance meets metabolomics (bulk, single-cell and\/or spatial): Progress, potential, and perspective. Front Oncol. 2022;12:1054233.","journal-title":"Front Oncol"},{"key":"2165_CR20","doi-asserted-by":"publisher","first-page":"175883592110278","DOI":"10.1177\/17588359211027836","volume":"13","author":"Y Yuan","year":"2021","unstructured":"Yuan Y, et al. NDUFA4L2 promotes trastuzumab resistance in HER2-positive breast cancer. Ther Adv Med Oncol. 2021;13:17588359211027836.","journal-title":"Ther Adv Med Oncol"},{"key":"2165_CR21","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1111\/cas.14412","volume":"111","author":"L Ma","year":"2020","unstructured":"Ma L, et al. Activator of thyroid and retinoid receptor increases sorafenib resistance in hepatocellular carcinoma by facilitating the Warburg effect. Cancer Sci. 2020;111:2028\u201340.","journal-title":"Cancer Sci"},{"key":"2165_CR22","doi-asserted-by":"publisher","first-page":"e1367","DOI":"10.1038\/cddis.2014.297","volume":"5","author":"X Peng","year":"2014","unstructured":"Peng X, et al. Autophagy promotes paclitaxel resistance of cervical cancer cells: involvement of Warburg effect activated hypoxia-induced factor 1-\u03b1-mediated signaling. Cell Death Dis. 2014;5:e1367.","journal-title":"Cell Death Dis"},{"key":"2165_CR23","doi-asserted-by":"publisher","first-page":"216020","DOI":"10.1016\/j.canlet.2022.216020","volume":"554","author":"J Qiu","year":"2023","unstructured":"Qiu J, et al. mTOR inhibitor, gemcitabine and PD-L1 antibody blockade combination therapy suppresses pancreatic cancer progression via metabolic reprogramming and immune microenvironment remodeling in Trp53(flox\/+)LSL-Kras(G12D\/+)pdx-1-Cre murine models. Cancer Lett. 2023;554:216020.","journal-title":"Cancer Lett"},{"key":"2165_CR24","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1158\/0008-5472.613.65.2","volume":"65","author":"RH Xu","year":"2005","unstructured":"Xu RH, et al. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 2005;65:613\u201321.","journal-title":"Cancer Res"},{"key":"2165_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12964-015-0114-x","volume":"13","author":"W Wagner","year":"2015","unstructured":"Wagner W, Ciszewski WM, Kania KD. L- and D-lactate enhance DNA repair and modulate the resistance of cervical carcinoma cells to anticancer drugs via histone deacetylase inhibition and hydroxycarboxylic acid receptor 1 activation. Cell Commun Signal. 2015;13:36.","journal-title":"Cell Commun Signal"},{"key":"2165_CR26","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/bjc.2016.26","volume":"114","author":"LE Botzer","year":"2016","unstructured":"Botzer LE, et al. Hexokinase 2 is a determinant of neuroblastoma metastasis. Br J Cancer. 2016;114:759\u201366.","journal-title":"Br J Cancer"},{"key":"2165_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science. 1956;123:309\u201314.","journal-title":"Science"},{"key":"2165_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW. The Warburg Effect: how does it Benefit Cancer cells? Trends Biochem Sci. 2016;41:211\u20138.","journal-title":"Trends Biochem Sci"},{"key":"2165_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40360-019-0301-2","volume":"20","author":"A Korga","year":"2019","unstructured":"Korga A, et al. Apigenin and hesperidin augment the toxic effect of doxorubicin against HepG2 cells. BMC Pharmacol Toxicol. 2019;20:22.","journal-title":"BMC Pharmacol Toxicol"},{"key":"2165_CR30","doi-asserted-by":"publisher","first-page":"16875","DOI":"10.18632\/oncotarget.15171","volume":"8","author":"J Wang","year":"2017","unstructured":"Wang J, et al. Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis. Oncotarget. 2017;8:16875\u201386.","journal-title":"Oncotarget"},{"key":"2165_CR31","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.1158\/1538-7445.AM2016-4746","volume":"76","author":"C Kopitz","year":"2016","unstructured":"Kopitz C, et al. Abstract 4746: Pharmacological characterization of BAY-876, a novel highly selective inhibitor of glucose transporter (GLUT)-1 in vitro and in vivo. Cancer Res. 2016;76:4746\u20134746.","journal-title":"Cancer Res"},{"key":"2165_CR32","doi-asserted-by":"publisher","first-page":"6923","DOI":"10.1016\/j.bmcl.2013.09.037","volume":"23","author":"T Tuccinardi","year":"2013","unstructured":"Tuccinardi T, et al. Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells. Bioorg Med Chem Lett. 2013;23:6923\u20137.","journal-title":"Bioorg Med Chem Lett"},{"key":"2165_CR33","doi-asserted-by":"publisher","first-page":"7285","DOI":"10.2174\/0929867326666181213092652","volume":"26","author":"SN Garcia","year":"2019","unstructured":"Garcia SN, Guedes RC, Marques MM. Unlocking the potential of HK2 in Cancer metabolism and therapeutics. Curr Med Chem. 2019;26:7285\u2013322.","journal-title":"Curr Med Chem"},{"key":"2165_CR34","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S0969-8051(02)00288-3","volume":"29","author":"RS Brown","year":"2002","unstructured":"Brown RS, Goodman TM, Zasadny KR, Greenson JK, Wahl RL. Expression of hexokinase II and Glut-1 in untreated human breast cancer. Nucl Med Biol. 2002;29:443\u201353.","journal-title":"Nucl Med Biol"},{"key":"2165_CR35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ccr.2013.06.014","volume":"24","author":"KC Patra","year":"2013","unstructured":"Patra KC, et al. Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer. Cancer Cell. 2013;24:213\u201328.","journal-title":"Cancer Cell"},{"issue":"1","key":"2165_CR36","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/ijms21010234","volume":"21","author":"B Pajak","year":"2019","unstructured":"Pajak B, et al. 2-Deoxy-d-Glucose and its analogs:\u00a0from diagnostic to therapeutic agents. Int J Mol Sci. 2019;21(1):234.","journal-title":"Int J Mol Sci"},{"key":"2165_CR37","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00280-012-2045-1","volume":"71","author":"LE Raez","year":"2013","unstructured":"Raez LE, et al. A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2013;71:523\u201330.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2165_CR38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.redox.2014.12.001","volume":"4","author":"L Li","year":"2015","unstructured":"Li L, Fath MA, Scarbrough PM, Watson WH, Spitz DR. Combined inhibition of glycolysis, the pentose cycle, and thioredoxin metabolism selectively increases cytotoxicity and oxidative stress in human breast and prostate cancer. Redox Biol. 2015;4:127\u201335.","journal-title":"Redox Biol"},{"key":"2165_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/0008-5472.CAN-03-3294","volume":"64","author":"G Maschek","year":"2004","unstructured":"Maschek G, et al. 2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo. Cancer Res. 2004;64:31\u20134.","journal-title":"Cancer Res"},{"key":"2165_CR40","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1038\/sj.onc.1209597","volume":"25","author":"H Pelicano","year":"2006","unstructured":"Pelicano H, Martin DS, Xu RH, Huang P. Glycolysis inhibition for anticancer treatment. Oncogene. 2006;25:4633\u201346.","journal-title":"Oncogene"},{"key":"2165_CR41","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/S0360-3016(01)01534-6","volume":"50","author":"BS Dwarkanath","year":"2001","unstructured":"Dwarkanath BS, et al. Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines. Int J Radiat Oncol Biol Phys. 2001;50:1051\u201361.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 1","key":"2165_CR42","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.4103\/0973-1482.55137","volume":"5","author":"BS Dwarakanath","year":"2009","unstructured":"Dwarakanath BS. Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose in vitro. J Cancer Res Ther. 2009;5(Suppl 1):S27\u201331.","journal-title":"J Cancer Res Ther"},{"key":"2165_CR43","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.canlet.2014.09.003","volume":"355","author":"D Zhang","year":"2014","unstructured":"Zhang D, et al. 2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy. Cancer Lett. 2014;355:176\u201383.","journal-title":"Cancer Lett"},{"key":"2165_CR44","doi-asserted-by":"publisher","first-page":"e2625","DOI":"10.1038\/cddis.2017.43","volume":"8","author":"YL Yang","year":"2017","unstructured":"Yang YL, et al. Ginsenoside Rg5 increases cardiomyocyte resistance to ischemic injury through regulation of mitochondrial hexokinase-II and dynamin-related protein 1. Cell Death Dis. 2017;8:e2625.","journal-title":"Cell Death Dis"},{"key":"2165_CR45","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.3892\/or.2013.2299","volume":"29","author":"H Miwa","year":"2013","unstructured":"Miwa H, et al. Leukemia cells demonstrate a different metabolic perturbation provoked by 2-deoxyglucose. Oncol Rep. 2013;29:2053\u20137.","journal-title":"Oncol Rep"},{"key":"2165_CR46","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00280-013-2366-8","volume":"73","author":"EJ Sullivan","year":"2014","unstructured":"Sullivan EJ, Kurtoglu M, Brenneman R, Liu H, Lampidis TJ. Targeting cisplatin-resistant human tumor cells with metabolic inhibitors. Cancer Chemother Pharmacol. 2014;73:417\u201327.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2165_CR47","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cmet.2018.05.005","volume":"28","author":"H Iwamoto","year":"2018","unstructured":"Iwamoto H, et al. Cancer lipid metabolism confers antiangiogenic Drug Resistance. Cell Metab. 2018;28:104\u2013e117105.","journal-title":"Cell Metab"},{"key":"2165_CR48","doi-asserted-by":"crossref","unstructured":"Defenouill\u00e8re Q, et al. The induction of HAD-like phosphatases by multiple signaling pathways confers resistance to the metabolic inhibitor 2-deoxyglucose. Sci Signal. 2019;12(597):eaaw8000.","DOI":"10.1126\/scisignal.aaw8000"},{"key":"2165_CR49","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1038\/s41467-017-01830-8","volume":"8","author":"D Schmid","year":"2017","unstructured":"Schmid D, et al. T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity. Nat Commun. 2017;8:1747.","journal-title":"Nat Commun"},{"key":"2165_CR50","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1158\/0008-5472.CAN-18-0306","volume":"78","author":"F Zhang","year":"2018","unstructured":"Zhang F, et al. Nanoparticles that reshape the Tumor Milieu create a therapeutic window for effective T-cell therapy in solid malignancies. Cancer Res. 2018;78:3718\u201330.","journal-title":"Cancer Res"},{"key":"2165_CR51","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1021\/acsami.9b23084","volume":"12","author":"K Tu","year":"2020","unstructured":"Tu K, et al. Reshaping Tumor Immune Microenvironment through Acidity-Responsive nanoparticles featured with CRISPR\/Cas9-Mediated programmed death-ligand 1 attenuation and Chemotherapeutics-Induced Immunogenic Cell Death. ACS Appl Mater Interfaces. 2020;12:16018\u201330.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2165_CR52","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000217529","volume":"8","author":"A Hennipman","year":"1987","unstructured":"Hennipman A, et al. Glycolytic enzymes in breast cancer, benign breast disease and normal breast tissue. Tumour Biol. 1987;8:251\u201363.","journal-title":"Tumour Biol"},{"key":"2165_CR53","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/14728222.2018.1498082","volume":"22","author":"R Bartrons","year":"2018","unstructured":"Bartrons R, et al. The potential utility of PFKFB3 as a therapeutic target. Expert Opin Ther Targets. 2018;22:659\u201374.","journal-title":"Expert Opin Ther Targets"},{"key":"2165_CR54","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3233\/CBM-160143","volume":"18","author":"J Han","year":"2017","unstructured":"Han J, Meng Q, Xi Q, Wang H, Wu G. PFKFB3 was overexpressed in gastric cancer patients and promoted the proliferation and migration of gastric cancer cells. Cancer Biomark. 2017;18:249\u201356.","journal-title":"Cancer Biomark"},{"key":"2165_CR55","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.bbrc.2017.01.031","volume":"483","author":"Y Feng","year":"2017","unstructured":"Feng Y, Wu L. mTOR up-regulation of PFKFB3 is essential for acute myeloid leukemia cell survival. Biochem Biophys Res Commun. 2017;483:897\u2013903.","journal-title":"Biochem Biophys Res Commun"},{"key":"2165_CR56","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41467-018-02950-5","volume":"9","author":"FL Li","year":"2018","unstructured":"Li FL, et al. Acetylation accumulates PFKFB3 in cytoplasm to promote glycolysis and protects cells from cisplatin-induced apoptosis. Nat Commun. 2018;9:508.","journal-title":"Nat Commun"},{"key":"2165_CR57","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/ijc.31868","volume":"144","author":"S Mondal","year":"2019","unstructured":"Mondal S, et al. Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers. Int J Cancer. 2019;144:178\u201389.","journal-title":"Int J Cancer"},{"key":"2165_CR58","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.tem.2012.06.010","volume":"23","author":"W Luo","year":"2012","unstructured":"Luo W, Semenza GL. Emerging roles of PKM2 in cell metabolism and cancer progression. Trends Endocrinol Metab. 2012;23:560\u20136.","journal-title":"Trends Endocrinol Metab"},{"key":"2165_CR59","doi-asserted-by":"publisher","first-page":"e8690","DOI":"10.1097\/MD.0000000000008690","volume":"96","author":"Y Yang","year":"2017","unstructured":"Yang Y, et al. Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer: a meta-analysis. Med (Baltim). 2017;96:e8690.","journal-title":"Med (Baltim)"},{"key":"2165_CR60","doi-asserted-by":"publisher","first-page":"12513","DOI":"10.1073\/pnas.93.22.12513","volume":"93","author":"G K\u00e9ri","year":"1996","unstructured":"K\u00e9ri G, et al. A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity. Proc Natl Acad Sci U S A. 1996;93:12513\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2165_CR61","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.7150\/ijbs.27854","volume":"14","author":"Y Wang","year":"2018","unstructured":"Wang Y, et al. PKM2 inhibitor shikonin overcomes the cisplatin resistance in bladder Cancer by inducing necroptosis. Int J Biol Sci. 2018;14:1883\u201391.","journal-title":"Int J Biol Sci"},{"key":"2165_CR62","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13046-020-01605-y","volume":"39","author":"SP Martin","year":"2020","unstructured":"Martin SP, et al. PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma. J Exp Clin Cancer Res. 2020;39:99.","journal-title":"J Exp Clin Cancer Res"},{"key":"2165_CR63","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tibs.2018.10.011","volume":"44","author":"L Ippolito","year":"2019","unstructured":"Ippolito L, Morandi A, Giannoni E, Chiarugi P. Lactate: a metabolic driver in the Tumour Landscape. Trends Biochem Sci. 2019;44:153\u201366.","journal-title":"Trends Biochem Sci"},{"key":"2165_CR64","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1073\/pnas.0914433107","volume":"107","author":"A Le","year":"2010","unstructured":"Le A, et al. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci U S A. 2010;107:2037\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2165_CR65","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","volume":"109","author":"K Fischer","year":"2007","unstructured":"Fischer K, et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood. 2007;109:3812\u20139.","journal-title":"Blood"},{"key":"2165_CR66","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1476-4598-9-33","volume":"9","author":"M Zhou","year":"2010","unstructured":"Zhou M, et al. Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol. Mol Cancer. 2010;9:33.","journal-title":"Mol Cancer"},{"key":"2165_CR67","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1158\/0008-5472.CAN-11-0127","volume":"71","author":"Y Zhao","year":"2011","unstructured":"Zhao Y, et al. Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism. Cancer Res. 2011;71:4585\u201397.","journal-title":"Cancer Res"},{"key":"2165_CR68","first-page":"963","volume":"11","author":"TW Chung","year":"2019","unstructured":"Chung TW, et al. Machilin A inhibits Tumor Growth and Macrophage M2 polarization through the reduction of Lactic Acid. Cancers\u00a0(Basel). 2019;11:963.","journal-title":"Cancers\u00a0(Basel)"},{"key":"2165_CR69","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41586-020-2475-6","volume":"585","author":"I Mart\u00ednez-Reyes","year":"2020","unstructured":"Mart\u00ednez-Reyes I, et al. Mitochondrial ubiquinol oxidation is necessary for tumour growth. Nature. 2020;585:288\u201392.","journal-title":"Nature"},{"key":"2165_CR70","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1158\/1078-0432.CCR-14-2290","volume":"21","author":"TT Vellinga","year":"2015","unstructured":"Vellinga TT, et al. SIRT1\/PGC1\u03b1-Dependent increase in oxidative phosphorylation supports chemotherapy resistance of Colon cancer. Clin Cancer Res. 2015;21:2870\u20139.","journal-title":"Clin Cancer Res"},{"key":"2165_CR71","doi-asserted-by":"publisher","first-page":"61890","DOI":"10.18632\/oncotarget.11301","volume":"7","author":"L Ippolito","year":"2016","unstructured":"Ippolito L, et al. Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells. Oncotarget. 2016;7:61890\u2013904.","journal-title":"Oncotarget"},{"key":"2165_CR72","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1757-2215-5-19","volume":"5","author":"DK Chan","year":"2012","unstructured":"Chan DK, Miskimins WK. Metformin and phenethyl isothiocyanate combined treatment in vitro is cytotoxic to ovarian cancer cultures. J Ovarian Res. 2012;5:19.","journal-title":"J Ovarian Res"},{"key":"2165_CR73","first-page":"867","volume":"13","author":"A Ferretti","year":"1993","unstructured":"Ferretti A, et al. Pentose phosphate pathway alterations in multi-drug resistant leukemic T-cells: 31P NMR and enzymatic studies. Anticancer Res. 1993;13:867\u201372.","journal-title":"Anticancer Res"},{"key":"2165_CR74","doi-asserted-by":"publisher","first-page":"10086","DOI":"10.1158\/0008-5472.CAN-08-0360","volume":"68","author":"CV Recktenwald","year":"2008","unstructured":"Recktenwald CV, Kellner R, Lichtenfels R, Seliger B. Altered detoxification status and increased resistance to oxidative stress by K-ras transformation. Cancer Res. 2008;68:10086\u201393.","journal-title":"Cancer Res"},{"key":"2165_CR75","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4062\/biomolther.2017.179","volume":"26","author":"ES Cho","year":"2018","unstructured":"Cho ES, Cha YH, Kim HS, Kim NH, Yook JI. The Pentose Phosphate Pathway as a potential target for Cancer Therapy. Biomol Ther (Seoul). 2018;26:29\u201338.","journal-title":"Biomol Ther (Seoul)"},{"key":"2165_CR76","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1186\/s12885-018-4757-z","volume":"18","author":"S Hultsch","year":"2018","unstructured":"Hultsch S, et al. Association of tamoxifen resistance and lipid reprogramming in breast cancer. BMC Cancer. 2018;18:850.","journal-title":"BMC Cancer"},{"key":"2165_CR77","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41586-019-0904-1","volume":"566","author":"K Vriens","year":"2019","unstructured":"Vriens K, et al. Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity. Nature. 2019;566:403\u20136.","journal-title":"Nature"},{"key":"2165_CR78","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1194\/jlr.M600177-JLR200","volume":"47","author":"Y Wang","year":"2006","unstructured":"Wang Y, et al. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J Lipid Res. 2006;47:2028\u201341.","journal-title":"J Lipid Res"},{"key":"2165_CR79","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/MCO.0b013e328342991c","volume":"14","author":"DB Jump","year":"2011","unstructured":"Jump DB. Fatty acid regulation of hepatic lipid metabolism. Curr Opin Clin Nutr Metab Care. 2011;14:115\u201320.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2165_CR80","doi-asserted-by":"publisher","first-page":"8547","DOI":"10.1158\/0008-5472.CAN-08-1235","volume":"68","author":"T Migita","year":"2008","unstructured":"Migita T, et al. ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer. Cancer Res. 2008;68:8547\u201354.","journal-title":"Cancer Res"},{"key":"2165_CR81","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1158\/0008-5472.CAN-05-1489","volume":"66","author":"V Chaj\u00e8s","year":"2006","unstructured":"Chaj\u00e8s V, Cambot M, Moreau K, Lenoir GM, Joulin V. Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival. Cancer Res. 2006;66:5287\u201394.","journal-title":"Cancer Res"},{"key":"2165_CR82","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00109-019-01863-0","volume":"98","author":"AD Khwairakpam","year":"2020","unstructured":"Khwairakpam AD, et al. The vital role of ATP citrate lyase in chronic diseases. J Mol Med (Berl). 2020;98:71\u201395.","journal-title":"J Mol Med (Berl)"},{"key":"2165_CR83","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ccr.2005.09.008","volume":"8","author":"G Hatzivassiliou","year":"2005","unstructured":"Hatzivassiliou G, et al. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell. 2005;8:311\u201321.","journal-title":"Cancer Cell"},{"key":"2165_CR84","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s43018-021-00183-y","volume":"2","author":"GB Ferraro","year":"2021","unstructured":"Ferraro GB, et al. FATTY ACID SYNTHESIS IS REQUIRED FOR BREAST CANCER BRAIN METASTASIS. Nat Cancer. 2021;2:414\u201328.","journal-title":"Nat Cancer"},{"key":"2165_CR85","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cmet.2017.11.001","volume":"27","author":"T Wang","year":"2018","unstructured":"Wang T, et al. JAK\/STAT3-Regulated fatty acid \u03b2-Oxidation is critical for breast Cancer Stem Cell Self-Renewal and Chemoresistance. Cell Metab. 2018;27:136\u2013e150135.","journal-title":"Cell Metab"},{"key":"2165_CR86","doi-asserted-by":"publisher","first-page":"31522","DOI":"10.18632\/oncotarget.5159","volume":"6","author":"ZQ Wang","year":"2015","unstructured":"Wang ZQ, et al. BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism. Oncotarget. 2015;6:31522\u201343.","journal-title":"Oncotarget"},{"key":"2165_CR87","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.cmet.2018.12.020","volume":"29","author":"RE Ericksen","year":"2019","unstructured":"Ericksen RE, et al. Loss of BCAA catabolism during carcinogenesis enhances mTORC1 activity and promotes Tumor Development and Progression. Cell Metab. 2019;29:1151\u2013e11651156.","journal-title":"Cell Metab"},{"key":"2165_CR88","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1158\/0008-5472.CAN-19-1023","volume":"80","author":"YY Qu","year":"2020","unstructured":"Qu YY, et al. Inactivation of the AMPK-GATA3-ECHS1 pathway induces fatty acid synthesis that promotes clear cell renal cell Carcinoma Growth. Cancer Res. 2020;80:319\u201333.","journal-title":"Cancer Res"},{"key":"2165_CR89","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.bbrc.2017.02.101","volume":"486","author":"L Zhang","year":"2017","unstructured":"Zhang L, Han J. Branched-chain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTOR-mediated mitochondrial biogenesis and function. Biochem Biophys Res Commun. 2017;486:224\u201331.","journal-title":"Biochem Biophys Res Commun"},{"key":"2165_CR90","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1042\/BCJ20190754","volume":"477","author":"SB Martin","year":"2020","unstructured":"Martin SB, et al. Leucine and branched-chain amino acid metabolism contribute to the growth of bone sarcomas by regulating AMPK and mTORC1 signaling. Biochem J. 2020;477:1579\u201399.","journal-title":"Biochem J"},{"key":"2165_CR91","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cca.2015.05.008","volume":"447","author":"F Cheng","year":"2015","unstructured":"Cheng F, Wang Z, Huang Y, Duan Y, Wang X. Investigation of salivary free amino acid profile for early diagnosis of breast cancer with ultra performance liquid chromatography-mass spectrometry. Clin Chim Acta. 2015;447:23\u201331.","journal-title":"Clin Chim Acta"},{"key":"2165_CR92","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1172\/JCI69600","volume":"123","author":"CT Hensley","year":"2013","unstructured":"Hensley CT, Wasti AT, DeBerardinis RJ. Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest. 2013;123:3678\u201384.","journal-title":"J Clin Invest"},{"key":"2165_CR93","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev-bioeng-071516-044546","volume":"19","author":"L Yang","year":"2017","unstructured":"Yang L, Venneti S, Nagrath D, Glutaminolysis. A Hallmark of Cancer Metabolism. Annu Rev Biomed Eng. 2017;19:163\u201394.","journal-title":"Annu Rev Biomed Eng"},{"key":"2165_CR94","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1530\/ERC-12-0398","volume":"20","author":"S Kim","year":"2013","unstructured":"Kim S, Kim DH, Jung WH, Koo JS. Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer. Endocrine-related Cancer. 2013;20:339\u201348.","journal-title":"Endocrine-related Cancer"},{"key":"2165_CR95","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","volume":"35","author":"DR Wise","year":"2010","unstructured":"Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci. 2010;35:427\u201333.","journal-title":"Trends Biochem Sci"},{"key":"2165_CR96","doi-asserted-by":"publisher","first-page":"12156","DOI":"10.1038\/ncomms12156","volume":"7","author":"G Deblois","year":"2016","unstructured":"Deblois G, et al. ERR\u03b1 mediates metabolic adaptations driving lapatinib resistance in breast cancer. Nat Commun. 2016;7:12156.","journal-title":"Nat Commun"},{"key":"2165_CR97","doi-asserted-by":"crossref","unstructured":"Ko PJ, Dixon SJ. Protein palmitoylation and cancer. EMBO Rep. 2018;19(10):e46666.","DOI":"10.15252\/embr.201846666"},{"key":"2165_CR98","doi-asserted-by":"crossref","unstructured":"Ali A, et al. Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancer. EMBO Mol Med. 2018;10(3):e8313.","DOI":"10.15252\/emmm.201708313"},{"key":"2165_CR99","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10555-018-9769-2","volume":"37","author":"PM Herst","year":"2018","unstructured":"Herst PM, Grasso C, Berridge MV. Metabolic reprogramming of mitochondrial respiration in metastatic cancer. Cancer Metastasis Rev. 2018;37:643\u201353.","journal-title":"Cancer Metastasis Rev"},{"key":"2165_CR100","doi-asserted-by":"crossref","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368(6487):eaaw5473.","DOI":"10.1126\/science.aaw5473"},{"key":"2165_CR101","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.canlet.2016.05.004","volume":"378","author":"J Wang","year":"2016","unstructured":"Wang J, et al. Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes. Cancer Lett. 2016;378:69\u201379.","journal-title":"Cancer Lett"},{"key":"2165_CR102","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11060-013-1232-1","volume":"115","author":"M Wang","year":"2013","unstructured":"Wang M, Maier P, Wenz F, Giordano FA, Herskind C. Mitogenic signalling in the absence of epidermal growth factor receptor activation in a human glioblastoma cell line. J Neurooncol. 2013;115:323\u201331.","journal-title":"J Neurooncol"},{"key":"2165_CR103","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-1-4939-1789-1_10","volume":"1233","author":"HM Itkonen","year":"2015","unstructured":"Itkonen HM, Mills IG. Studying N-linked glycosylation of receptor tyrosine kinases. Methods Mol Biol. 2015;1233:103\u20139.","journal-title":"Methods Mol Biol"},{"key":"2165_CR104","doi-asserted-by":"crossref","unstructured":"Chiaradonna F, Ricciardiello F, Palorini R. The nutrient-sensing hexosamine Biosynthetic Pathway as the hub of Cancer metabolic rewiring. Cells. 2018;7(6):53.","DOI":"10.3390\/cells7060053"},{"key":"2165_CR105","doi-asserted-by":"publisher","first-page":"10823","DOI":"10.1158\/0008-5472.CAN-07-0783","volume":"67","author":"C Xia","year":"2007","unstructured":"Xia C, et al. Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res. 2007;67:10823\u201330.","journal-title":"Cancer Res"},{"key":"2165_CR106","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.canlet.2008.02.028","volume":"266","author":"A Galanis","year":"2008","unstructured":"Galanis A, et al. Reactive oxygen species and HIF-1 signalling in cancer. Cancer Lett. 2008;266:12\u201320.","journal-title":"Cancer Lett"},{"key":"2165_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2018.11.001","volume":"41","author":"Q Cui","year":"2018","unstructured":"Cui Q, et al. Modulating ROS to overcome multidrug resistance in cancer. Drug Resist Updat. 2018;41:1\u201325.","journal-title":"Drug Resist Updat"},{"key":"2165_CR108","doi-asserted-by":"publisher","first-page":"103334","DOI":"10.1016\/j.critrevonc.2021.103334","volume":"162","author":"SR Vitale","year":"2021","unstructured":"Vitale SR, et al. PI3K inhibition in breast cancer: identifying and overcoming different flavors of resistance. Crit Rev Oncol Hematol. 2021;162:103334.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2165_CR109","doi-asserted-by":"crossref","unstructured":"Shin MH, Kim J, Lim SA, Kim J, Lee KM. Current insights into combination therapies with MAPK inhibitors and Immune Checkpoint Blockade. Int J Mol Sci. 2020;21(7):2531.","DOI":"10.3390\/ijms21072531"},{"key":"2165_CR110","doi-asserted-by":"publisher","first-page":"544288","DOI":"10.3389\/fonc.2020.544288","volume":"10","author":"W Guo","year":"2020","unstructured":"Guo W, et al. Pyruvate kinase M2 promotes prostate Cancer Metastasis through regulating ERK1\/2-COX-2 signaling. Front Oncol. 2020;10:544288.","journal-title":"Front Oncol"},{"key":"2165_CR111","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1158\/1535-7163.MCT-14-0330","volume":"13","author":"E Rozengurt","year":"2014","unstructured":"Rozengurt E, Soares HP, Sinnet-Smith J. Suppression of feedback loops mediated by PI3K\/mTOR induces multiple overactivation of compensatory pathways: an unintended consequence leading to drug resistance. Mol Cancer Ther. 2014;13:2477\u201388.","journal-title":"Mol Cancer Ther"},{"key":"2165_CR112","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.copbio.2014.11.012","volume":"34","author":"A Carrer","year":"2015","unstructured":"Carrer A, Wellen KE. Metabolism and epigenetics: a link cancer cells exploit. Curr Opin Biotechnol. 2015;34:23\u20139.","journal-title":"Curr Opin Biotechnol"},{"key":"2165_CR113","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.celrep.2016.12.055","volume":"18","author":"V Bulusu","year":"2017","unstructured":"Bulusu V, et al. Acetate recapturing by nuclear Acetyl-CoA synthetase 2 prevents loss of histone acetylation during oxygen and serum limitation. Cell Rep. 2017;18:647\u201358.","journal-title":"Cell Rep"},{"key":"2165_CR114","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-1-4939-9027-6_9","volume":"1928","author":"S Sidoli","year":"2019","unstructured":"Sidoli S, Trefely S, Garcia BA, Carrer A. Integrated Analysis of Acetyl-CoA and Histone Modification via Mass Spectrometry to Investigate Metabolically Driven Acetylation. Methods Mol Biol. 2019;1928:125\u201347.","journal-title":"Methods Mol Biol"},{"key":"2165_CR115","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.molcel.2020.03.004","volume":"78","author":"SA Haws","year":"2020","unstructured":"Haws SA, et al. Methyl-metabolite depletion elicits adaptive responses to support heterochromatin Stability and Epigenetic Persistence. Mol Cell. 2020;78:210\u2013e223218.","journal-title":"Mol Cell"},{"key":"2165_CR116","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1182\/blood-2019-131020","volume":"134","author":"JH Chung","year":"2019","unstructured":"Chung JH, et al. PRMT5 is a Key Epigenetic Regulator that promotes transcriptional activation in Mantle Cell Lymphoma by regulating the lysine methyltransferase SETD7 and MLL1 activity. Blood. 2019;134:2777\u20132777.","journal-title":"Blood"},{"key":"2165_CR117","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.tig.2020.12.005","volume":"37","author":"F Mattiroli","year":"2021","unstructured":"Mattiroli F, Penengo L. Histone ubiquitination: an Integrative Signaling Platform in Genome Stability. Trends Genet. 2021;37:566\u201381.","journal-title":"Trends Genet"},{"key":"2165_CR118","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1146\/annurev.biochem.75.103004.142422","volume":"75","author":"A Shilatifard","year":"2006","unstructured":"Shilatifard A. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu Rev Biochem. 2006;75:243\u201369.","journal-title":"Annu Rev Biochem"},{"key":"2165_CR119","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1111\/j.1742-4658.2011.08281.x","volume":"278","author":"A Flaus","year":"2011","unstructured":"Flaus A, Owen-Hughes T. Mechanisms for ATP-dependent chromatin remodelling: the means to the end. Febs j. 2011;278:3579\u201395.","journal-title":"Febs j"},{"key":"2165_CR120","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0968-0004(02)00005-1","volume":"28","author":"JM Denu","year":"2003","unstructured":"Denu JM. Linking chromatin function with metabolic networks: Sir2 family of NAD(+)-dependent deacetylases. Trends Biochem Sci. 2003;28:41\u20138.","journal-title":"Trends Biochem Sci"},{"key":"2165_CR121","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1016\/j.celrep.2016.05.050","volume":"15","author":"H Luo","year":"2016","unstructured":"Luo H, et al. MOF acetylates the histone demethylase LSD1 to suppress epithelial-to-mesenchymal transition. Cell Rep. 2016;15:2665\u201378.","journal-title":"Cell Rep"},{"key":"2165_CR122","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.semcancer.2020.12.004","volume":"82","author":"OA Sukocheva","year":"2022","unstructured":"Sukocheva OA, et al. The crucial role of epigenetic regulation in breast cancer anti-estrogen resistance: current findings and future perspectives. Semin Cancer Biol. 2022;82:35\u201359.","journal-title":"Semin Cancer Biol"},{"key":"2165_CR123","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s10549-011-1480-8","volume":"131","author":"Y Huang","year":"2012","unstructured":"Huang Y, Vasilatos SN, Boric L, Shaw PG, Davidson NE. Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells. Breast Cancer Res Treat. 2012;131:777\u201389.","journal-title":"Breast Cancer Res Treat"},{"key":"2165_CR124","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1101\/gad.13.18.2339","volume":"13","author":"RE Kingston","year":"1999","unstructured":"Kingston RE, Narlikar GJ. ATP-dependent remodeling and acetylation as regulators of chromatin fluidity. Genes Dev. 1999;13:2339\u201352.","journal-title":"Genes Dev"},{"key":"2165_CR125","doi-asserted-by":"publisher","first-page":"100973","DOI":"10.1016\/j.molmet.2020.100973","volume":"38","author":"AJ Morrison","year":"2020","unstructured":"Morrison AJ. Chromatin-remodeling links metabolic signaling to gene expression. Mol Metab. 2020;38:100973.","journal-title":"Mol Metab"},{"key":"2165_CR126","first-page":"637","volume":"33","author":"S Emanuele","year":"2008","unstructured":"Emanuele S, Lauricella M, Tesoriere G. Histone deacetylase inhibitors: apoptotic effects and clinical implications (review). Int J Oncol. 2008;33:637\u201346.","journal-title":"Int J Oncol"},{"key":"2165_CR127","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1517\/14712598.2013.819337","volume":"13","author":"FP Vendetti","year":"2013","unstructured":"Vendetti FP, Rudin CM. Epigenetic therapy in non-small-cell lung cancer: targeting DNA methyltransferases and histone deacetylases. Expert Opin Biol Ther. 2013;13:1273\u201385.","journal-title":"Expert Opin Biol Ther"},{"key":"2165_CR128","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.bcp.2011.11.010","volume":"83","author":"P Perego","year":"2012","unstructured":"Perego P, Zuco V, Gatti L, Zunino F. Sensitization of tumor cells by targeting histone deacetylases. Biochem Pharmacol. 2012;83:987\u201394.","journal-title":"Biochem Pharmacol"},{"key":"2165_CR129","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature12626","volume":"501","author":"MR Junttila","year":"2013","unstructured":"Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013;501:346\u201354.","journal-title":"Nature"},{"key":"2165_CR130","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrd3870","volume":"12","author":"DW McMillin","year":"2013","unstructured":"McMillin DW, Negri JM, Mitsiades CS. The role of tumour-stromal interactions in modifying drug response: challenges and opportunities. Nat Rev Drug Discov. 2013;12:217\u201328.","journal-title":"Nat Rev Drug Discov"},{"key":"2165_CR131","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1002\/ijc.29945","volume":"138","author":"L Andzinski","year":"2016","unstructured":"Andzinski L, et al. Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human. Int J Cancer. 2016;138:1982\u201393.","journal-title":"Int J Cancer"},{"key":"2165_CR132","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2016.01.043","volume":"387","author":"T Wu","year":"2017","unstructured":"Wu T, Dai Y. Tumor microenvironment and therapeutic response. Cancer Lett. 2017;387:61\u20138.","journal-title":"Cancer Lett"},{"key":"2165_CR133","doi-asserted-by":"publisher","first-page":"e1373237","DOI":"10.1080\/2162402X.2017.1373237","volume":"6","author":"C Vanpouille-Box","year":"2017","unstructured":"Vanpouille-Box C, et al. Trial watch: Immune checkpoint blockers for cancer therapy. Oncoimmunology. 2017;6:e1373237.","journal-title":"Oncoimmunology"},{"key":"2165_CR134","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1056\/NEJMoa1917346","volume":"383","author":"RS Herbst","year":"2020","unstructured":"Herbst RS, et al. Atezolizumab for First-Line treatment of PD-L1-Selected patients with NSCLC. N Engl J Med. 2020;383:1328\u201339.","journal-title":"N Engl J Med"},{"key":"2165_CR135","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1038\/s41388-021-01846-x","volume":"40","author":"A Lequeux","year":"2021","unstructured":"Lequeux A, et al. Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy. Oncogene. 2021;40:4725\u201335.","journal-title":"Oncogene"},{"key":"2165_CR136","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41571-019-0203-7","volume":"16","author":"X Li","year":"2019","unstructured":"Li X, et al. Navigating metabolic pathways to enhance antitumour immunity and immunotherapy. Nat Rev Clin Oncol. 2019;16:425\u201341.","journal-title":"Nat Rev Clin Oncol"},{"key":"2165_CR137","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","volume":"7","author":"RJ DeBerardinis","year":"2008","unstructured":"DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7:11\u201320.","journal-title":"Cell Metab"},{"key":"2165_CR138","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: from T cell basic science to clinical practice. Nat Rev Immunol. 2020;20:651\u201368.","journal-title":"Nat Rev Immunol"},{"key":"2165_CR139","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1146\/annurev-immunol-042617-053019","volume":"36","author":"RIK Geltink","year":"2018","unstructured":"Geltink RIK, Kyle RL, Pearce EL. Unraveling the Complex Interplay between T Cell metabolism and function. Annu Rev Immunol. 2018;36:461\u201388.","journal-title":"Annu Rev Immunol"},{"key":"2165_CR140","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41577-019-0203-y","volume":"20","author":"NM Chapman","year":"2020","unstructured":"Chapman NM, Boothby MR, Chi H. Metabolic coordination of T cell quiescence and activation. Nat Rev Immunol. 2020;20:55\u201370.","journal-title":"Nat Rev Immunol"},{"key":"2165_CR141","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/2049-3002-1-5","volume":"1","author":"AN Macintyre","year":"2013","unstructured":"Macintyre AN, Rathmell JC. Activated lymphocytes as a metabolic model for carcinogenesis. Cancer Metab. 2013;1:5.","journal-title":"Cancer Metab"},{"key":"2165_CR142","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1084\/jem.20151159","volume":"212","author":"MD Buck","year":"2015","unstructured":"Buck MD, O\u2019Sullivan D, Pearce EL. T cell metabolism drives immunity. J Exp Med. 2015;212:1345\u201360.","journal-title":"J Exp Med"},{"key":"2165_CR143","doi-asserted-by":"publisher","first-page":"1242454","DOI":"10.1126\/science.1242454","volume":"342","author":"EL Pearce","year":"2013","unstructured":"Pearce EL, Poffenberger MC, Chang CH, Jones RG. Fueling immunity: insights into metabolism and lymphocyte function. Science. 2013;342:1242454.","journal-title":"Science"},{"key":"2165_CR144","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.immuni.2014.06.005","volume":"41","author":"D O\u2019Sullivan","year":"2014","unstructured":"O\u2019Sullivan D, et al. Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. Immunity. 2014;41:75\u201388.","journal-title":"Immunity"},{"key":"2165_CR145","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1158\/2159-8274.CD-10-0028","volume":"1","author":"DG DeNardo","year":"2011","unstructured":"DeNardo DG, et al. Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov. 2011;1:54\u201367.","journal-title":"Cancer Discov"},{"key":"2165_CR146","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1186\/bcr2234","volume":"11","author":"A Rody","year":"2009","unstructured":"Rody A, et al. T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers. Breast Cancer Res. 2009;11:R15.","journal-title":"Breast Cancer Res"},{"key":"2165_CR147","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.cmet.2023.06.003","volume":"35","author":"W Zou","year":"2023","unstructured":"Zou W, Green DR. Beggars banquet: metabolism in the tumor immune microenvironment and cancer therapy. Cell Metab. 2023;35:1101\u201313.","journal-title":"Cell Metab"},{"key":"2165_CR148","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1600-065X.2012.01152.x","volume":"249","author":"AT Waickman","year":"2012","unstructured":"Waickman AT, Powell JD. mTOR, metabolism, and the regulation of T-cell differentiation and function. Immunol Rev. 2012;249:43\u201358.","journal-title":"Immunol Rev"},{"key":"2165_CR149","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S1074-7613(02)00323-0","volume":"16","author":"KA Frauwirth","year":"2002","unstructured":"Frauwirth KA, et al. The CD28 signaling pathway regulates glucose metabolism. Immunity. 2002;16:769\u201377.","journal-title":"Immunity"},{"key":"2165_CR150","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","volume":"2","author":"B Huang","year":"2020","unstructured":"Huang B, Song BL, Xu C. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities. Nat Metab. 2020;2:132\u201341.","journal-title":"Nat Metab"},{"key":"2165_CR151","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ajps.2020.02.005","volume":"15","author":"M Scalise","year":"2020","unstructured":"Scalise M, Pochini L, Galluccio M, Console L, Indiveri C. Glutamine transporters as pharmacological targets: from function to drug design. Asian J Pharm Sci. 2020;15:207\u201319.","journal-title":"Asian J Pharm Sci"},{"key":"2165_CR152","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.cell.2015.08.012","volume":"162","author":"PC Ho","year":"2015","unstructured":"Ho PC, et al. Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses. Cell. 2015;162:1217\u201328.","journal-title":"Cell"},{"key":"2165_CR153","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1186\/1471-2407-10-604","volume":"10","author":"AE Teschendorff","year":"2010","unstructured":"Teschendorff AE, et al. Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules. BMC Cancer. 2010;10:604.","journal-title":"BMC Cancer"},{"key":"2165_CR154","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1073\/pnas.1108781108","volume":"109","author":"VN Kristensen","year":"2012","unstructured":"Kristensen VN, et al. Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling. Proc Natl Acad Sci U S A. 2012;109:2802\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2165_CR155","doi-asserted-by":"publisher","first-page":"5656","DOI":"10.4049\/jimmunol.1100463","volume":"186","author":"PB Olkhanud","year":"2011","unstructured":"Olkhanud PB, et al. Thymic stromal lymphopoietin is a key mediator of breast cancer progression. J Immunol. 2011;186:5656\u201362.","journal-title":"J Immunol"},{"key":"2165_CR156","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1084\/jem.20102131","volume":"208","author":"A Pedroza-Gonzalez","year":"2011","unstructured":"Pedroza-Gonzalez A, et al. Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation. J Exp Med. 2011;208:479\u201390.","journal-title":"J Exp Med"},{"key":"2165_CR157","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.coi.2010.01.009","volume":"22","author":"A Mantovani","year":"2010","unstructured":"Mantovani A, Sica A. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol. 2010;22:231\u20137.","journal-title":"Curr Opin Immunol"},{"key":"2165_CR158","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccr.2009.06.018","volume":"16","author":"DG DeNardo","year":"2009","unstructured":"DeNardo DG, et al. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell. 2009;16:91\u2013102.","journal-title":"Cancer Cell"},{"key":"2165_CR159","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/intimm\/dxu079","volume":"27","author":"O Yoshie","year":"2015","unstructured":"Yoshie O, Matsushima K. CCR4 and its ligands: from bench to bedside. Int Immunol. 2015;27:11\u201320.","journal-title":"Int Immunol"},{"key":"2165_CR160","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1182\/blood-2003-09-3302","volume":"103","author":"L Cosmi","year":"2004","unstructured":"Cosmi L, et al. Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25\u2009+\u2009regulatory thymocytes because of their responsiveness to different cytokines. Blood. 2004;103:3117\u201321.","journal-title":"Blood"},{"key":"2165_CR161","doi-asserted-by":"publisher","first-page":"5996","DOI":"10.1158\/0008-5472.CAN-08-4619","volume":"69","author":"PB Olkhanud","year":"2009","unstructured":"Olkhanud PB, et al. Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells. Cancer Res. 2009;69:5996\u20136004.","journal-title":"Cancer Res"},{"key":"2165_CR162","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI31202","volume":"117","author":"TJ Curiel","year":"2007","unstructured":"Curiel TJ. Tregs and rethinking cancer immunotherapy. J Clin Invest. 2007;117:1167\u201374.","journal-title":"J Clin Invest"},{"key":"2165_CR163","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.4049\/jimmunol.172.6.3391","volume":"172","author":"B Martin","year":"2004","unstructured":"Martin B, et al. Suppression of CD4\u2009+\u2009T lymphocyte effector functions by CD4\u2009+\u2009CD25\u2009+\u2009cells in vivo. J Immunol. 2004;172:3391\u20138.","journal-title":"J Immunol"},{"key":"2165_CR164","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1158\/0008-5472.CAN-10-4316","volume":"71","author":"PB Olkhanud","year":"2011","unstructured":"Olkhanud PB, et al. Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4\u207a T cells to T-regulatory cells. Cancer Res. 2011;71:3505\u201315.","journal-title":"Cancer Res"},{"key":"2165_CR165","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.1200\/JCO.2006.05.9584","volume":"24","author":"GJ Bates","year":"2006","unstructured":"Bates GJ, et al. Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol. 2006;24:5373\u201380.","journal-title":"J Clin Oncol"},{"key":"2165_CR166","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel TJ, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004;10:942\u20139.","journal-title":"Nat Med"},{"key":"2165_CR167","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.it.2014.08.003","volume":"36","author":"H Zeng","year":"2015","unstructured":"Zeng H, Chi H. Metabolic control of regulatory T cell development and function. Trends Immunol. 2015;36:3\u201312.","journal-title":"Trends Immunol"},{"key":"2165_CR168","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/ni.3577","volume":"17","author":"VA Gerriets","year":"2016","unstructured":"Gerriets VA, et al. Foxp3 and toll-like receptor signaling balance T(reg) cell anabolic metabolism for suppression. Nat Immunol. 2016;17:1459\u201366.","journal-title":"Nat Immunol"},{"key":"2165_CR169","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/imm.13058","volume":"157","author":"MA Moreno Ayala","year":"2019","unstructured":"Moreno Ayala MA, Li Z, DuPage M. Treg programming and therapeutic reprogramming in cancer. Immunology. 2019;157:198\u2013209.","journal-title":"Immunology"},{"key":"2165_CR170","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41586-021-03235-6","volume":"591","author":"SA Lim","year":"2021","unstructured":"Lim SA, et al. Lipid signalling enforces functional specialization of T(reg) cells in tumours. Nature. 2021;591:306\u201311.","journal-title":"Nature"},{"key":"2165_CR171","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1158\/0008-5472.CAN-19-1577","volume":"80","author":"Y Long","year":"2020","unstructured":"Long Y, et al. Dysregulation of Glutamate Transport Enhances Treg function that promotes VEGF blockade resistance in Glioblastoma. Cancer Res. 2020;80:499\u2013509.","journal-title":"Cancer Res"},{"key":"2165_CR172","doi-asserted-by":"crossref","unstructured":"Lowe MM, et al. Regulatory T cells use arginase 2 to enhance their metabolic fitness in tissues. JCI Insight. 2019;4(24):e129756.","DOI":"10.1172\/jci.insight.129756"},{"key":"2165_CR173","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1158\/1078-0432.CCR-06-1726","volume":"13","author":"J Kurai","year":"2007","unstructured":"Kurai J, et al. Antibody-dependent cellular cytotoxicity mediated by cetuximab against lung cancer cell lines. Clin Cancer Res. 2007;13:1552\u201361.","journal-title":"Clin Cancer Res"},{"key":"2165_CR174","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/nri2832","volume":"10","author":"SA van de Pavert","year":"2010","unstructured":"van de Pavert SA, Mebius RE. New insights into the development of lymphoid tissues. Nat Rev Immunol. 2010;10:664\u201374.","journal-title":"Nat Rev Immunol"},{"key":"2165_CR175","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","volume":"577","author":"R Cabrita","year":"2020","unstructured":"Cabrita R, et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature. 2020;577:561\u20135.","journal-title":"Nature"},{"key":"2165_CR176","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","volume":"19","author":"WH Fridman","year":"2022","unstructured":"Fridman WH, et al. B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome. Nat Rev Clin Oncol. 2022;19:441\u201357.","journal-title":"Nat Rev Clin Oncol"},{"key":"2165_CR177","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","volume":"577","author":"BA Helmink","year":"2020","unstructured":"Helmink BA, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549\u201355.","journal-title":"Nature"},{"key":"2165_CR178","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","volume":"577","author":"F Petitprez","year":"2020","unstructured":"Petitprez F, et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature. 2020;577:556\u201360.","journal-title":"Nature"},{"issue":"151","key":"2165_CR179","first-page":"130","volume":"204","author":"AJ Marshall","year":"2020","unstructured":"Marshall AJ et al. PI3K-dependent reprogramming of hexokinase isoforms regulates B lymphocyte metabolism. J Immunol 204, 151.130-151.130 (2020).","journal-title":"J Immunol"},{"key":"2165_CR180","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/10409238.2016.1215288","volume":"51","author":"J Jellusova","year":"2016","unstructured":"Jellusova J, Rickert RC. The PI3K pathway in B cell metabolism. Crit Rev Biochem Mol Biol. 2016;51:359\u201378.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"2165_CR181","doi-asserted-by":"publisher","first-page":"7011","DOI":"10.1074\/jbc.M114.551051","volume":"289","author":"FJ Dufort","year":"2014","unstructured":"Dufort FJ, et al. Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation. J Biol Chem. 2014;289:7011\u201324.","journal-title":"J Biol Chem"},{"key":"2165_CR182","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cmet.2011.12.009","volume":"15","author":"A Le","year":"2012","unstructured":"Le A, et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 2012;15:110\u201321.","journal-title":"Cell Metab"},{"key":"2165_CR183","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"2165_CR184","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"I Vitale","year":"2019","unstructured":"Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Macrophages and metabolism in the Tumor Microenvironment. Cell Metab. 2019;30:36\u201350.","journal-title":"Cell Metab"},{"key":"2165_CR185","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","volume":"26","author":"Y Chen","year":"2019","unstructured":"Chen Y, et al. Tumor-associated macrophages: an accomplice in solid tumor progression. J Biomed Sci. 2019;26:78.","journal-title":"J Biomed Sci"},{"key":"2165_CR186","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.1252510","volume":"344","author":"RA Franklin","year":"2014","unstructured":"Franklin RA, et al. The cellular and molecular origin of tumor-associated macrophages. Science. 2014;344:921\u20135.","journal-title":"Science"},{"key":"2165_CR187","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ijc.23527","volume":"123","author":"I Shabo","year":"2008","unstructured":"Shabo I, St\u00e5l O, Olsson H, Dor\u00e9 S, Svanvik J. Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival. Int J Cancer. 2008;123:780\u20136.","journal-title":"Int J Cancer"},{"key":"2165_CR188","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s10549-012-2190-6","volume":"135","author":"SD Heys","year":"2012","unstructured":"Heys SD, et al. Characterisation of tumour-infiltrating macrophages: impact on response and survival in patients receiving primary chemotherapy for breast cancer. Breast Cancer Res Treat. 2012;135:539\u201348.","journal-title":"Breast Cancer Res Treat"},{"key":"2165_CR189","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/ni.3704","volume":"18","author":"EL Mills","year":"2017","unstructured":"Mills EL, Kelly B. O\u2019Neill, L.A.J. Mitochondria are the powerhouses of immunity. Nat Immunol. 2017;18:488\u201398.","journal-title":"Nat Immunol"},{"key":"2165_CR190","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-94-024-1170-6_5","volume":"1011","author":"Y Li","year":"2017","unstructured":"Li Y, Wan YY, Zhu B. Immune Cell Metabolism in Tumor Microenvironment. Adv Exp Med Biol. 2017;1011:163\u201396.","journal-title":"Adv Exp Med Biol"},{"key":"2165_CR191","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1080\/15384101.2019.1618125","volume":"18","author":"M Ghashghaeinia","year":"2019","unstructured":"Ghashghaeinia M, K\u00f6berle M, Mrowietz U, Bernhardt I. Proliferating tumor cells mimick glucose metabolism of mature human erythrocytes. Cell Cycle. 2019;18:1316\u201334.","journal-title":"Cell Cycle"},{"key":"2165_CR192","doi-asserted-by":"publisher","first-page":"9332","DOI":"10.7150\/thno.47137","volume":"10","author":"X Dai","year":"2020","unstructured":"Dai X, et al. USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated macrophages in Lung Cancer. Theranostics. 2020;10:9332\u201347.","journal-title":"Theranostics"},{"key":"2165_CR193","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/abbs\/gmaa081","volume":"52","author":"J Qing","year":"2020","unstructured":"Qing J, Zhang Z, Nov\u00e1k P, Zhao G, Yin K. Mitochondrial metabolism in regulating macrophage polarization: an emerging regulator of metabolic inflammatory diseases. Acta Biochim Biophys Sin (Shanghai). 2020;52:917\u201326.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"2165_CR194","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3389\/fimmu.2017.00837","volume":"8","author":"CY Tang","year":"2017","unstructured":"Tang CY, Mauro C. Similarities in the metabolic reprogramming of Immune System and Endothelium. Front Immunol. 2017;8:837.","journal-title":"Front Immunol"},{"key":"2165_CR195","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cell.2016.08.064","volume":"167","author":"EL Mills","year":"2016","unstructured":"Mills EL, et al. Succinate dehydrogenase supports metabolic repurposing of Mitochondria to Drive Inflammatory macrophages. Cell. 2016;167:457\u2013e470413.","journal-title":"Cell"},{"key":"2165_CR196","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11986","volume":"496","author":"GM Tannahill","year":"2013","unstructured":"Tannahill GM, et al. Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1. Nature. 2013;496:238\u201342.","journal-title":"Nature"},{"key":"2165_CR197","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cmet.2012.04.023","volume":"15","author":"A Haschemi","year":"2012","unstructured":"Haschemi A, et al. The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab. 2012;15:813\u201326.","journal-title":"Cell Metab"},{"key":"2165_CR198","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.imlet.2016.05.009","volume":"176","author":"H Suzuki","year":"2016","unstructured":"Suzuki H, et al. Glycolytic pathway affects differentiation of human monocytes to regulatory macrophages. Immunol Lett. 2016;176:18\u201327.","journal-title":"Immunol Lett"},{"key":"2165_CR199","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/febs.14295","volume":"285","author":"M Mazzone","year":"2018","unstructured":"Mazzone M, Menga A, Castegna A. Metabolism and TAM functions-it takes two to tango. Febs j. 2018;285:700\u201316.","journal-title":"Febs j"},{"key":"2165_CR200","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3109\/08830185.2014.969421","volume":"34","author":"L Zhu","year":"2015","unstructured":"Zhu L, Zhao Q, Yang T, Ding W, Zhao Y. Cellular metabolism and macrophage functional polarization. Int Rev Immunol. 2015;34:82\u2013100.","journal-title":"Int Rev Immunol"},{"key":"2165_CR201","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/ni1001-907","volume":"2","author":"C Bogdan","year":"2001","unstructured":"Bogdan C. Nitric oxide and the immune response. Nat Immunol. 2001;2:907\u201316.","journal-title":"Nat Immunol"},{"key":"2165_CR202","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/35014028","volume":"2","author":"W Xu","year":"2000","unstructured":"Xu W, Liu L, Smith GC. Charles l, G. Nitric oxide upregulates expression of DNA-PKcs to protect cells from DNA-damaging anti-tumour agents. Nat Cell Biol. 2000;2:339\u201345.","journal-title":"Nat Cell Biol"},{"key":"2165_CR203","doi-asserted-by":"publisher","first-page":"29914","DOI":"10.1038\/srep29914","volume":"6","author":"R Huber","year":"2016","unstructured":"Huber R, et al. Tumour hypoxia promotes melanoma growth and metastasis via high mobility Group Box-1 and M2-like macrophages. Sci Rep. 2016;6:29914.","journal-title":"Sci Rep"},{"key":"2165_CR204","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cmet.2006.05.011","volume":"4","author":"D Vats","year":"2006","unstructured":"Vats D, et al. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab. 2006;4:13\u201324.","journal-title":"Cell Metab"},{"key":"2165_CR205","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1158\/0008-5472.CAN-19-2994","volume":"80","author":"P Su","year":"2020","unstructured":"Su P, et al. Enhanced lipid Accumulation and Metabolism are required for the differentiation and activation of Tumor-Associated macrophages. Cancer Res. 2020;80:1438\u201350.","journal-title":"Cancer Res"},{"key":"2165_CR206","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.canlet.2015.12.019","volume":"380","author":"JW Ivey","year":"2016","unstructured":"Ivey JW, Bonakdar M, Kanitkar A, Davalos RV, Verbridge SS. Improving cancer therapies by targeting the physical and chemical hallmarks of the tumor microenvironment. Cancer Lett. 2016;380:330\u20139.","journal-title":"Cancer Lett"},{"key":"2165_CR207","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1158\/2326-6066.CIR-19-0261","volume":"8","author":"L Wu","year":"2020","unstructured":"Wu L, et al. RIPK3 orchestrates fatty acid metabolism in Tumor-Associated macrophages and Hepatocarcinogenesis. Cancer Immunol Res. 2020;8:710\u201321.","journal-title":"Cancer Immunol Res"},{"key":"2165_CR208","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","volume":"20","author":"S Jaillon","year":"2020","unstructured":"Jaillon S, et al. Neutrophil diversity and plasticity in tumour progression and therapy. Nat Rev Cancer. 2020;20:485\u2013503.","journal-title":"Nat Rev Cancer"},{"key":"2165_CR209","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41573-019-0054-z","volume":"19","author":"T N\u00e9meth","year":"2020","unstructured":"N\u00e9meth T, Sperandio M, M\u00f3csai A. Neutrophils as emerging therapeutic targets. Nat Rev Drug Discov. 2020;19:253\u201375.","journal-title":"Nat Rev Drug Discov"},{"key":"2165_CR210","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.actbio.2021.07.063","volume":"134","author":"J Ding","year":"2021","unstructured":"Ding J, et al. Sialic acid conjugate-modified liposomes enable tumor homing of epirubicin via neutrophil\/monocyte infiltration for tumor therapy. Acta Biomater. 2021;134:702\u201315.","journal-title":"Acta Biomater"},{"key":"2165_CR211","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fimmu.2013.00048","volume":"4","author":"S Berger-Achituv","year":"2013","unstructured":"Berger-Achituv S, et al. A proposed role for neutrophil extracellular traps in cancer immunoediting. Front Immunol. 2013;4:48.","journal-title":"Front Immunol"},{"key":"2165_CR212","doi-asserted-by":"publisher","first-page":"867516","DOI":"10.3389\/fimmu.2022.867516","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, et al. Neutrophil Extracellular traps (NETs) promote Non-small Cell Lung Cancer Metastasis by suppressing lncRNA MIR503HG to activate the NF-\u03baB\/NLRP3 inflammasome pathway. Front Immunol. 2022;13:867516.","journal-title":"Front Immunol"},{"key":"2165_CR213","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13045-019-0836-0","volume":"13","author":"LY Yang","year":"2020","unstructured":"Yang LY, et al. Increased neutrophil extracellular traps promote metastasis potential of hepatocellular carcinoma via provoking tumorous inflammatory response. J Hematol Oncol. 2020;13:3.","journal-title":"J Hematol Oncol"},{"key":"2165_CR214","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1038\/s41467-023-37515-8","volume":"14","author":"JY Chung","year":"2023","unstructured":"Chung JY, et al. Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma. Nat Commun. 2023;14:1794.","journal-title":"Nat Commun"},{"key":"2165_CR215","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nrc.2016.52","volume":"16","author":"SB Coffelt","year":"2016","unstructured":"Coffelt SB, Wellenstein MD, de Visser KE. Neutrophils in cancer: neutral no more. Nat Rev Cancer. 2016;16:431\u201346.","journal-title":"Nat Rev Cancer"},{"key":"2165_CR216","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.smim.2016.02.003","volume":"28","author":"C Hagerling","year":"2016","unstructured":"Hagerling C, Werb Z, Neutrophils. Critical components in experimental animal models of cancer. Semin Immunol. 2016;28:197\u2013204.","journal-title":"Semin Immunol"},{"key":"2165_CR217","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.arr.2017.03.008","volume":"36","author":"C Jackaman","year":"2017","unstructured":"Jackaman C, et al. Aging and cancer: the role of macrophages and neutrophils. Ageing Res Rev. 2017;36:105\u201316.","journal-title":"Ageing Res Rev"},{"key":"2165_CR218","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.3389\/fimmu.2019.02368","volume":"10","author":"L Ye","year":"2019","unstructured":"Ye L, et al. Tumor-infiltrating Immune cells Act as a marker for prognosis in Colorectal Cancer. Front Immunol. 2019;10:2368.","journal-title":"Front Immunol"},{"key":"2165_CR219","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/imm.12437","volume":"145","author":"O Rodr\u00edguez-Espinosa","year":"2015","unstructured":"Rodr\u00edguez-Espinosa O, Rojas-Espinosa O, Moreno-Altamirano MM, L\u00f3pez-Villegas EO, S\u00e1nchez-Garc\u00eda FJ. Metabolic requirements for neutrophil extracellular traps formation. Immunology. 2015;145:213\u201324.","journal-title":"Immunology"},{"key":"2165_CR220","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1074\/jbc.R115.693903","volume":"291","author":"RM Loftus","year":"2016","unstructured":"Loftus RM, Finlay DK, Immunometabolism. Cellular Metabolism turns Immune Regulator. J Biol Chem. 2016;291:1\u201310.","journal-title":"J Biol Chem"},{"key":"2165_CR221","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1158\/0008-5472.CAN-20-2870","volume":"81","author":"PB Ancey","year":"2021","unstructured":"Ancey PB, et al. GLUT1 expression in Tumor-Associated neutrophils promotes Lung Cancer Growth and Resistance to Radiotherapy. Cancer Res. 2021;81:2345\u201357.","journal-title":"Cancer Res"},{"key":"2165_CR222","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1038\/s41467-018-07505-2","volume":"9","author":"CM Rice","year":"2018","unstructured":"Rice CM, et al. Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression. Nat Commun. 2018;9:5099.","journal-title":"Nat Commun"},{"key":"2165_CR223","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00335-018-9781-4","volume":"29","author":"C Guillerey","year":"2018","unstructured":"Guillerey C. Roles of cytotoxic and helper innate lymphoid cells in cancer. Mamm Genome. 2018;29:777\u201389.","journal-title":"Mamm Genome"},{"key":"2165_CR224","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41577-018-0061-z","volume":"18","author":"L Chiossone","year":"2018","unstructured":"Chiossone L, Dumas PY, Vienne M, Vivier E. Natural killer cells and other innate lymphoid cells in cancer. Nat Rev Immunol. 2018;18:671\u201388.","journal-title":"Nat Rev Immunol"},{"key":"2165_CR225","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","volume":"23","author":"LL Lanier","year":"2005","unstructured":"Lanier LL. NK cell recognition. Annu Rev Immunol. 2005;23:225\u201374.","journal-title":"Annu Rev Immunol"},{"key":"2165_CR226","doi-asserted-by":"publisher","first-page":"6983","DOI":"10.4049\/jimmunol.177.10.6983","volume":"177","author":"O Wald","year":"2006","unstructured":"Wald O, et al. CD4\u2009+\u2009CXCR4highCD69\u2009+\u2009T cells accumulate in lung adenocarcinoma. J Immunol. 2006;177:6983\u201390.","journal-title":"J Immunol"},{"key":"2165_CR227","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1593\/neo.09296","volume":"11","author":"G Sconocchia","year":"2009","unstructured":"Sconocchia G, et al. Defective infiltration of natural killer cells in MICA\/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interaction. Neoplasia. 2009;11:662\u201371.","journal-title":"Neoplasia"},{"key":"2165_CR228","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1172\/JCI45816","volume":"121","author":"E Mamessier","year":"2011","unstructured":"Mamessier E, et al. Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J Clin Invest. 2011;121:3609\u201322.","journal-title":"J Clin Invest"},{"key":"2165_CR229","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41590-020-0728-z","volume":"21","author":"T Bald","year":"2020","unstructured":"Bald T, Krummel MF, Smyth MJ, Barry KC. The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies. Nat Immunol. 2020;21:835\u201347.","journal-title":"Nat Immunol"},{"key":"2165_CR230","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1084\/jem.20181454","volume":"216","author":"I Prager","year":"2019","unstructured":"Prager I, et al. NK cells switch from granzyme B to death receptor-mediated cytotoxicity during serial killing. J Exp Med. 2019;216:2113\u201327.","journal-title":"J Exp Med"},{"key":"2165_CR231","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1038\/s41467-018-04719-2","volume":"9","author":"RM Loftus","year":"2018","unstructured":"Loftus RM, et al. Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice. Nat Commun. 2018;9:2341.","journal-title":"Nat Commun"},{"key":"2165_CR232","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.4049\/jimmunol.1402099","volume":"194","author":"MP Keppel","year":"2015","unstructured":"Keppel MP, Saucier N, Mah AY, Vogel TP, Cooper MA. Activation-specific metabolic requirements for NK Cell IFN-\u03b3 production. J Immunol. 2015;194:1954\u201362.","journal-title":"J Immunol"},{"key":"2165_CR233","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cmet.2018.07.008","volume":"28","author":"B Isaacson","year":"2018","unstructured":"Isaacson B, Mandelboim O. Sweet killers: NK cells need glycolysis to kill tumors. Cell Metab. 2018;28:183\u20134.","journal-title":"Cell Metab"},{"key":"2165_CR234","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1158\/2326-6066.CIR-18-0481","volume":"7","author":"C Harmon","year":"2019","unstructured":"Harmon C, et al. Lactate-mediated acidification of Tumor Microenvironment induces apoptosis of Liver-Resident NK cells in Colorectal Liver Metastasis. Cancer Immunol Res. 2019;7:335\u201346.","journal-title":"Cancer Immunol Res"},{"key":"2165_CR235","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/s41590-018-0251-7","volume":"19","author":"X Michelet","year":"2018","unstructured":"Michelet X, et al. Metabolic reprogramming of natural killer cells in obesity limits antitumor responses. Nat Immunol. 2018;19:1330\u201340.","journal-title":"Nat Immunol"},{"key":"2165_CR236","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/ni.3838","volume":"18","author":"N Assmann","year":"2017","unstructured":"Assmann N, et al. Srebp-controlled glucose metabolism is essential for NK cell functional responses. Nat Immunol. 2017;18:1197\u2013206.","journal-title":"Nat Immunol"},{"key":"2165_CR237","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1038\/s41467-019-10015-4","volume":"10","author":"N Kedia-Mehta","year":"2019","unstructured":"Kedia-Mehta N, Finlay DK. Competition for nutrients and its role in controlling immune responses. Nat Commun. 2019;10:2123.","journal-title":"Nat Commun"},{"key":"2165_CR238","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.cmet.2017.08.012","volume":"26","author":"PM Thwe","year":"2017","unstructured":"Thwe PM, et al. Cell-intrinsic glycogen metabolism supports early glycolytic reprogramming required for dendritic cell Immune responses. Cell Metab. 2017;26:558\u2013e567555.","journal-title":"Cell Metab"},{"key":"2165_CR239","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1182\/blood-2009-10-249540","volume":"115","author":"CM Krawczyk","year":"2010","unstructured":"Krawczyk CM, et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood. 2010;115:4742\u20139.","journal-title":"Blood"},{"key":"2165_CR240","doi-asserted-by":"publisher","first-page":"5174","DOI":"10.4049\/jimmunol.1303316","volume":"194","author":"F Malinarich","year":"2015","unstructured":"Malinarich F, et al. High mitochondrial respiration and glycolytic capacity represent a metabolic phenotype of human tolerogenic dendritic cells. J Immunol. 2015;194:5174\u201386.","journal-title":"J Immunol"},{"key":"2165_CR241","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/intimm\/dxaa020","volume":"32","author":"K Hosomi","year":"2020","unstructured":"Hosomi K, Kunisawa J. Diversity of energy metabolism in immune responses regulated by micro-organisms and dietary nutrition. Int Immunol. 2020;32:447\u201354.","journal-title":"Int Immunol"},{"key":"2165_CR242","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1189\/jlb.5VMR1116-458RRR","volume":"102","author":"JA Chesney","year":"2017","unstructured":"Chesney JA, Mitchell RA, Yaddanapudi K. Myeloid-derived suppressor cells-a new therapeutic target to overcome resistance to cancer immunotherapy. J Leukoc Biol. 2017;102:727\u201340.","journal-title":"J Leukoc Biol"},{"key":"2165_CR243","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1158\/2326-6066.CIR-15-0036","volume":"3","author":"F Hossain","year":"2015","unstructured":"Hossain F, et al. Inhibition of fatty acid oxidation modulates immunosuppressive functions of myeloid-derived suppressor cells and enhances Cancer therapies. Cancer Immunol Res. 2015;3:1236\u201347.","journal-title":"Cancer Immunol Res"},{"key":"2165_CR244","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2018.04.022","volume":"28","author":"W Li","year":"2018","unstructured":"Li W, et al. Aerobic glycolysis controls myeloid-derived suppressor cells and Tumor Immunity via a specific CEBPB isoform in Triple-negative breast Cancer. Cell Metab. 2018;28:87\u2013e103106.","journal-title":"Cell Metab"},{"key":"2165_CR245","doi-asserted-by":"publisher","first-page":"e1344804","DOI":"10.1080\/2162402X.2017.1344804","volume":"6","author":"AA Al-Khami","year":"2017","unstructured":"Al-Khami AA, et al. Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells. Oncoimmunology. 2017;6:e1344804.","journal-title":"Oncoimmunology"},{"key":"2165_CR246","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.canlet.2015.07.044","volume":"380","author":"Y Sun","year":"2016","unstructured":"Sun Y. Tumor microenvironment and cancer therapy resistance. Cancer Lett. 2016;380:205\u201315.","journal-title":"Cancer Lett"},{"key":"2165_CR247","doi-asserted-by":"crossref","unstructured":"Marshall LA, et al. Tumors establish resistance to immunotherapy by regulating T(reg) recruitment via CCR4. J Immunother Cancer. 2020;8(2):e000764.","DOI":"10.1136\/jitc-2020-000764"},{"key":"2165_CR248","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jhep.2021.08.029","volume":"76","author":"Y Gao","year":"2022","unstructured":"Gao Y, et al. Intratumoral stem-like CCR4\u2009+\u2009regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B. J Hepatol. 2022;76:148\u201359.","journal-title":"J Hepatol"},{"key":"2165_CR249","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1158\/1078-0432.CCR-08-0783","volume":"15","author":"A Ribas","year":"2009","unstructured":"Ribas A, et al. Intratumoral immune cell infiltrates, FoxP3, and indoleamine 2,3-dioxygenase in patients with melanoma undergoing CTLA4 blockade. Clin Cancer Res. 2009;15:390\u20139.","journal-title":"Clin Cancer Res"},{"key":"2165_CR250","doi-asserted-by":"publisher","first-page":"656364","DOI":"10.3389\/fimmu.2021.656364","volume":"12","author":"K Khalaf","year":"2021","unstructured":"Khalaf K, et al. Aspects of the Tumor Microenvironment involved in Immune Resistance and Drug Resistance. Front Immunol. 2021;12:656364.","journal-title":"Front Immunol"},{"key":"2165_CR251","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/cas.14230","volume":"111","author":"D Li","year":"2020","unstructured":"Li D, et al. Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K\/Akt\/mTOR in breast cancer. Cancer Sci. 2020;111:47\u201358.","journal-title":"Cancer Sci"},{"key":"2165_CR252","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.4161\/onci.21678","volume":"1","author":"J de Boniface","year":"2012","unstructured":"de Boniface J, Mao Y, Schmidt-Mende J, Kiessling R, Poschke I. Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients. Oncoimmunology. 2012;1:1305\u201312.","journal-title":"Oncoimmunology"},{"key":"2165_CR253","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12943-023-01725-x","volume":"22","author":"H Zhang","year":"2023","unstructured":"Zhang H, et al. Roles of tumor-associated macrophages in anti-PD-1\/PD-L1 immunotherapy for solid cancers. Mol Cancer. 2023;22:58.","journal-title":"Mol Cancer"},{"key":"2165_CR254","doi-asserted-by":"publisher","first-page":"5599660","DOI":"10.1155\/2023\/5599660","volume":"2023","author":"H Zuo","year":"2023","unstructured":"Zuo H, et al. Targeting Neutrophil Extracellular Traps: A Novel Antitumor Strategy. J Immunol Res. 2023;2023:5599660.","journal-title":"J Immunol Res"},{"key":"2165_CR255","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ccell.2023.03.008","volume":"41","author":"A Mousset","year":"2023","unstructured":"Mousset A, et al. Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-\u03b2 activation. Cancer Cell. 2023;41:757\u2013e775710.","journal-title":"Cancer Cell"},{"key":"2165_CR256","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1016\/j.cell.2023.07.034","volume":"186","author":"F Tang","year":"2023","unstructured":"Tang F, et al. A pan-cancer single-cell panorama of human natural killer cells. Cell. 2023;186:4235\u2013e42514220.","journal-title":"Cell"},{"key":"2165_CR257","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2009.08.019","volume":"16","author":"D Chauhan","year":"2009","unstructured":"Chauhan D, et al. Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target. Cancer Cell. 2009;16:309\u201323.","journal-title":"Cancer Cell"},{"key":"2165_CR258","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/7410","volume":"5","author":"CY Wang","year":"1999","unstructured":"Wang CY, Cusack JC Jr., Liu R, Baldwin AS. Jr. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med. 1999;5:412\u20137.","journal-title":"Nat Med"},{"key":"2165_CR259","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","volume":"21","author":"F Veglia","year":"2021","unstructured":"Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol. 2021;21:485\u201398.","journal-title":"Nat Rev Immunol"},{"key":"2165_CR260","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1600-065X.2008.00608.x","volume":"222","author":"PC Rodr\u00edguez","year":"2008","unstructured":"Rodr\u00edguez PC, Ochoa AC. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol Rev. 2008;222:180\u201391.","journal-title":"Immunol Rev"},{"key":"2165_CR261","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.4049\/jimmunol.1500959","volume":"195","author":"C Cimen Bozkus","year":"2015","unstructured":"Cimen Bozkus C, Elzey BD, Crist SA, Ellies LG, Ratliff TL. Expression of Cationic amino acid transporter 2 is required for myeloid-derived suppressor cell-mediated control of T cell immunity. J Immunol. 2015;195:5237\u201350.","journal-title":"J Immunol"},{"key":"2165_CR262","first-page":"796","volume":"19","author":"JP Antonios","year":"2017","unstructured":"Antonios JP, et al. Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1\/PD-L1 mechanism in glioblastoma. Neuro Oncol. 2017;19:796\u2013807.","journal-title":"Neuro Oncol"},{"key":"2165_CR263","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1158\/2326-6066.CIR-13-0016","volume":"1","author":"Y de Pico","year":"2013","unstructured":"de Pico Y, et al. Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid-derived suppressor cells as well as their Arginase1 production. Cancer Immunol Res. 2013;1:158\u201362.","journal-title":"Cancer Immunol Res"},{"key":"2165_CR264","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3389\/fimmu.2019.00348","volume":"10","author":"M Segovia-Mendoza","year":"2019","unstructured":"Segovia-Mendoza M, Morales-Montor J. Immune Tumor Microenvironment in breast Cancer and the participation of Estrogen and its receptors in Cancer Physiopathology. Front Immunol. 2019;10:348.","journal-title":"Front Immunol"},{"key":"2165_CR265","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41419-017-0061-0","volume":"9","author":"MB Schaaf","year":"2018","unstructured":"Schaaf MB, Garg AD, Agostinis P. Defining the role of the tumor vasculature in antitumor immunity and immunotherapy. Cell Death Dis. 2018;9:115.","journal-title":"Cell Death Dis"},{"key":"2165_CR266","doi-asserted-by":"crossref","unstructured":"Li G, Gao J, Ding P, Gao Y. The role of endothelial cell-pericyte interactions in vascularization and diseases. J Adv Res. 2024:S2090-1232(24)00029-8.","DOI":"10.1016\/j.jare.2024.01.016"},{"key":"2165_CR267","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2016.08.054","volume":"167","author":"H Xin","year":"2016","unstructured":"Xin H, Zhong C, Nudleman E, Ferrara N. Evidence for pro-angiogenic functions of VEGF-Ax. Cell. 2016;167:275\u2013e284276.","journal-title":"Cell"},{"key":"2165_CR268","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1023\/A:1026544214667","volume":"19","author":"GL Semenza","year":"2000","unstructured":"Semenza GL. HIF-1: using two hands to flip the angiogenic switch. Cancer Metastasis Rev. 2000;19:59\u201365.","journal-title":"Cancer Metastasis Rev"},{"key":"2165_CR269","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1152\/jappl.2000.88.4.1474","volume":"88","author":"GL Semenza","year":"2000","unstructured":"Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol (1985). 2000;88:1474\u201380.","journal-title":"J Appl Physiol (1985)"},{"key":"2165_CR270","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.pharmthera.2018.06.003","volume":"191","author":"S Bousseau","year":"2018","unstructured":"Bousseau S, et al. Glycosylation as new pharmacological strategies for diseases associated with excessive angiogenesis. Pharmacol Ther. 2018;191:92\u2013122.","journal-title":"Pharmacol Ther"},{"key":"2165_CR271","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.ccell.2022.08.012","volume":"40","author":"Q Shi","year":"2022","unstructured":"Shi Q, et al. Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal cathepsin B to promote cancer metastasis and chemoresistance. Cancer Cell. 2022;40:1207\u2013e12221210.","journal-title":"Cancer Cell"},{"key":"2165_CR272","doi-asserted-by":"publisher","first-page":"13117","DOI":"10.1074\/jbc.RA119.008643","volume":"294","author":"KB Chandler","year":"2019","unstructured":"Chandler KB, et al. N-Glycosylation regulates ligand-dependent activation and signaling of vascular endothelial growth factor receptor 2 (VEGFR2). J Biol Chem. 2019;294:13117\u201330.","journal-title":"J Biol Chem"},{"key":"2165_CR273","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1038\/s41388-021-01659-y","volume":"40","author":"E Varone","year":"2021","unstructured":"Varone E, et al. The ER stress response mediator ERO1 triggers cancer metastasis by favoring the angiogenic switch in hypoxic conditions. Oncogene. 2021;40:1721\u201336.","journal-title":"Oncogene"},{"key":"2165_CR274","doi-asserted-by":"publisher","first-page":"102455","DOI":"10.1016\/j.redox.2022.102455","volume":"56","author":"E Varone","year":"2022","unstructured":"Varone E, et al. ERO1 alpha deficiency impairs angiogenesis by increasing N-glycosylation of a proangiogenic VEGFA. Redox Biol. 2022;56:102455.","journal-title":"Redox Biol"},{"key":"2165_CR275","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1158\/0008-5472.CAN-22-1844","volume":"83","author":"JH Fang","year":"2023","unstructured":"Fang JH, et al. Fructose Metabolism in Tumor endothelial cells promotes angiogenesis by activating AMPK Signaling and mitochondrial respiration. Cancer Res. 2023;83:1249\u201363.","journal-title":"Cancer Res"},{"key":"2165_CR276","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1093\/glycob\/cwu083","volume":"24","author":"DO Croci","year":"2014","unstructured":"Croci DO, Cerliani JP, Pinto NA, Morosi LG, Rabinovich GA. Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment. Glycobiology. 2014;24:1283\u201390.","journal-title":"Glycobiology"},{"key":"2165_CR277","doi-asserted-by":"publisher","first-page":"6531","DOI":"10.1038\/onc.2017.243","volume":"36","author":"P Chiodelli","year":"2017","unstructured":"Chiodelli P, et al. Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis. Oncogene. 2017;36:6531\u201341.","journal-title":"Oncogene"},{"key":"2165_CR278","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.cell.2014.01.043","volume":"156","author":"DO Croci","year":"2014","unstructured":"Croci DO, et al. Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors. Cell. 2014;156:744\u201358.","journal-title":"Cell"},{"key":"2165_CR279","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.ccell.2016.10.006","volume":"30","author":"AR Cantelmo","year":"2016","unstructured":"Cantelmo AR, et al. Inhibition of the glycolytic activator PFKFB3 in Endothelium induces Tumor Vessel normalization, Impairs Metastasis, and improves chemotherapy. Cancer Cell. 2016;30:968\u201385.","journal-title":"Cancer Cell"},{"key":"2165_CR280","doi-asserted-by":"publisher","first-page":"eadj4678","DOI":"10.1126\/sciadv.adj4678","volume":"10","author":"F Yang","year":"2024","unstructured":"Yang F, et al. An immunosuppressive vascular niche drives macrophage polarization and immunotherapy resistance in glioblastoma. Sci Adv. 2024;10:eadj4678.","journal-title":"Sci Adv"},{"key":"2165_CR281","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ccr.2014.01.028","volume":"25","author":"J Shi","year":"2014","unstructured":"Shi J, et al. Disrupting the interaction of BRD4 with diacetylated twist suppresses tumorigenesis in basal-like breast cancer. Cancer Cell. 2014;25:210\u201325.","journal-title":"Cancer Cell"},{"key":"2165_CR282","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1158\/0008-5472.CAN-23-2640","volume":"84","author":"M Zhang","year":"2024","unstructured":"Zhang M, et al. A subpopulation of luminal progenitors secretes Pleiotrophin to promote angiogenesis and metastasis in inflammatory breast Cancer. Cancer Res. 2024;84:1781\u201398.","journal-title":"Cancer Res"},{"key":"2165_CR283","doi-asserted-by":"publisher","first-page":"e2302717","DOI":"10.1002\/advs.202302717","volume":"10","author":"X Li","year":"2023","unstructured":"Li X, et al. TCAF2 in Pericytes promotes colorectal Cancer Liver Metastasis via Inhibiting Cold-sensing TRPM8 Channel. Adv Sci (Weinh). 2023;10:e2302717.","journal-title":"Adv Sci (Weinh)"},{"key":"2165_CR284","doi-asserted-by":"crossref","unstructured":"Lovisa S, et al. Endothelial-to-mesenchymal transition compromises vascular integrity to induce myc-mediated metabolic reprogramming in kidney fibrosis. Sci Signal. 2020;13(635):eaaz2597.","DOI":"10.1126\/scisignal.aaz2597"},{"key":"2165_CR285","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.ejcb.2018.07.005","volume":"97","author":"L Hong","year":"2018","unstructured":"Hong L, et al. EndMT: a promising and controversial field. Eur J Cell Biol. 2018;97:493\u2013500.","journal-title":"Eur J Cell Biol"},{"key":"2165_CR286","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1161\/CIRCRESAHA.121.319590","volume":"129","author":"X Liang","year":"2021","unstructured":"Liang X, et al. LARP7 suppresses endothelial-to-mesenchymal transition by coupling with TRIM28. Circ Res. 2021;129:843\u201356.","journal-title":"Circ Res"},{"key":"2165_CR287","doi-asserted-by":"crossref","unstructured":"Ciszewski WM, Wawro ME, Sacewicz-Hofman I, Sobierajska K. Cytoskeleton reorganization in EndMT-The role in Cancer and Fibrotic diseases. Int J Mol Sci. 2021;22(21):11607.","DOI":"10.3390\/ijms222111607"},{"key":"2165_CR288","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen Y, McAndrews KM, Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol. 2021;18:792\u2013804.","journal-title":"Nat Rev Clin Oncol"},{"key":"2165_CR289","doi-asserted-by":"publisher","first-page":"811485","DOI":"10.3389\/fimmu.2021.811485","volume":"12","author":"Z Lamplugh","year":"2021","unstructured":"Lamplugh Z, Fan Y. Vascular microenvironment, Tumor Immunity and Immunotherapy. Front Immunol. 2021;12:811485.","journal-title":"Front Immunol"},{"key":"2165_CR290","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374\u2013403.","journal-title":"Cancer Cell"},{"key":"2165_CR291","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.trecan.2023.11.004","volume":"10","author":"L Monteran","year":"2024","unstructured":"Monteran L, Zait Y, Erez N. It\u2019s all about the base: stromal cells are central orchestrators of metastasis. Trends Cancer. 2024;10:208\u201329.","journal-title":"Trends Cancer"},{"key":"2165_CR292","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12943-024-01990-4","volume":"23","author":"M Kundu","year":"2024","unstructured":"Kundu M, et al. Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer. Mol Cancer. 2024;23:92.","journal-title":"Mol Cancer"},{"key":"2165_CR293","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.tcb.2021.11.008","volume":"32","author":"M Kochetkova","year":"2022","unstructured":"Kochetkova M, Samuel MS. Differentiation of the tumor microenvironment: are CAFs the organizer? Trends Cell Biol. 2022;32:285\u201394.","journal-title":"Trends Cell Biol"},{"key":"2165_CR294","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12935-022-02599-7","volume":"22","author":"B Feng","year":"2022","unstructured":"Feng B, Wu J, Shen B, Jiang F, Feng J. Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures. Cancer Cell Int. 2022;22:166.","journal-title":"Cancer Cell Int"},{"key":"2165_CR295","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.devcel.2020.06.018","volume":"54","author":"F Li","year":"2020","unstructured":"Li F, Simon MC. Cancer cells don\u2019t live alone: metabolic communication within Tumor Microenvironments. Dev Cell. 2020;54:183\u201395.","journal-title":"Dev Cell"},{"key":"2165_CR296","doi-asserted-by":"crossref","unstructured":"Liang L, et al. \u2018Reverse Warburg effect\u2019 of cancer\u2013associated fibroblasts (Review). Int J Oncol. 2022;60(6):67.","DOI":"10.3892\/ijo.2022.5357"},{"key":"2165_CR297","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.1158\/0008-5472.CAN-12-1949","volume":"72","author":"T Fiaschi","year":"2012","unstructured":"Fiaschi T, et al. Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. Cancer Res. 2012;72:5130\u201340.","journal-title":"Cancer Res"},{"key":"2165_CR298","doi-asserted-by":"publisher","first-page":"107701","DOI":"10.1016\/j.celrep.2020.107701","volume":"31","author":"LM Becker","year":"2020","unstructured":"Becker LM, et al. Epigenetic reprogramming of Cancer-Associated fibroblasts deregulates glucose metabolism and facilitates progression of breast Cancer. Cell Rep. 2020;31:107701.","journal-title":"Cell Rep"},{"key":"2165_CR299","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12943-021-01463-y","volume":"20","author":"C Li","year":"2021","unstructured":"Li C, Teixeira AF, Zhu HJ. Ten Dijke, P. Cancer associated-fibroblast-derived exosomes in cancer progression. Mol Cancer. 2021;20:154.","journal-title":"Mol Cancer"},{"key":"2165_CR300","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.ccell.2024.03.005","volume":"42","author":"N Niu","year":"2024","unstructured":"Niu N, et al. Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer. Cancer Cell. 2024;42:869\u2013e884869.","journal-title":"Cancer Cell"},{"key":"2165_CR301","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.matbio.2023.05.006","volume":"121","author":"T Wu","year":"2023","unstructured":"Wu T, et al. Matrix stiffening facilitates the collective invasion of breast cancer through the periostin-integrin mechanotransduction pathway. Matrix Biol. 2023;121:22\u201340.","journal-title":"Matrix Biol"},{"key":"2165_CR302","doi-asserted-by":"publisher","first-page":"9713","DOI":"10.1021\/acsnano.4c01499","volume":"18","author":"ZW Qiu","year":"2024","unstructured":"Qiu ZW, et al. Breaking physical barrier of fibrotic breast Cancer for photodynamic immunotherapy by remodeling Tumor Extracellular Matrix and Reprogramming Cancer-Associated fibroblasts. ACS Nano. 2024;18:9713\u201335.","journal-title":"ACS Nano"},{"key":"2165_CR303","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.cell.2018.01.009","volume":"172","author":"S Su","year":"2018","unstructured":"Su S, et al. CD10(+)GPR77(+) Cancer-Associated fibroblasts promote Cancer formation and chemoresistance by sustaining Cancer Stemness. Cell. 2018;172:841\u2013e856816.","journal-title":"Cell"},{"key":"2165_CR304","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jconrel.2023.02.041","volume":"356","author":"S Geng","year":"2023","unstructured":"Geng S, et al. Safe engineering of cancer-associated fibroblasts enhances checkpoint blockade immunotherapy. J Control Release. 2023;356:272\u201387.","journal-title":"J Control Release"},{"key":"2165_CR305","doi-asserted-by":"publisher","first-page":"1199225","DOI":"10.3389\/fphys.2023.1199225","volume":"14","author":"X Yao","year":"2023","unstructured":"Yao X, Zeng Y. Tumour associated endothelial cells: origin, characteristics and role in metastasis and anti-angiogenic resistance. Front Physiol. 2023;14:1199225.","journal-title":"Front Physiol"},{"key":"2165_CR306","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/nature21724","volume":"544","author":"L Tian","year":"2017","unstructured":"Tian L, et al. Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming. Nature. 2017;544:250\u20134.","journal-title":"Nature"},{"key":"2165_CR307","doi-asserted-by":"publisher","first-page":"4915","DOI":"10.7150\/ijbs.86039","volume":"19","author":"Y Liang","year":"2023","unstructured":"Liang Y, et al. The emerging roles of metabolism in the crosstalk between breast cancer cells and tumor-associated macrophages. Int J Biol Sci. 2023;19:4915\u201330.","journal-title":"Int J Biol Sci"},{"key":"2165_CR308","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, Han F, Du Y, Shi H, Zhou W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8:70.","journal-title":"Signal Transduct Target Ther"},{"key":"2165_CR309","doi-asserted-by":"publisher","first-page":"331","DOI":"10.5306\/wjco.v7.i4.331","volume":"7","author":"M Zafrakas","year":"2016","unstructured":"Zafrakas M, Papasozomenou P, Emmanouilides C. Sorafenib in breast cancer treatment: a systematic review and overview of clinical trials. World J Clin Oncol. 2016;7:331\u20136.","journal-title":"World J Clin Oncol"},{"key":"2165_CR310","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3389\/fcell.2020.00766","volume":"8","author":"L Nagl","year":"2020","unstructured":"Nagl L, Horvath L, Pircher A, Wolf D. Tumor endothelial cells (TECs) as potential Immune directors of the Tumor Microenvironment - New findings and Future perspectives. Front Cell Dev Biol. 2020;8:766.","journal-title":"Front Cell Dev Biol"},{"key":"2165_CR311","doi-asserted-by":"publisher","first-page":"e2306676","DOI":"10.1002\/adma.202306676","volume":"36","author":"Y Cai","year":"2024","unstructured":"Cai Y, et al. Inhibiting endothelial cell-mediated T lymphocyte apoptosis with integrin-targeting peptide-drug Conjugate filaments for Chemoimmunotherapy of Triple-negative breast Cancer. Adv Mater. 2024;36:e2306676.","journal-title":"Adv Mater"},{"key":"2165_CR312","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1158\/0008-5472.CAN-19-3791","volume":"80","author":"H Kikuchi","year":"2020","unstructured":"Kikuchi H, et al. Chemotherapy-Induced IL8 Upregulates MDR1\/ABCB1 in Tumor Blood vessels and results in unfavorable outcome. Cancer Res. 2020;80:2996\u20133008.","journal-title":"Cancer Res"},{"key":"2165_CR313","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1038\/s41467-021-24703-7","volume":"12","author":"J Xu","year":"2021","unstructured":"Xu J, et al. TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer. Nat Commun. 2021;12:4413.","journal-title":"Nat Commun"},{"key":"2165_CR314","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41586-024-07698-1","volume":"632","author":"X Pan","year":"2024","unstructured":"Pan X, et al. Tumour vasculature at single-cell resolution. Nature. 2024;632:429\u201336.","journal-title":"Nature"},{"key":"2165_CR315","doi-asserted-by":"publisher","first-page":"e2207257","DOI":"10.1002\/advs.202207257","volume":"10","author":"T Jiang","year":"2023","unstructured":"Jiang T, et al. Targeting lncRNA DDIT4-AS1 sensitizes Triple negative breast Cancer to Chemotherapy via suppressing of Autophagy. Adv Sci (Weinh). 2023;10:e2207257.","journal-title":"Adv Sci (Weinh)"},{"key":"2165_CR316","doi-asserted-by":"publisher","first-page":"963689723122007","DOI":"10.1177\/09636897231220073","volume":"32","author":"L Zhang","year":"2023","unstructured":"Zhang L. The role of mesenchymal stem cells in modulating the breast Cancer Microenvironment. Cell Transpl. 2023;32:9636897231220073.","journal-title":"Cell Transpl"},{"key":"2165_CR317","doi-asserted-by":"crossref","unstructured":"Almouh M et al. Exosomes released by oxidative stress-induced mesenchymal stem cells promote murine mammary tumor progression through activating the STAT3 signaling pathway. Mol Cell Biochem. 2024;479(12):3375\u201391.","DOI":"10.1007\/s11010-024-04934-0"},{"key":"2165_CR318","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1039\/D1BM01722E","volume":"10","author":"J Mu","year":"2022","unstructured":"Mu J, et al. Hypoxia-stimulated mesenchymal stem cell-derived exosomes loaded by adhesive hydrogel for effective angiogenic treatment of spinal cord injury. Biomater Sci. 2022;10:1803\u201311.","journal-title":"Biomater Sci"},{"key":"2165_CR319","doi-asserted-by":"crossref","unstructured":"Harrell CR, Volarevic A, Djonov VG, Jovicic N, Volarevic V. Mesenchymal stem cell: a friend or foe in Anti-tumor Immunity. Int J Mol Sci. 2021;22(22):12429.","DOI":"10.3390\/ijms222212429"},{"key":"2165_CR320","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/stem.2509","volume":"35","author":"LC Davies","year":"2017","unstructured":"Davies LC, Heldring N, Kadri N, Le Blanc K. Mesenchymal stromal cell secretion of programmed Death-1 Ligands regulates T cell mediated Immunosuppression. Stem Cells. 2017;35:766\u201376.","journal-title":"Stem Cells"},{"key":"2165_CR321","doi-asserted-by":"publisher","first-page":"619","DOI":"10.4252\/wjsc.v13.i6.619","volume":"13","author":"R Szydlak","year":"2021","unstructured":"Szydlak R. Biological, chemical and mechanical factors regulating migration and homing of mesenchymal stem cells. World J Stem Cells. 2021;13:619\u201331.","journal-title":"World J Stem Cells"},{"key":"2165_CR322","doi-asserted-by":"publisher","first-page":"114300","DOI":"10.1016\/j.addr.2022.114300","volume":"185","author":"T Zhang","year":"2022","unstructured":"Zhang T, Lin R, Wu H, Jiang X, Gao J. Mesenchymal stem cells: a living carrier for active tumor-targeted delivery. Adv Drug Deliv Rev. 2022;185:114300.","journal-title":"Adv Drug Deliv Rev"},{"key":"2165_CR323","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12943-022-01650-5","volume":"21","author":"Z Lin","year":"2022","unstructured":"Lin Z, et al. Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential. Mol Cancer. 2022;21:179.","journal-title":"Mol Cancer"},{"key":"2165_CR324","doi-asserted-by":"publisher","first-page":"108612","DOI":"10.1016\/j.pharmthera.2024.108612","volume":"256","author":"YW Meng","year":"2024","unstructured":"Meng YW, Liu JY. Pathological and pharmacological functions of the metabolites of polyunsaturated fatty acids mediated by cyclooxygenases, lipoxygenases, and cytochrome P450s in cancers. Pharmacol Ther. 2024;256:108612.","journal-title":"Pharmacol Ther"},{"key":"2165_CR325","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41422-024-00946-z","volume":"34","author":"Q Xu","year":"2024","unstructured":"Xu Q, et al. Multiple cancer cell types release LIF and Gal3 to hijack neural signals. Cell Res. 2024;34:345\u201354.","journal-title":"Cell Res"},{"key":"2165_CR326","doi-asserted-by":"crossref","unstructured":"Padmanaban V, et al. Neuronal substance P drives metastasis through an extracellular RNA-TLR7 axis. Nature. 2024;633(8028):207\u201315.","DOI":"10.1038\/s41586-024-07767-5"},{"key":"2165_CR327","doi-asserted-by":"crossref","unstructured":"Zhang Y et al. Cancer cells co-opt nociceptive nerves to thrive in nutrient-poor environments and upon nutrient-starvation therapies. Cell Metab 34, 1999\u20132017.e1910 (2022).","DOI":"10.1016\/j.cmet.2022.10.012"},{"key":"2165_CR328","doi-asserted-by":"crossref","unstructured":"Ledford H. Breast-cancer cells enlist nerves to spread throughout the body. Nature (2024).","DOI":"10.1038\/d41586-024-02555-7"},{"key":"2165_CR329","doi-asserted-by":"crossref","unstructured":"Gysler SM, Drapkin R. Tumor innervation: peripheral nerves take control of the tumor microenvironment. J Clin Invest. 2021;131(11):e147276.","DOI":"10.1172\/JCI147276"},{"key":"2165_CR330","doi-asserted-by":"publisher","first-page":"188828","DOI":"10.1016\/j.bbcan.2022.188828","volume":"1877","author":"J Hu","year":"2022","unstructured":"Hu J, Chen W, Shen L, Chen Z, Huang J. Crosstalk between the peripheral nervous system and breast cancer influences tumor progression. Biochim Biophys Acta Rev Cancer. 2022;1877:188828.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2165_CR331","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","volume":"19","author":"R Dhanasekaran","year":"2022","unstructured":"Dhanasekaran R, et al. The MYC oncogene - the grand orchestrator of cancer growth and immune evasion. Nat Rev Clin Oncol. 2022;19:23\u201336.","journal-title":"Nat Rev Clin Oncol"},{"key":"2165_CR332","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00262-019-02463-0","volume":"69","author":"N Erin","year":"2020","unstructured":"Erin N. Role of sensory neurons, neuroimmune pathways, and transient receptor potential vanilloid 1 (TRPV1) channels in a murine model of breast cancer metastasis. Cancer Immunol Immunother. 2020;69:307\u201314.","journal-title":"Cancer Immunol Immunother"},{"key":"2165_CR333","doi-asserted-by":"publisher","first-page":"685297","DOI":"10.3389\/fonc.2021.685297","volume":"11","author":"N Bencze","year":"2021","unstructured":"Bencze N, et al. Desensitization of capsaicin-sensitive afferents accelerates early Tumor Growth via increased vascular leakage in a murine model of Triple negative breast Cancer. Front Oncol. 2021;11:685297.","journal-title":"Front Oncol"},{"key":"2165_CR334","doi-asserted-by":"publisher","first-page":"14824","DOI":"10.1038\/s41598-020-71670-y","volume":"10","author":"GA McCallum","year":"2020","unstructured":"McCallum GA, et al. Chronic neural activity recorded within breast tumors. Sci Rep. 2020;10:14824.","journal-title":"Sci Rep"},{"key":"2165_CR335","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41413-021-00137-1","volume":"9","author":"F Conceicao","year":"2021","unstructured":"Conceicao F, Sousa DM, Paredes J, Lamghari M. Sympathetic activity in breast cancer and metastasis: partners in crime. Bone Res. 2021;9:9.","journal-title":"Bone Res"},{"key":"2165_CR336","doi-asserted-by":"crossref","unstructured":"Xiong SY, et al. A brain-tumor neural circuit controls breast cancer progression in mice. J Clin Invest. 2023 Dec 15;133(24):e167725.","DOI":"10.1172\/JCI167725"},{"key":"2165_CR337","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bbi.2015.12.014","volume":"53","author":"MJ Szpunar","year":"2016","unstructured":"Szpunar MJ, Belcher EK, Dawes RP, Madden KS. Sympathetic innervation, norepinephrine content, and norepinephrine turnover in orthotopic and spontaneous models of breast cancer. Brain Behav Immun. 2016;53:223\u201333.","journal-title":"Brain Behav Immun"},{"key":"2165_CR338","first-page":"3500","volume":"20","author":"M Xia","year":"2016","unstructured":"Xia M, et al. Dexmedetomidine regulate the malignancy of breast cancer cells by activating \u03b12-adrenoceptor\/ERK signaling pathway. Eur Rev Med Pharmacol Sci. 2016;20:3500\u20136.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2165_CR339","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/s41467-020-15308-7","volume":"11","author":"Q Li","year":"2020","unstructured":"Li Q, et al. Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer. Nat Commun. 2020;11:1456.","journal-title":"Nat Commun"},{"key":"2165_CR340","doi-asserted-by":"publisher","first-page":"830","DOI":"10.4143\/crt.2019.510","volume":"52","author":"J Zhou","year":"2020","unstructured":"Zhou J, et al. Activation of \u03b22-Adrenergic receptor promotes growth and angiogenesis in breast Cancer by Down-regulating PPAR\u03b3. Cancer Res Treat. 2020;52:830\u201347.","journal-title":"Cancer Res Treat"},{"key":"2165_CR341","doi-asserted-by":"publisher","first-page":"e2308435","DOI":"10.1002\/advs.202308435","volume":"11","author":"H Bian","year":"2024","unstructured":"Bian H, et al. In Silico Discovery of stapled peptide inhibitor targeting the Nur77-PPAR\u03b3 Interaction and its Anti-breast-cancer Efficacy. Adv Sci (Weinh). 2024;11:e2308435.","journal-title":"Adv Sci (Weinh)"},{"key":"2165_CR342","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13058-015-0655-3","volume":"17","author":"SJ Creed","year":"2015","unstructured":"Creed SJ, et al. \u03b22-adrenoceptor signaling regulates invadopodia formation to enhance tumor cell invasion. Breast Cancer Res. 2015;17:145.","journal-title":"Breast Cancer Res"},{"key":"2165_CR343","doi-asserted-by":"publisher","first-page":"115333","DOI":"10.1016\/j.bcp.2022.115333","volume":"206","author":"W Shao","year":"2022","unstructured":"Shao W, Liu L, Zheng F, Ma Y, Zhang J. The potent role of src kinase-regulating glucose metabolism in cancer. Biochem Pharmacol. 2022;206:115333.","journal-title":"Biochem Pharmacol"},{"key":"2165_CR344","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/onc.2015.58","volume":"35","author":"D Liu","year":"2016","unstructured":"Liu D, et al. \u03b22-AR signaling controls trastuzumab resistance-dependent pathway. Oncogene. 2016;35:47\u201358.","journal-title":"Oncogene"},{"key":"2165_CR345","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2967\/jnumed.113.121327","volume":"55","author":"F Kang","year":"2014","unstructured":"Kang F, et al. Propranolol inhibits glucose metabolism and 18F-FDG uptake of breast cancer through posttranscriptional downregulation of hexokinase-2. J Nucl Med. 2014;55:439\u201345.","journal-title":"J Nucl Med"},{"key":"2165_CR346","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/s41416-022-01891-7","volume":"127","author":"LL L\u00f8fling","year":"2022","unstructured":"L\u00f8fling LL, et al. \u03b2-blockers and breast cancer survival by molecular subtypes: a population-based cohort study and meta-analysis. Br J Cancer. 2022;127:1086\u201396.","journal-title":"Br J Cancer"},{"key":"2165_CR347","doi-asserted-by":"publisher","first-page":"eadf1147","DOI":"10.1126\/scitranslmed.adf1147","volume":"15","author":"A Chang","year":"2023","unstructured":"Chang A, et al. Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer. Sci Transl Med. 2023;15:eadf1147.","journal-title":"Sci Transl Med"},{"key":"2165_CR348","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1158\/1078-0432.CCR-19-2641","volume":"26","author":"JG Hiller","year":"2020","unstructured":"Hiller JG, et al. Preoperative \u03b2-Blockade with Propranolol reduces biomarkers of metastasis in breast Cancer: a phase II randomized trial. Clin Cancer Res. 2020;26:1803\u201311.","journal-title":"Clin Cancer Res"},{"key":"2165_CR349","doi-asserted-by":"publisher","first-page":"10058","DOI":"10.18632\/oncotarget.2460","volume":"5","author":"L Gargiulo","year":"2014","unstructured":"Gargiulo L, et al. Differential \u03b2\u2082-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines. Oncotarget. 2014;5:10058\u201369.","journal-title":"Oncotarget"},{"key":"2165_CR350","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.1476-5381.2011.01791.x","volume":"166","author":"C P\u00e9rez Pi\u00f1ero","year":"2012","unstructured":"P\u00e9rez Pi\u00f1ero C, Bruzzone A, Sarappa MG, Castillo LF, L\u00fcthy IA. Involvement of \u03b12- and \u03b22-adrenoceptors on breast cancer cell proliferation and tumour growth regulation. Br J Pharmacol. 2012;166:721\u201336.","journal-title":"Br J Pharmacol"},{"key":"2165_CR351","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1023\/A:1006338232150","volume":"60","author":"TA Slotkin","year":"2000","unstructured":"Slotkin TA, et al. Beta-adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat. 2000;60:153\u201366.","journal-title":"Breast Cancer Res Treat"},{"key":"2165_CR352","doi-asserted-by":"publisher","first-page":"101042831879902","DOI":"10.1177\/1010428318799028","volume":"40","author":"PH Nguyen","year":"2018","unstructured":"Nguyen PH, et al. Acetylcholine induces stem cell properties of gastric cancer cells of diffuse type. Tumour Biol. 2018;40:1010428318799028.","journal-title":"Tumour Biol"},{"key":"2165_CR353","doi-asserted-by":"publisher","first-page":"40802","DOI":"10.1038\/srep40802","volume":"7","author":"H Yu","year":"2017","unstructured":"Yu H, et al. Acetylcholine acts through M3 muscarinic receptor to activate the EGFR signaling and promotes gastric cancer cell proliferation. Sci Rep. 2017;7:40802.","journal-title":"Sci Rep"},{"key":"2165_CR354","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.canep.2015.11.007","volume":"40","author":"M De Couck","year":"2016","unstructured":"De Couck M, Marechal R, Moorthamers S, Van Laethem JL, Gidron Y. Vagal nerve activity predicts overall survival in metastatic pancreatic cancer, mediated by inflammation. Cancer Epidemiol. 2016;40:47\u201351.","journal-title":"Cancer Epidemiol"},{"key":"2165_CR355","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1158\/2159-8290.CD-18-0046","volume":"8","author":"BW Renz","year":"2018","unstructured":"Renz BW, et al. Cholinergic Signaling via Muscarinic receptors directly and indirectly suppresses pancreatic tumorigenesis and Cancer stemness. Cancer Discov. 2018;8:1458\u201373.","journal-title":"Cancer Discov"},{"key":"2165_CR356","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1056\/NEJM197205182862006","volume":"286","author":"GB Koelle","year":"1972","unstructured":"Koelle GB. Acetylcholine\u2013current status in physiology, pharmacology and medicine. N Engl J Med. 1972;286:1086\u201390.","journal-title":"N Engl J Med"},{"key":"2165_CR357","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.suronc.2019.09.003","volume":"31","author":"J Chen","year":"2019","unstructured":"Chen J, Cheuk IWY, Shin VY, Kwong A. Acetylcholine receptors: Key players in cancer development. Surg Oncol. 2019;31:46\u201353.","journal-title":"Surg Oncol"},{"key":"2165_CR358","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10286-020-00724-y","volume":"31","author":"A Kamiya","year":"2021","unstructured":"Kamiya A, Hiyama T, Fujimura A, Yoshikawa S. Sympathetic and parasympathetic innervation in cancer: therapeutic implications. Clin Auton Res. 2021;31:165\u201378.","journal-title":"Clin Auton Res"},{"key":"2165_CR359","doi-asserted-by":"publisher","first-page":"8473","DOI":"10.1158\/0008-5472.CAN-08-0131","volume":"68","author":"J Guo","year":"2008","unstructured":"Guo J, et al. Nicotine promotes mammary tumor migration via a signaling cascade involving protein kinase C and CDC42. Cancer Res. 2008;68:8473\u201381.","journal-title":"Cancer Res"},{"key":"2165_CR360","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1158\/0008-5472.CAN-18-0619","volume":"78","author":"MDM Maldonado","year":"2018","unstructured":"Maldonado MDM, Dharmawardhane S. Targeting Rac and Cdc42 GTPases in Cancer. Cancer Res. 2018;78:3101\u201311.","journal-title":"Cancer Res"},{"key":"2165_CR361","doi-asserted-by":"publisher","first-page":"R113","DOI":"10.1186\/bcr3055","volume":"13","author":"T Nishioka","year":"2011","unstructured":"Nishioka T, et al. Sensitization of epithelial growth factor receptors by nicotine exposure to promote breast cancer cell growth. Breast Cancer Res. 2011;13:R113.","journal-title":"Breast Cancer Res"},{"key":"2165_CR362","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/jcp.20326","volume":"204","author":"E Jimenez","year":"2005","unstructured":"Jimenez E, Montiel M. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells. J Cell Physiol. 2005;204:678\u201386.","journal-title":"J Cell Physiol"},{"key":"2165_CR363","doi-asserted-by":"publisher","first-page":"6667","DOI":"10.1038\/s41467-021-27093-y","volume":"12","author":"AE Smith","year":"2021","unstructured":"Smith AE, et al. HER2\u2009+\u2009breast cancers evade anti-HER2 therapy via a switch in driver pathway. Nat Commun. 2021;12:6667.","journal-title":"Nat Commun"},{"key":"2165_CR364","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ccell.2018.08.008","volume":"34","author":"P Razavi","year":"2018","unstructured":"Razavi P, et al. The genomic Landscape of Endocrine-Resistant Advanced breast cancers. Cancer Cell. 2018;34:427\u2013e438426.","journal-title":"Cancer Cell"},{"key":"2165_CR365","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1158\/0008-5472.CAN-14-3180","volume":"75","author":"P Jobling","year":"2015","unstructured":"Jobling P, et al. Nerve-Cancer cell cross-talk: a novel promoter of Tumor Progression. Cancer Res. 2015;75:1777\u201381.","journal-title":"Cancer Res"},{"key":"2165_CR366","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12307-018-0207-3","volume":"11","author":"N Kuol","year":"2018","unstructured":"Kuol N, Stojanovska L, Apostolopoulos V, Nurgali K. Role of the nervous system in Tumor Angiogenesis. Cancer Microenviron. 2018;11:1\u201311.","journal-title":"Cancer Microenviron"},{"key":"2165_CR367","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1126\/science.aah5072","volume":"358","author":"AH Zahalka","year":"2017","unstructured":"Zahalka AH, et al. Adrenergic nerves activate an angio-metabolic switch in prostate cancer. Science. 2017;358:321\u20136.","journal-title":"Science"},{"key":"2165_CR368","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/87895","volume":"7","author":"S Basu","year":"2001","unstructured":"Basu S, et al. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor\/vascular endothelial growth factor. Nat Med. 2001;7:569\u201374.","journal-title":"Nat Med"},{"key":"2165_CR369","doi-asserted-by":"publisher","first-page":"R345","DOI":"10.1186\/bcr1005","volume":"7","author":"E de la Torre","year":"2005","unstructured":"de la Torre E, et al. Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice. Breast Cancer Res. 2005;7:R345\u2013352.","journal-title":"Breast Cancer Res"},{"key":"2165_CR370","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41586-023-06568-6","volume":"622","author":"AM Globig","year":"2023","unstructured":"Globig AM, et al. The \u03b2(1)-adrenergic receptor links sympathetic nerves to T cell exhaustion. Nature. 2023;622:383\u201392.","journal-title":"Nature"},{"key":"2165_CR371","doi-asserted-by":"publisher","first-page":"H1126","DOI":"10.1152\/ajpheart.00476.2023","volume":"325","author":"AG Rodrigues","year":"2023","unstructured":"Rodrigues AG, et al. Sympathetic neural overdrive and diminished exercise capacity in reduced ejection fraction heart failure related to anthracycline-based chemotherapy. Am J Physiol Heart Circ Physiol. 2023;325:H1126\u201332.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2165_CR372","doi-asserted-by":"publisher","first-page":"122603","DOI":"10.1016\/j.biomaterials.2024.122603","volume":"309","author":"S Zuo","year":"2024","unstructured":"Zuo S, et al. Regulating tumor innervation by nanodrugs potentiates cancer immunochemotherapy and relieve chemotherapy-induced neuropathic pain. Biomaterials. 2024;309:122603.","journal-title":"Biomaterials"},{"key":"2165_CR373","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.ijrobp.2018.12.009","volume":"103","author":"RL Bakst","year":"2019","unstructured":"Bakst RL, et al. Perineural Invasion and Perineural Tumor Spread in Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2019;103:1109\u201324.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2165_CR374","doi-asserted-by":"crossref","unstructured":"Wang J, Chen Y, Li X, Zou X. Perineural Invasion and Associated Pain Transmission in Pancreatic Cancer. Cancers (Basel). 2021;13(18):4594.","DOI":"10.3390\/cancers13184594"},{"key":"2165_CR375","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1158\/1055-9965.EPI-16-0237","volume":"26","author":"P Zareba","year":"2017","unstructured":"Zareba P, et al. Perineural Invasion and Risk of Lethal prostate Cancer. Cancer Epidemiol Biomarkers Prev. 2017;26:719\u201326.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2165_CR376","doi-asserted-by":"publisher","first-page":"12781","DOI":"10.1038\/s41598-021-92343-4","volume":"11","author":"P Narayan","year":"2021","unstructured":"Narayan P, et al. Perineural invasion as a risk factor for locoregional recurrence of invasive breast cancer. Sci Rep. 2021;11:12781.","journal-title":"Sci Rep"},{"key":"2165_CR377","doi-asserted-by":"publisher","first-page":"208","DOI":"10.21873\/cdp.10203","volume":"3","author":"K Hosoya","year":"2023","unstructured":"Hosoya K, Wakahara M, Ikeda K, Umekita Y. Perineural Invasion predicts unfavorable prognosis in patients with invasive breast Cancer. Cancer Diagn Progn. 2023;3:208\u201314.","journal-title":"Cancer Diagn Progn"},{"key":"2165_CR378","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s13402-023-00901-x","volume":"47","author":"B Han","year":"2024","unstructured":"Han B, et al. Stiffened tumor microenvironment enhances perineural invasion in breast cancer via integrin signaling. Cell Oncol (Dordr). 2024;47:867\u201382.","journal-title":"Cell Oncol (Dordr)"},{"key":"2165_CR379","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/FPC.0000000000000498","volume":"33","author":"J Jian","year":"2023","unstructured":"Jian J, et al. Mouse nerve growth factor suppresses neuronal apoptosis in valproic acid-induced autism spectrum disorder rats by regulating the phosphoinositide-3-kinase\/serine\/threonine kinase signaling pathway. Pharmacogenet Genomics. 2023;33:101\u201310.","journal-title":"Pharmacogenet Genomics"},{"key":"2165_CR380","doi-asserted-by":"publisher","first-page":"e0212732","DOI":"10.1371\/journal.pone.0212732","volume":"14","author":"BO Balzamino","year":"2019","unstructured":"Balzamino BO, Esposito G, Marino R, Keller F, Micera A. Changes in vitreal protein profile and retina mRNAs in Reeler mice: NGF, IL33 and Muller cell activation. PLoS ONE. 2019;14:e0212732.","journal-title":"PLoS ONE"},{"key":"2165_CR381","doi-asserted-by":"publisher","first-page":"k2179","DOI":"10.1136\/bmj.k2179","volume":"361","author":"AM Valdes","year":"2018","unstructured":"Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in nutrition and health. BMJ. 2018;361:k2179.","journal-title":"BMJ"},{"key":"2165_CR382","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41579-023-00890-6","volume":"21","author":"HC Barreto","year":"2023","unstructured":"Barreto HC, Gordo I. Intrahost evolution of the gut microbiota. Nat Rev Microbiol. 2023;21:590\u2013603.","journal-title":"Nat Rev Microbiol"},{"key":"2165_CR383","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.abj2972","volume":"376","author":"MR Olm","year":"2022","unstructured":"Olm MR, et al. Robust variation in infant gut microbiome assembly across a spectrum of lifestyles. Science. 2022;376:1220\u20133.","journal-title":"Science"},{"key":"2165_CR384","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","volume":"71","author":"WM de Vos","year":"2022","unstructured":"de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022;71:1020\u201332.","journal-title":"Gut"},{"key":"2165_CR385","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41590-020-0602-z","volume":"21","author":"KR James","year":"2020","unstructured":"James KR, et al. Distinct microbial and immune niches of the human colon. Nat Immunol. 2020;21:343\u201353.","journal-title":"Nat Immunol"},{"key":"2165_CR386","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1136\/gutjnl-2020-323071","volume":"70","author":"A Agus","year":"2021","unstructured":"Agus A, Cl\u00e9ment K, Sokol H. Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut. 2021;70:1174\u201382.","journal-title":"Gut"},{"key":"2165_CR387","doi-asserted-by":"publisher","first-page":"e2200470","DOI":"10.1002\/advs.202200470","volume":"9","author":"Y Xie","year":"2022","unstructured":"Xie Y, et al. Microbiota in tumors: from understanding to application. Adv Sci (Weinh). 2022;9:e2200470.","journal-title":"Adv Sci (Weinh)"},{"key":"2165_CR388","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman D, et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science. 2020;368:973\u201380.","journal-title":"Science"},{"key":"2165_CR389","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","volume":"178","author":"E Riquelme","year":"2019","unstructured":"Riquelme E, et al. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer outcomes. Cell. 2019;178:795\u2013e806712.","journal-title":"Cell"},{"key":"2165_CR390","doi-asserted-by":"publisher","first-page":"2156255","DOI":"10.1080\/19490976.2022.2156255","volume":"15","author":"X Chai","year":"2023","unstructured":"Chai X, et al. Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma. Gut Microbes. 2023;15:2156255.","journal-title":"Gut Microbes"},{"key":"2165_CR391","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cmet.2023.03.003","volume":"35","author":"H Chen","year":"2023","unstructured":"Chen H, et al. Urea cycle activation triggered by host-microbiota maladaptation driving colorectal tumorigenesis. Cell Metab. 2023;35:651\u2013e666657.","journal-title":"Cell Metab"},{"key":"2165_CR392","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","volume":"611","author":"JL Galeano Ni\u00f1o","year":"2022","unstructured":"Galeano Ni\u00f1o JL, et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature. 2022;611:810\u20137.","journal-title":"Nature"},{"key":"2165_CR393","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s41419-021-04092-x","volume":"12","author":"S Banerjee","year":"2021","unstructured":"Banerjee S, et al. Prognostic correlations with the microbiome of breast cancer subtypes. Cell Death Dis. 2021;12:831.","journal-title":"Cell Death Dis"},{"key":"2165_CR394","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-022-01304-4","volume":"8","author":"L Yang","year":"2023","unstructured":"Yang L, Li A, Wang Y, Zhang Y. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy. Signal Transduct Target Ther. 2023;8:35.","journal-title":"Signal Transduct Target Ther"},{"key":"2165_CR395","first-page":"37","volume":"13","author":"X Lou","year":"2021","unstructured":"Lou X, Chen Z, He Z, Sun M, Sun J. Bacteria-mediated synergistic Cancer therapy: small Microbiome has a big Hope. Nanomicro Lett. 2021;13:37.","journal-title":"Nanomicro Lett"},{"key":"2165_CR396","doi-asserted-by":"crossref","unstructured":"Arnone AA, Cook KL. Gut and breast microbiota as endocrine regulators of hormone receptor-positive breast Cancer Risk and Therapy Response. Endocrinology. 2022;164(1):bqac177.","DOI":"10.1210\/endocr\/bqac177"},{"key":"2165_CR397","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/procel\/pwae005","volume":"15","author":"W Ma","year":"2024","unstructured":"Ma W, et al. Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1. Protein Cell. 2024;15:419\u201340.","journal-title":"Protein Cell"},{"key":"2165_CR398","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1158\/2159-8290.CD-20-0537","volume":"11","author":"S Parida","year":"2021","unstructured":"Parida S, et al. A procarcinogenic Colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates notch and \u03b2-Catenin axes. Cancer Discov. 2021;11:1138\u201357.","journal-title":"Cancer Discov"},{"key":"2165_CR399","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1038\/s41467-024-48662-x","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang Y, et al. Long-term relapse-free survival enabled by integrating targeted antibacteria in antitumor treatment. Nat Commun. 2024;15:4194.","journal-title":"Nat Commun"},{"key":"2165_CR400","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cmet.2022.02.010","volume":"34","author":"H Wang","year":"2022","unstructured":"Wang H, et al. The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer. Cell Metab. 2022;34:581\u2013e594588.","journal-title":"Cell Metab"},{"key":"2165_CR401","doi-asserted-by":"publisher","first-page":"1290414","DOI":"10.3389\/fimmu.2023.1290414","volume":"14","author":"J Liu","year":"2023","unstructured":"Liu J, et al. Microbial metabolites are involved in tumorigenesis and development by regulating immune responses. Front Immunol. 2023;14:1290414.","journal-title":"Front Immunol"},{"key":"2165_CR402","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","volume":"12","author":"M Luu","year":"2021","unstructured":"Luu M, et al. Microbial short-chain fatty acids modulate CD8(+) T cell responses and improve adoptive immunotherapy for cancer. Nat Commun. 2021;12:4077.","journal-title":"Nat Commun"},{"key":"2165_CR403","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/imcb.12461","volume":"99","author":"PM Gubser","year":"2021","unstructured":"Gubser PM, Vasanthakumar A. Going sugar free: Treg cells avoid glucose to maintain functional fitness. Immunol Cell Biol. 2021;99:558\u201360.","journal-title":"Immunol Cell Biol"},{"key":"2165_CR404","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson MJ, et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature. 2021;591:645\u201351.","journal-title":"Nature"},{"key":"2165_CR405","doi-asserted-by":"publisher","first-page":"110986","DOI":"10.1016\/j.celrep.2022.110986","volume":"39","author":"J Gu","year":"2022","unstructured":"Gu J, et al. Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-\u03b2 signaling in regulatory T cells. Cell Rep. 2022;39:110986.","journal-title":"Cell Rep"},{"key":"2165_CR406","doi-asserted-by":"publisher","first-page":"9613","DOI":"10.1021\/acsnano.3c13194","volume":"18","author":"J Zhang","year":"2024","unstructured":"Zhang J, et al. Programmed nanocloak of commensal Bacteria-derived nanovesicles amplify strong immunoreactivity against Tumor Growth and metastatic progression. ACS Nano. 2024;18:9613\u201326.","journal-title":"ACS Nano"},{"key":"2165_CR407","doi-asserted-by":"crossref","unstructured":"Wang YN, et al. Vinblastine resets tumor-associated macrophages toward M1 phenotype and promotes antitumor immune response. J Immunother Cancer. 2023;11(8):e007253.","DOI":"10.1136\/jitc-2023-007253"},{"key":"2165_CR408","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1158\/0008-5472.CAN-20-2990","volume":"81","author":"NR Anderson","year":"2021","unstructured":"Anderson NR, Minutolo NG, Gill S, Klichinsky M. Macrophage-based approaches for Cancer Immunotherapy. Cancer Res. 2021;81:1201\u20138.","journal-title":"Cancer Res"},{"key":"2165_CR409","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.tcb.2022.11.007","volume":"33","author":"A Fu","year":"2023","unstructured":"Fu A, Yao B, Dong T, Cai S. Emerging roles of intratumor microbiota in cancer metastasis. Trends Cell Biol. 2023;33:583\u201393.","journal-title":"Trends Cell Biol"},{"key":"2165_CR410","doi-asserted-by":"publisher","first-page":"e2105222","DOI":"10.1002\/advs.202105222","volume":"9","author":"H Liu","year":"2022","unstructured":"Liu H, et al. Fusobacterium nucleatum promotes Colorectal Cancer Cell to acquire Stem Cell-Like features by manipulating lipid droplet-mediated numb degradation. Adv Sci (Weinh). 2022;9:e2105222.","journal-title":"Adv Sci (Weinh)"},{"key":"2165_CR411","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","volume":"357","author":"LT Geller","year":"2017","unstructured":"Geller LT, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357:1156\u201360.","journal-title":"Science"},{"key":"2165_CR412","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.trecan.2024.01.001","volume":"10","author":"CD Johnston","year":"2024","unstructured":"Johnston CD, Bullman S. Bacteria-derived L-lactate fuels cervical cancer chemoradiotherapy resistance. Trends Cancer. 2024;10:97\u20139.","journal-title":"Trends Cancer"},{"key":"2165_CR413","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.ccell.2023.09.012","volume":"41","author":"LE Colbert","year":"2023","unstructured":"Colbert LE, et al. Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancer Cell. 2023;41:1945\u201362. e1911.","journal-title":"Cancer Cell"},{"key":"2165_CR414","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.cell.2022.02.027","volume":"185","author":"A Fu","year":"2022","unstructured":"Fu A, et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell. 2022;185:1356\u2013e13721326.","journal-title":"Cell"},{"key":"2165_CR415","doi-asserted-by":"publisher","first-page":"e2313953","DOI":"10.1002\/adma.202313953","volume":"36","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, et al. Synergistic brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy. Adv Mater. 2024;36:e2313953.","journal-title":"Adv Mater"},{"key":"2165_CR416","doi-asserted-by":"publisher","first-page":"1286429","DOI":"10.3389\/fmicb.2023.1286429","volume":"14","author":"X Zhang","year":"2023","unstructured":"Zhang X, et al. The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review. Front Microbiol. 2023;14:1286429.","journal-title":"Front Microbiol"},{"key":"2165_CR417","doi-asserted-by":"publisher","first-page":"114614","DOI":"10.1016\/j.addr.2022.114614","volume":"191","author":"R Sun","year":"2022","unstructured":"Sun R, et al. The tumor EPR effect for cancer drug delivery: current status, limitations, and alternatives. Adv Drug Deliv Rev. 2022;191:114614.","journal-title":"Adv Drug Deliv Rev"},{"key":"2165_CR418","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41586-018-0343-4","volume":"560","author":"BD Hopkins","year":"2018","unstructured":"Hopkins BD, et al. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors. Nature. 2018;560:499\u2013503.","journal-title":"Nature"},{"key":"2165_CR419","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41586-020-2502-7","volume":"583","author":"I Caffa","year":"2020","unstructured":"Caffa I, et al. Fasting-mimicking diet and hormone therapy induce breast cancer regression. Nature. 2020;583:620\u20134.","journal-title":"Nature"},{"key":"2165_CR420","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nature22056","volume":"544","author":"ODK Maddocks","year":"2017","unstructured":"Maddocks ODK, et al. Modulating the therapeutic response of tumours to dietary serine and glycine starvation. Nature. 2017;544:372\u20136.","journal-title":"Nature"},{"key":"2165_CR421","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.tem.2018.01.008","volume":"29","author":"R Buono","year":"2018","unstructured":"Buono R, Longo VD, Starvation. Stress resistance, and Cancer. Trends Endocrinol Metab. 2018;29:271\u201380.","journal-title":"Trends Endocrinol Metab"},{"key":"2165_CR422","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1056\/NEJMra1905136","volume":"381","author":"R de Cabo","year":"2019","unstructured":"de Cabo R, Mattson MP. Effects of Intermittent Fasting on Health, Aging, and Disease. N Engl J Med. 2019;381:2541\u201351.","journal-title":"N Engl J Med"},{"key":"2165_CR423","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/s41568-018-0061-0","volume":"18","author":"A Nencioni","year":"2018","unstructured":"Nencioni A, Caffa I, Cortellino S, Longo VD. Fasting and cancer: molecular mechanisms and clinical application. Nat Rev Cancer. 2018;18:707\u201319.","journal-title":"Nat Rev Cancer"},{"key":"2165_CR424","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1158\/2159-8290.CD-21-0030","volume":"12","author":"C Vernieri","year":"2022","unstructured":"Vernieri C, et al. Fasting-mimicking Diet is safe and reshapes metabolism and Antitumor Immunity in patients with Cancer. Cancer Discov. 2022;12:90\u2013107.","journal-title":"Cancer Discov"},{"key":"2165_CR425","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1038\/s41467-020-16243-3","volume":"11","author":"M Di Tano","year":"2020","unstructured":"Di Tano M, et al. Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers. Nat Commun. 2020;11:2332.","journal-title":"Nat Commun"},{"key":"2165_CR426","doi-asserted-by":"publisher","first-page":"124ra127","DOI":"10.1126\/scitranslmed.3003293","volume":"4","author":"C Lee","year":"2012","unstructured":"Lee C, et al. Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci Transl Med. 2012;4:124ra127.","journal-title":"Sci Transl Med"},{"key":"2165_CR427","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","volume":"14","author":"UE Martinez-Outschoorn","year":"2017","unstructured":"Martinez-Outschoorn UE, Peiris-Pag\u00e9s M, Pestell RG, Sotgia F, Lisanti MP. Cancer metabolism: a therapeutic perspective. Nat Rev Clin Oncol. 2017;14:11\u201331.","journal-title":"Nat Rev Clin Oncol"},{"key":"2165_CR428","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ccell.2016.05.016","volume":"30","author":"F Pietrocola","year":"2016","unstructured":"Pietrocola F, et al. Caloric restriction mimetics enhance Anticancer Immunosurveillance. Cancer Cell. 2016;30:147\u201360.","journal-title":"Cancer Cell"},{"key":"2165_CR429","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.stem.2014.04.014","volume":"14","author":"CW Cheng","year":"2014","unstructured":"Cheng CW, et al. Prolonged fasting reduces IGF-1\/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. Cell Stem Cell. 2014;14:810\u201323.","journal-title":"Cell Stem Cell"},{"key":"2165_CR430","doi-asserted-by":"publisher","first-page":"74649","DOI":"10.18632\/oncotarget.20301","volume":"8","author":"P Sun","year":"2017","unstructured":"Sun P, et al. Fasting inhibits colorectal cancer growth by reducing M2 polarization of tumor-associated macrophages. Oncotarget. 2017;8:74649\u201360.","journal-title":"Oncotarget"},{"key":"2165_CR431","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ccell.2016.06.005","volume":"30","author":"S Di Biase","year":"2016","unstructured":"Di Biase S, et al. Fasting-mimicking Diet reduces HO-1 to promote T cell-mediated tumor cytotoxicity. Cancer Cell. 2016;30:136\u201346.","journal-title":"Cancer Cell"},{"key":"2165_CR432","doi-asserted-by":"publisher","first-page":"e814s","DOI":"10.6061\/clinics\/2018\/e814s","volume":"73","author":"F Antunes","year":"2018","unstructured":"Antunes F, et al. Autophagy and intermittent fasting: the connection for cancer therapy? Clin (Sao Paulo). 2018;73:e814s.","journal-title":"Clin (Sao Paulo)"},{"key":"2165_CR433","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11892-017-0951-7","volume":"17","author":"S Golbidi","year":"2017","unstructured":"Golbidi S, et al. Health benefits of fasting and caloric restriction. Curr Diab Rep. 2017;17:123.","journal-title":"Curr Diab Rep"},{"key":"2165_CR434","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1080\/10408398.2020.1847030","volume":"62","author":"L Barrea","year":"2022","unstructured":"Barrea L, et al. Could ketogenic diet starve cancer? Emerging evidence. Crit Rev Food Sci Nutr. 2022;62:1800\u201321.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"2165_CR435","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3390\/cimb43020042","volume":"43","author":"WH Talib","year":"2021","unstructured":"Talib WH, et al. Ketogenic Diet in Cancer Prevention and Therapy: molecular targets and Therapeutic opportunities. Curr Issues Mol Biol. 2021;43:558\u201389.","journal-title":"Curr Issues Mol Biol"},{"key":"2165_CR436","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/MCO.0000000000000944","volume":"26","author":"WH Talib","year":"2023","unstructured":"Talib WH, Al-Dalaeen A, Mahmod AI. Ketogenic diet in cancer management. Curr Opin Clin Nutr Metab Care. 2023;26:369\u201376.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2165_CR437","doi-asserted-by":"crossref","unstructured":"Egashira R, et al. Long-Term effects of a ketogenic Diet for Cancer. Nutrients. 2023;15(10):2334.","DOI":"10.3390\/nu15102334"},{"key":"2165_CR438","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.molmet.2019.06.026","volume":"33","author":"DD Weber","year":"2020","unstructured":"Weber DD, et al. Ketogenic diet in the treatment of cancer - where do we stand? Mol Metab. 2020;33:102\u201321.","journal-title":"Mol Metab"},{"key":"2165_CR439","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1017\/erm.2019.4","volume":"21","author":"JE Unterlass","year":"2019","unstructured":"Unterlass JE, Curtin NJ. Warburg and Krebs and related effects in cancer. Expert Rev Mol Med. 2019;21:e4.","journal-title":"Expert Rev Mol Med"},{"key":"2165_CR440","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.bbadis.2016.11.029","volume":"1863","author":"K Iizuka","year":"2017","unstructured":"Iizuka K. The transcription factor carbohydrate-response element-binding protein (ChREBP): a possible link between metabolic disease and cancer. Biochim Biophys Acta Mol Basis Dis. 2017;1863:474\u201385.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2165_CR441","first-page":"606","volume":"56","author":"CC Ji","year":"2020","unstructured":"Ji CC, et al. A ketogenic diet attenuates proliferation and stemness of glioma stem\u2013like cells by altering metabolism resulting in increased ROS production. Int J Oncol. 2020;56:606\u201317.","journal-title":"Int J Oncol"},{"key":"2165_CR442","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.redox.2014.08.002","volume":"2","author":"BG Allen","year":"2014","unstructured":"Allen BG, et al. Ketogenic diets as an adjuvant cancer therapy: history and potential mechanism. Redox Biol. 2014;2:963\u201370.","journal-title":"Redox Biol"},{"key":"2165_CR443","doi-asserted-by":"publisher","first-page":"4484","DOI":"10.1158\/0008-5472.CAN-10-3973","volume":"71","author":"VW Ho","year":"2011","unstructured":"Ho VW, et al. A low carbohydrate, high protein diet slows tumor growth and prevents cancer initiation. Cancer Res. 2011;71:4484\u201393.","journal-title":"Cancer Res"},{"key":"2165_CR444","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.1158\/1078-0432.CCR-12-0287","volume":"19","author":"BG Allen","year":"2013","unstructured":"Allen BG, et al. Ketogenic diets enhance oxidative stress and radio-chemo-therapy responses in lung cancer xenografts. Clin Cancer Res. 2013;19:3905\u201313.","journal-title":"Clin Cancer Res"},{"key":"2165_CR445","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/1471-2407-8-122","volume":"8","author":"C Otto","year":"2008","unstructured":"Otto C, et al. Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides. BMC Cancer. 2008;8:122.","journal-title":"BMC Cancer"},{"key":"2165_CR446","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/01635580701510150","volume":"60","author":"KE Wheatley","year":"2008","unstructured":"Wheatley KE, et al. Low-carbohydrate diet versus caloric restriction: effects on weight loss, hormones, and colon tumor growth in obese mice. Nutr Cancer. 2008;60:61\u20138.","journal-title":"Nutr Cancer"},{"key":"2165_CR447","doi-asserted-by":"crossref","unstructured":"Hagihara K, et al. Promising effect of a New Ketogenic Diet Regimen in patients with Advanced Cancer. Nutrients. 2020;12(5):1473.","DOI":"10.3390\/nu12051473"},{"issue":"Suppl 2","key":"2165_CR448","first-page":"S94","volume":"11","author":"H Vainio","year":"2002","unstructured":"Vainio H, Kaaks R, Bianchini F. Weight control and physical activity in cancer prevention: international evaluation of the evidence. Eur J Cancer Prev. 2002;11(Suppl 2):S94\u2013100.","journal-title":"Eur J Cancer Prev"},{"key":"2165_CR449","doi-asserted-by":"publisher","first-page":"1335256","DOI":"10.3389\/fimmu.2023.1335256","volume":"14","author":"B Hapuarachi","year":"2023","unstructured":"Hapuarachi B, Danson S, Wadsley J, Muthana M. Exercise to transform tumours from cold to hot and improve immunotherapy responsiveness. Front Immunol. 2023;14:1335256.","journal-title":"Front Immunol"},{"key":"2165_CR450","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/s42255-020-00277-4","volume":"2","author":"GJ Koelwyn","year":"2020","unstructured":"Koelwyn GJ, Zhuang X, Tammela T, Schietinger A, Jones LW. Exercise and immunometabolic regulation in cancer. Nat Metab. 2020;2:849\u201357.","journal-title":"Nat Metab"},{"key":"2165_CR451","doi-asserted-by":"crossref","unstructured":"Rundqvist H, et al. Cytotoxic T-cells mediate exercise-induced reductions in tumor growth. Elife. 2020;9:e59996.","DOI":"10.7554\/eLife.59996"},{"key":"2165_CR452","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1249\/MSS.0000000000002117","volume":"51","author":"AV Patel","year":"2019","unstructured":"Patel AV, et al. American College of Sports Medicine Roundtable Report on Physical Activity, Sedentary Behavior, and Cancer Prevention and Control. Med Sci Sports Exerc. 2019;51:2391\u2013402.","journal-title":"Med Sci Sports Exerc"},{"key":"2165_CR453","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cmet.2017.09.015","volume":"27","author":"P Hojman","year":"2018","unstructured":"Hojman P, Gehl J, Christensen JF, Pedersen BK. Molecular mechanisms linking Exercise to Cancer Prevention and Treatment. Cell Metab. 2018;27:10\u201321.","journal-title":"Cell Metab"},{"key":"2165_CR454","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/nrc.2017.78","volume":"17","author":"GJ Koelwyn","year":"2017","unstructured":"Koelwyn GJ, Quail DF, Zhang X, White RM, Jones LW. Exercise-dependent regulation of the tumour microenvironment. Nat Rev Cancer. 2017;17:620\u201332.","journal-title":"Nat Rev Cancer"},{"key":"2165_CR455","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1161\/CIRCULATIONAHA.106.171016","volume":"113","author":"P Poirier","year":"2006","unstructured":"Poirier P, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and heart disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and metabolism. Circulation. 2006;113:898\u2013918.","journal-title":"Circulation"},{"key":"2165_CR456","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMp068177","volume":"356","author":"P Hossain","year":"2007","unstructured":"Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world\u2013a growing challenge. N Engl J Med. 2007;356:213\u20135.","journal-title":"N Engl J Med"},{"key":"2165_CR457","doi-asserted-by":"publisher","first-page":"182","DOI":"10.7326\/0003-4819-112-3-182","volume":"112","author":"DV Schapira","year":"1990","unstructured":"Schapira DV, Kumar NB, Lyman GH, Cox CE. Abdominal obesity and breast cancer risk. Ann Intern Med. 1990;112:182\u20136.","journal-title":"Ann Intern Med"},{"key":"2165_CR458","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1200\/JCO.2010.32.1752","volume":"29","author":"FA Sinicrope","year":"2011","unstructured":"Sinicrope FA, Dannenberg AJ. Obesity and breast cancer prognosis: weight of the evidence. J Clin Oncol. 2011;29:4\u20137.","journal-title":"J Clin Oncol"},{"key":"2165_CR459","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41575-018-0025-6","volume":"15","author":"PD Cani","year":"2018","unstructured":"Cani PD, Jordan BF. Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer. Nat Rev Gastroenterol Hepatol. 2018;15:671\u201382.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2165_CR460","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/gutjnl-2013-304988","volume":"63","author":"M Hull","year":"2014","unstructured":"Hull M, Lagergren J. Obesity and colorectal cancer. Gut. 2014;63:205.","journal-title":"Gut"},{"key":"2165_CR461","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJM200011023431804","volume":"343","author":"WH Chow","year":"2000","unstructured":"Chow WH, Gridley G, Fraumeni JF Jr., J\u00e4rvholm B. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med. 2000;343:1305\u201311.","journal-title":"N Engl J Med"},{"key":"2165_CR462","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.7150\/jca.16884","volume":"7","author":"R Divella","year":"2016","unstructured":"Divella R, De Luca R, Abbate I, Naglieri E, Daniele A. Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation. J Cancer. 2016;7:2346\u201359.","journal-title":"J Cancer"},{"key":"2165_CR463","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436\u201344.","journal-title":"Nature"},{"key":"2165_CR464","doi-asserted-by":"publisher","first-page":"e457","DOI":"10.1016\/S1470-2045(17)30411-4","volume":"18","author":"J Kerr","year":"2017","unstructured":"Kerr J, Anderson C, Lippman SM. Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence. Lancet Oncol. 2017;18:e457\u201371.","journal-title":"Lancet Oncol"},{"key":"2165_CR465","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1123\/jpah.2021-0243","volume":"18","author":"LS Pescatello","year":"2021","unstructured":"Pescatello LS, et al. Best practices for Meta-Reviews in Physical Activity and Health Research: insights from the physical activity guidelines for americans Advisory Committee Scientific Report. J Phys Act Health. 2021;18:1437\u201345.","journal-title":"J Phys Act Health"},{"key":"2165_CR466","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretan","year":"2016","unstructured":"Lauby-Secretan B, et al. Body fatness and Cancer\u2013viewpoint of the IARC Working Group. N Engl J Med. 2016;375:794\u20138.","journal-title":"N Engl J Med"},{"key":"2165_CR467","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman KM, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011;17:1498\u2013503.","journal-title":"Nat Med"},{"key":"2165_CR468","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1749-6632.2010.05875.x","volume":"1212","author":"Y Deng","year":"2010","unstructured":"Deng Y, Scherer PE. Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann N Y Acad Sci. 2010;1212:E1\u201319.","journal-title":"Ann N Y Acad Sci"},{"key":"2165_CR469","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1200\/JCO.2016.69.6187","volume":"34","author":"AE Lohmann","year":"2016","unstructured":"Lohmann AE, et al. Association of obesity-related metabolic disruptions with Cancer Risk and Outcome. J Clin Oncol. 2016;34:4249\u201355.","journal-title":"J Clin Oncol"},{"key":"2165_CR470","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrendo.2014.94","volume":"10","author":"J Park","year":"2014","unstructured":"Park J, Morley TS, Kim M, Clegg DJ, Scherer PE. Obesity and cancer\u2013mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol. 2014;10:455\u201365.","journal-title":"Nat Rev Endocrinol"},{"key":"2165_CR471","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nm.2277","volume":"17","author":"WL Holland","year":"2011","unstructured":"Holland WL, et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med. 2011;17:55\u201363.","journal-title":"Nat Med"},{"key":"2165_CR472","doi-asserted-by":"publisher","first-page":"42660","DOI":"10.1074\/jbc.M304984200","volume":"278","author":"M Onuma","year":"2003","unstructured":"Onuma M, Bub JD, Rummel TL, Iwamoto Y. Prostate cancer cell-adipocyte interaction: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase. J Biol Chem. 2003;278:42660\u20137.","journal-title":"J Biol Chem"},{"key":"2165_CR473","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/jcb.21911","volume":"105","author":"D Cirillo","year":"2008","unstructured":"Cirillo D, Rachiglio AM, la Montagna R, Giordano A. Normanno, N. Leptin signaling in breast cancer: an overview. J Cell Biochem. 2008;105:956\u201364.","journal-title":"J Cell Biochem"},{"key":"2165_CR474","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","volume":"140","author":"EJ Park","year":"2010","unstructured":"Park EJ, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell. 2010;140:197\u2013208.","journal-title":"Cell"},{"key":"2165_CR475","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.cell.2013.09.031","volume":"155","author":"G He","year":"2013","unstructured":"He G, et al. Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling. Cell. 2013;155:384\u201396.","journal-title":"Cell"},{"key":"2165_CR476","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1053\/j.gastro.2012.05.045","volume":"RETRACTED","author":"MBS Flores","year":"2012","unstructured":"Flores MBS, et al. Obesity-induced increase in tumor necrosis factor-\u03b1 leads to development of colon cancer in mice. Gastroenterol 143. 2012;RETRACTED:741\u2013e753744.","journal-title":"Gastroenterol 143"},{"key":"2165_CR477","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.diabres.2004.11.007","volume":"69","author":"HS Park","year":"2005","unstructured":"Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract. 2005;69:29\u201335.","journal-title":"Diabetes Res Clin Pract"},{"key":"2165_CR478","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nrc3174","volume":"11","author":"MJ Khandekar","year":"2011","unstructured":"Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer. 2011;11:886\u201395.","journal-title":"Nat Rev Cancer"},{"key":"2165_CR479","doi-asserted-by":"publisher","first-page":"11565","DOI":"10.1158\/0008-5472.CAN-06-2540","volume":"66","author":"B Yan","year":"2006","unstructured":"Yan B, et al. Tumor necrosis factor-alpha is a potent endogenous mutagen that promotes cellular transformation. Cancer Res. 2006;66:11565\u201370.","journal-title":"Cancer Res"},{"key":"2165_CR480","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.smim.2014.01.001","volume":"26","author":"K Taniguchi","year":"2014","unstructured":"Taniguchi K, Karin M. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Semin Immunol. 2014;26:54\u201374.","journal-title":"Semin Immunol"},{"key":"2165_CR481","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","volume":"148","author":"VT Samuel","year":"2012","unstructured":"Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148:852\u201371.","journal-title":"Cell"},{"key":"2165_CR482","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV. Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11:325\u201337.","journal-title":"Nat Rev Cancer"},{"key":"2165_CR483","doi-asserted-by":"publisher","first-page":"21058","DOI":"10.1073\/pnas.1214400109","volume":"109","author":"J Park","year":"2012","unstructured":"Park J, Sarode VR, Euhus D, Kittler R, Scherer PE. Neuregulin 1-HER axis as a key mediator of hyperglycemic memory effects in breast cancer. Proc Natl Acad Sci U S A. 2012;109:21058\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2165_CR484","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.2337\/db07-1631","volume":"57","author":"ZV Wang","year":"2008","unstructured":"Wang ZV, et al. PANIC-ATTAC: a mouse model for inducible and reversible beta-cell ablation. Diabetes. 2008;57:2137\u201348.","journal-title":"Diabetes"},{"key":"2165_CR485","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1007\/s00018-020-03752-z","volume":"78","author":"A Kulkarni","year":"2021","unstructured":"Kulkarni A, Bowers LW. The role of immune dysfunction in obesity-associated cancer risk, progression, and metastasis. Cell Mol Life Sci. 2021;78:3423\u201342.","journal-title":"Cell Mol Life Sci"},{"key":"2165_CR486","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","volume":"12","author":"Y Lin","year":"2019","unstructured":"Lin Y, Xu J, Lan H. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J Hematol Oncol. 2019;12:76.","journal-title":"J Hematol Oncol"},{"issue":"Suppl 3","key":"2165_CR487","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1038\/sj.ejcn.1601484","volume":"56","author":"O Lamas","year":"2002","unstructured":"Lamas O, Marti A, Mart\u00ednez JA. Obesity and immunocompetence. Eur J Clin Nutr. 2002;56(Suppl 3):S42\u201345.","journal-title":"Eur J Clin Nutr"},{"key":"2165_CR488","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/ijo.2011.208","volume":"36","author":"PA Sheridan","year":"2012","unstructured":"Sheridan PA, et al. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (Lond). 2012;36:1072\u20137.","journal-title":"Int J Obes (Lond)"},{"key":"2165_CR489","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.nutres.2012.07.003","volume":"32","author":"TF Teixeira","year":"2012","unstructured":"Teixeira TF, Collado MC, Ferreira CL, Bressan J. Peluzio Mdo, C. Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nutr Res. 2012;32:637\u201347.","journal-title":"Nutr Res"},{"key":"2165_CR490","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/nrc3610","volume":"13","author":"RF Schwabe","year":"2013","unstructured":"Schwabe RF, Jobin C. The microbiome and cancer. Nat Rev Cancer. 2013;13:800\u201312.","journal-title":"Nat Rev Cancer"},{"key":"2165_CR491","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13045-023-01498-2","volume":"16","author":"HR Jin","year":"2023","unstructured":"Jin HR, et al. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics. J Hematol Oncol. 2023;16:103.","journal-title":"J Hematol Oncol"},{"key":"2165_CR492","doi-asserted-by":"publisher","first-page":"1327717","DOI":"10.3389\/fphar.2023.1327717","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, et al. Metabolic reprogramming in the tumor microenvironment: unleashing T cell stemness for enhanced cancer immunotherapy. Front Pharmacol. 2023;14:1327717.","journal-title":"Front Pharmacol"},{"key":"2165_CR493","first-page":"643","volume":"46","author":"YC Huang","year":"2023","unstructured":"Huang YC, et al. Involvement of ACACA (acetyl-CoA carboxylase \u03b1) in the lung pre-metastatic niche formation in breast cancer by senescence phenotypic conversion in fibroblasts. Cell Oncol (Dordrecht Netherlands). 2023;46:643\u201360.","journal-title":"Cell Oncol (Dordrecht Netherlands)"},{"key":"2165_CR494","doi-asserted-by":"crossref","unstructured":"Cosentino G, Plantamura I, Tagliabue E, Iorio MV, Cataldo A. Breast Cancer Drug Resistance: overcoming the challenge by capitalizing on MicroRNA and Tumor Microenvironment Interplay. Cancers (Basel). 2021;13(15):3691.","DOI":"10.3390\/cancers13153691"},{"key":"2165_CR495","doi-asserted-by":"crossref","unstructured":"Kinnel B, Singh SK, Oprea-Ilies G, Singh R. Targeted therapy and mechanisms of drug resistance in breast Cancer. Cancers (Basel). 2023;15(4):1320.","DOI":"10.3390\/cancers15041320"},{"key":"2165_CR496","doi-asserted-by":"crossref","unstructured":"Gote V, Nookala AR, Bolla PK, Pal D. Drug Resistance in metastatic breast Cancer: Tumor targeted nanomedicine to the rescue. Int J Mol Sci. 2021;22(9):4673.","DOI":"10.3390\/ijms22094673"},{"key":"2165_CR497","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/annonc\/mdx483","volume":"29","author":"C Fribbens","year":"2018","unstructured":"Fribbens C, et al. Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancer. Annals Oncology: Official J Eur Soc Med Oncol. 2018;29:145\u201353.","journal-title":"Annals Oncology: Official J Eur Soc Med Oncol"},{"key":"2165_CR498","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.1038\/s41467-023-42656-x","volume":"14","author":"WD Pontius","year":"2023","unstructured":"Pontius WD, et al. Temporal chromatin accessibility changes define transcriptional states essential for osteosarcoma metastasis. Nat Commun. 2023;14:7209.","journal-title":"Nat Commun"},{"key":"2165_CR499","doi-asserted-by":"publisher","first-page":"e12042","DOI":"10.1002\/jev2.12042","volume":"10","author":"SE Henrich","year":"2020","unstructured":"Henrich SE, et al. Prostate cancer extracellular vesicles mediate intercellular communication with bone marrow cells and promote metastasis in a cholesterol-dependent manner. J Extracell Vesicles. 2020;10:e12042.","journal-title":"J Extracell Vesicles"},{"key":"2165_CR500","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.semcancer.2019.10.011","volume":"60","author":"R Carvalho","year":"2020","unstructured":"Carvalho R, Paredes J, Ribeiro AS. Impact of breast cancer cells\u00b4 secretome on the brain metastatic niche remodeling. Sem Cancer Biol. 2020;60:294\u2013301.","journal-title":"Sem Cancer Biol"},{"key":"2165_CR501","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jcmgh.2022.06.010","volume":"14","author":"YH Sheng","year":"2022","unstructured":"Sheng YH, et al. MUC1-mediated macrophage activation promotes colitis-associated Colorectal Cancer via activating the Interleukin-6\/ Signal Transducer and activator of transcription 3 Axis. Cell Mol Gastroenterol Hepatol. 2022;14:789\u2013811.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"2165_CR502","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/cac2.12259","volume":"42","author":"N Huang","year":"2022","unstructured":"Huang N, et al. Evolution of tumor microenvironment in colorectal liver metastases under treatment stress. Cancer Commun. 2022;42:471\u20135.","journal-title":"Cancer Commun"},{"key":"2165_CR503","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ccell.2022.06.013","volume":"40","author":"BM Murphy","year":"2022","unstructured":"Murphy BM, Burd CE. The aging lung microenvironment awakens melanoma metastases. Cancer Cell. 2022;40:815\u20137.","journal-title":"Cancer Cell"},{"key":"2165_CR504","doi-asserted-by":"publisher","first-page":"e21562","DOI":"10.1200\/JCO.2022.40.16_suppl.e21562","volume":"40","author":"LZ Kurbanova","year":"2022","unstructured":"Kurbanova LZ, et al. Antimetastatic effect of benzimidazole derivative on the model of melanoma B16 in the experiment. J Clin Oncol. 2022;40:e21562\u201321562.","journal-title":"J Clin Oncol"},{"key":"2165_CR505","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.3324\/haematol.2019.231944","volume":"106","author":"CG Julia","year":"2021","unstructured":"Julia CG, et al. CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidity. Haematologica. 2021;106:2102\u201313.","journal-title":"Haematologica"},{"key":"2165_CR506","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1158\/1535-7163.MCT-17-0784","volume":"17","author":"J Guan","year":"2018","unstructured":"Guan J, Huang D, Yakimchuk K, Okret S. p110\u03b1 inhibition overcomes stromal cell\u2013mediated Ibrutinib Resistance in Mantle Cell Lymphoma. Mol Cancer Ther. 2018;17:1090\u2013100.","journal-title":"Mol Cancer Ther"},{"key":"2165_CR507","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.semcancer.2017.03.006","volume":"44","author":"J Dittmer","year":"2017","unstructured":"Dittmer J. Mechanisms governing metastatic dormancy in breast cancer. Sem Cancer Biol. 2017;44:72\u201382.","journal-title":"Sem Cancer Biol"},{"key":"2165_CR508","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1038\/s41388-018-0637-x","volume":"38","author":"T Motohara","year":"2019","unstructured":"Motohara T, et al. An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment. Oncogene. 2019;38:2885\u201398.","journal-title":"Oncogene"},{"key":"2165_CR509","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.3390\/ijms22042067","volume":"22","author":"RS Dmello","year":"2021","unstructured":"Dmello RS, To SQ, Chand AL. Therapeutic targeting of the Tumour Microenvironment in Metastatic Colorectal Cancer. Int J Mol Sci. 2021;22:2067.","journal-title":"Int J Mol Sci"},{"key":"2165_CR510","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.trecan.2023.02.005","volume":"9","author":"K Ganguly","year":"2023","unstructured":"Ganguly K, Kimmelman AC. Reprogramming of tissue metabolism during cancer metastasis. Trends Cancer. 2023;9:461\u201371.","journal-title":"Trends Cancer"},{"key":"2165_CR511","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13058-019-1123-2","volume":"21","author":"MA Alzubi","year":"2019","unstructured":"Alzubi MA, et al. Separation of breast cancer and organ microenvironment transcriptomes in metastases. Breast Cancer Res. 2019;21:36.","journal-title":"Breast Cancer Res"},{"key":"2165_CR512","doi-asserted-by":"publisher","first-page":"e12125","DOI":"10.1002\/jev2.12125","volume":"10","author":"F Urabe","year":"2021","unstructured":"Urabe F, Patil K, Ramm GA, Ochiya T, Soekmadji C. Extracellular vesicles in the development of organ-specific metastasis. J Extracell Vesicles. 2021;10:e12125.","journal-title":"J Extracell Vesicles"},{"key":"2165_CR513","doi-asserted-by":"crossref","unstructured":"Nolan E, Kang Y, Malanchi I. Mechanisms of organ-specific metastasis of breast Cancer. Cold Spring Harb Perspect Med. 2023;13(11):a041326.","DOI":"10.1101\/cshperspect.a041326"},{"key":"2165_CR514","doi-asserted-by":"crossref","unstructured":"Sun X, et al. Metabolic reprogramming in Triple-negative breast Cancer. Front Oncol. 2020;10:428.","DOI":"10.3389\/fonc.2020.00428"},{"key":"2165_CR515","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.7150\/ijbs.92125","volume":"20","author":"J Wang","year":"2024","unstructured":"Wang J, et al. Reprogramming of lipid metabolism mediates crosstalk, remodeling, and intervention of Microenvironment components in breast Cancer. Int J Biol Sci. 2024;20:1884\u2013904.","journal-title":"Int J Biol Sci"},{"key":"2165_CR516","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s43018-023-00513-2","volume":"4","author":"P Altea-Manzano","year":"2023","unstructured":"Altea-Manzano P, et al. A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-\u03baB signaling. Nat Cancer. 2023;4:344\u201364.","journal-title":"Nat Cancer"},{"key":"2165_CR517","doi-asserted-by":"crossref","unstructured":"Li Y, et al. Extracellular vesicle-mediated pre-metastatic niche formation via altering host microenvironments. Front Immunol. 2024;15:1367373.","DOI":"10.3389\/fimmu.2024.1367373"},{"key":"2165_CR518","doi-asserted-by":"crossref","unstructured":"Ganguly D, et al. Pleiotrophin drives a prometastatic immune niche in breast cancer. J Exp Med. 2023;220(5):e20220610.","DOI":"10.1084\/jem.20220610"},{"key":"2165_CR519","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/s41423-020-00534-2","volume":"18","author":"X Zeng","year":"2021","unstructured":"Zeng X, et al. Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis. Cell Mol Immunol. 2021;18:1005\u201315.","journal-title":"Cell Mol Immunol"},{"key":"2165_CR520","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.semcancer.2017.03.009","volume":"44","author":"K Rycaj","year":"2017","unstructured":"Rycaj K, Li H, Zhou J, Chen X, Tang DG. Cellular determinants and microenvironmental regulation of prostate cancer metastasis. Sem Cancer Biol. 2017;44:83\u201397.","journal-title":"Sem Cancer Biol"},{"key":"2165_CR521","doi-asserted-by":"crossref","unstructured":"Ni Y, et al. The role of tumor-stroma interactions in Drug Resistance within Tumor Microenvironment. Front Cell Dev Biol. 2021;9:637675.","DOI":"10.3389\/fcell.2021.637675"},{"key":"2165_CR522","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41568-023-00634-x","volume":"24","author":"EB Pasquale","year":"2024","unstructured":"Pasquale EB. Eph receptors and ephrins in cancer progression. Nat Rev Cancer. 2024;24:5\u201327.","journal-title":"Nat Rev Cancer"},{"key":"2165_CR523","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.cmet.2021.09.002","volume":"33","author":"SM Morrissey","year":"2021","unstructured":"Morrissey SM, et al. Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming. Cell Metab. 2021;33:2040\u201358. e2010.","journal-title":"Cell Metab"},{"key":"2165_CR524","doi-asserted-by":"publisher","first-page":"703640","DOI":"10.3389\/fmolb.2021.703640","volume":"8","author":"X Yang","year":"2021","unstructured":"Yang X, et al. The Key Role of exosomes on the pre-metastatic niche formation in tumors. Front Mol Biosci. 2021;8:703640.","journal-title":"Front Mol Biosci"},{"key":"2165_CR525","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/s41467-020-14869-x","volume":"11","author":"Q Ji","year":"2020","unstructured":"Ji Q, et al. Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation. Nat Commun. 2020;11:1211.","journal-title":"Nat Commun"},{"key":"2165_CR526","doi-asserted-by":"crossref","unstructured":"Li R, Wen A, Lin J. Pro-inflammatory cytokines in the formation of the Pre-metastatic Niche. Cancers (Basel). 2020;12(12):3752.","DOI":"10.3390\/cancers12123752"},{"key":"2165_CR527","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41416-018-0333-1","volume":"120","author":"C Groth","year":"2019","unstructured":"Groth C, et al. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression. Br J Cancer. 2019;120:16\u201325.","journal-title":"Br J Cancer"},{"key":"2165_CR528","doi-asserted-by":"publisher","first-page":"873792","DOI":"10.3389\/fphar.2022.873792","volume":"13","author":"Z Xie","year":"2022","unstructured":"Xie Z, et al. Targeting GGT1 eliminates the tumor-promoting effect and enhanced immunosuppressive function of myeloid-derived suppressor cells caused by G-CSF. Front Pharmacol. 2022;13:873792.","journal-title":"Front Pharmacol"},{"key":"2165_CR529","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.ccell.2018.02.007","volume":"33","author":"K Nakamura","year":"2018","unstructured":"Nakamura K, et al. Dysregulated IL-18 is a key driver of Immunosuppression and a possible therapeutic target in the multiple Myeloma Microenvironment. Cancer Cell. 2018;33:634\u2013e648635.","journal-title":"Cancer Cell"},{"key":"2165_CR530","doi-asserted-by":"crossref","unstructured":"Habanjar O, et al. Crosstalk of inflammatory cytokines within the breast Tumor Microenvironment. Int J Mol Sci. 2023;24(4):4002.","DOI":"10.3390\/ijms24044002"},{"key":"2165_CR531","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/eji.201948161","volume":"49","author":"C Symowski","year":"2019","unstructured":"Symowski C, Voehringer D. Th2 cell-derived IL-4\/IL-13 promote ILC2 accumulation in the lung by ILC2-intrinsic STAT6 signaling in mice. Eur J Immunol. 2019;49:1421\u201332.","journal-title":"Eur J Immunol"},{"key":"2165_CR532","doi-asserted-by":"publisher","first-page":"734188","DOI":"10.3389\/fimmu.2021.734188","volume":"12","author":"S SenGupta","year":"2021","unstructured":"SenGupta S, Hein LE, Parent CA. The recruitment of neutrophils to the Tumor Microenvironment is regulated by multiple mediators. Front Immunol. 2021;12:734188.","journal-title":"Front Immunol"},{"key":"2165_CR533","doi-asserted-by":"crossref","unstructured":"Hamze Sinno S, et al. Egfl6 promotes ovarian cancer progression by enhancing the immunosuppressive functions of tumor-associated myeloid cells. J Clin Invest. 2024;134(21):e175147.","DOI":"10.1172\/JCI175147"},{"key":"2165_CR534","doi-asserted-by":"crossref","unstructured":"Cabanos HF, Hata AN. Emerging insights into targeted therapy-tolerant Persister cells in Cancer. Cancers (Basel). 2021;13(11):2666.","DOI":"10.3390\/cancers13112666"},{"key":"2165_CR535","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan VS, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547:453\u20137.","journal-title":"Nature"},{"key":"2165_CR536","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cell.2016.02.025","volume":"165","author":"S Malladi","year":"2016","unstructured":"Malladi S, et al. Metastatic latency and Immune Evasion through Autocrine inhibition of WNT. Cell. 2016;165:45\u201360.","journal-title":"Cell"},{"key":"2165_CR537","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1038\/s41388-018-0656-7","volume":"38","author":"G Domenici","year":"2019","unstructured":"Domenici G, et al. A Sox2-Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells. Oncogene. 2019;38:3151\u201369.","journal-title":"Oncogene"},{"key":"2165_CR538","doi-asserted-by":"publisher","first-page":"5236","DOI":"10.1182\/blood-2009-04-219204","volume":"114","author":"M Tremmel","year":"2009","unstructured":"Tremmel M, et al. A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis. Blood. 2009;114:5236\u201344.","journal-title":"Blood"},{"key":"2165_CR539","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10138","volume":"475","author":"BZ Qian","year":"2011","unstructured":"Qian BZ, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 2011;475:222\u20135.","journal-title":"Nature"},{"key":"2165_CR540","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/j.0022-202X.2004.23460.x","volume":"123","author":"J Graells","year":"2004","unstructured":"Graells J, et al. Overproduction of VEGF concomitantly expressed with its receptors promotes growth and survival of melanoma cells through MAPK and PI3K signaling. J Invest Dermatol. 2004;123:1151\u201361.","journal-title":"J Invest Dermatol"},{"key":"2165_CR541","doi-asserted-by":"publisher","first-page":"29087","DOI":"10.1074\/jbc.M109.035899","volume":"284","author":"X Lu","year":"2009","unstructured":"Lu X, Kang Y. Chemokine (C-C motif) ligand 2 engages CCR2\u2009+\u2009stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone. J Biol Chem. 2009;284:29087\u201396.","journal-title":"J Biol Chem"},{"key":"2165_CR542","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.7150\/thno.45351","volume":"11","author":"X Yuan","year":"2021","unstructured":"Yuan X, et al. Breast cancer exosomes contribute to pre-metastatic niche formation and promote bone metastasis of tumor cells. Theranostics. 2021;11:1429\u201345.","journal-title":"Theranostics"},{"key":"2165_CR543","doi-asserted-by":"publisher","first-page":"733627","DOI":"10.3389\/fcell.2021.733627","volume":"9","author":"Q Dong","year":"2021","unstructured":"Dong Q, et al. Pre-metastatic niche formation in different organs Induced by Tumor Extracellular vesicles. Front Cell Dev Biol. 2021;9:733627.","journal-title":"Front Cell Dev Biol"},{"key":"2165_CR544","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1039\/C8LC00100F","volume":"18","author":"L Gorgannezhad","year":"2018","unstructured":"Gorgannezhad L, Umer M, Islam MN, Nguyen NT, Shiddiky MJA. Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies. Lab Chip. 2018;18:1174\u201396.","journal-title":"Lab Chip"},{"key":"2165_CR545","doi-asserted-by":"crossref","unstructured":"Keup C, et al. Multimodal targeted deep sequencing of circulating Tumor cells and matched cell-free DNA provides a more Comprehensive Tool to identify therapeutic targets in metastatic breast Cancer patients. Cancers (Basel). 2020;12(5):1084.","DOI":"10.3390\/cancers12051084"},{"key":"2165_CR546","doi-asserted-by":"publisher","first-page":"2103497","DOI":"10.1002\/adma.202103497","volume":"33","author":"Y Wang","year":"2021","unstructured":"Wang Y, et al. Engineering Endogenous Tumor-Associated macrophage-targeted biomimetic Nano-RBC to Reprogram Tumor Immunosuppressive Microenvironment for enhanced chemo-immunotherapy. Adv Mater. 2021;33:2103497.","journal-title":"Adv Mater"},{"key":"2165_CR547","doi-asserted-by":"crossref","unstructured":"Liu K et al. IL-35 regulates the function of Immune cells in Tumor Microenvironment. Front Immunol 12 (2021).","DOI":"10.3389\/fimmu.2021.683332"},{"key":"2165_CR548","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13046-022-02588-8","volume":"42","author":"T Wu","year":"2023","unstructured":"Wu T, et al. RETRACTED ARTICLE: LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer. J Experimental Clin Cancer Res. 2023;42:14.","journal-title":"J Experimental Clin Cancer Res"},{"key":"2165_CR549","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13046-021-01974-y","volume":"40","author":"G-H Li","year":"2021","unstructured":"Li G-H, et al. Super-enhancers: a new frontier for epigenetic modifiers in cancer chemoresistance. J Experimental Clin Cancer Res. 2021;40:174.","journal-title":"J Experimental Clin Cancer Res"},{"key":"2165_CR550","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1158\/1538-7445.AM2021-1335","volume":"81","author":"GJ Goreczny","year":"2021","unstructured":"Goreczny GJ, Escobedo J, Sandanayaka V. Abstract 1335: dual MCT1\/4 inhibition promotes anti-tumor immunity in triple-negative breast cancer. Cancer Res. 2021;81:1335\u20131335.","journal-title":"Cancer Res"},{"key":"2165_CR551","doi-asserted-by":"crossref","unstructured":"Han X, et al. Study on the mechanism of MDSC-platelets and their role in the breast cancer microenvironment. Front Cell Dev Biol. 2024;12:1310442.","DOI":"10.3389\/fcell.2024.1310442"},{"key":"2165_CR552","doi-asserted-by":"publisher","first-page":"2301343","DOI":"10.1002\/adhm.202301343","volume":"12","author":"X Han","year":"2023","unstructured":"Han X, et al. Bacterial magnetosome-hitchhiked quick-frozen neutrophils for targeted Destruction of Pre-metastatic Niche and Prevention of Tumor Metastasis. Adv Healthc Mater. 2023;12:2301343.","journal-title":"Adv Healthc Mater"},{"key":"2165_CR553","doi-asserted-by":"publisher","first-page":"eaao4227","DOI":"10.1126\/science.aao4227","volume":"361","author":"J Albrengues","year":"2018","unstructured":"Albrengues J, et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science. 2018;361:eaao4227.","journal-title":"Science"},{"key":"2165_CR554","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41419-021-03745-1","volume":"12","author":"M Liu","year":"2021","unstructured":"Liu M, et al. Myeloid-derived suppressor cells regulate the immunosuppressive functions of PD-1 \u2013 PD-L1\u2009+\u2009bregs through PD-L1\/PI3K\/AKT\/NF-\u03baB axis in breast cancer. Cell Death Dis. 2021;12:465.","journal-title":"Cell Death Dis"},{"key":"2165_CR555","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/ncb3355","volume":"18","author":"T Welte","year":"2016","unstructured":"Welte T, et al. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol. 2016;18:632\u201344.","journal-title":"Nat Cell Biol"},{"key":"2165_CR556","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.molimm.2019.11.014","volume":"117","author":"BH Li","year":"2020","unstructured":"Li BH, Garstka MA, Li ZF. Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor. Mol Immunol. 2020;117:201\u201315.","journal-title":"Mol Immunol"},{"key":"2165_CR557","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.4049\/jimmunol.1400833","volume":"193","author":"J Yu","year":"2014","unstructured":"Yu J, et al. Noncanonical NF-\u03baB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancer. J Immunol. 2014;193:2574\u201386.","journal-title":"J Immunol"},{"key":"2165_CR558","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s12272-016-0822-9","volume":"39","author":"HJ Ko","year":"2016","unstructured":"Ko HJ, Kim YJ. Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer. Arch Pharm Res. 2016;39:1597\u2013608.","journal-title":"Arch Pharm Res"},{"key":"2165_CR559","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1182\/blood.V126.23.644.644","volume":"126","author":"L Andzinski","year":"2015","unstructured":"Andzinski L, et al. The mechanism of type I Interferon-mediated polarization of Tumor-Associated neutrophils in mice and human. Blood. 2015;126:644\u2013644.","journal-title":"Blood"},{"key":"2165_CR560","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3390\/ijms22020753","volume":"22","author":"S Ghatak","year":"2021","unstructured":"Ghatak S, Hascall VC, Markwald RR, Misra S. FOLFOX Therapy induces Feedback Upregulation of CD44v6 through YB-1 to maintain stemness in Colon initiating cells. Int J Mol Sci. 2021;22:753.","journal-title":"Int J Mol Sci"},{"key":"2165_CR561","doi-asserted-by":"publisher","first-page":"e1019","DOI":"10.1002\/ctm2.1019","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, et al. Chrysin targets myeloid-derived suppressor cells and enhances tumour response to anti-PD-1 immunotherapy. Clin Translational Med. 2022;12:e1019.","journal-title":"Clin Translational Med"},{"key":"2165_CR562","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3892\/or.2021.7936","volume":"45","author":"MH Rashid","year":"2021","unstructured":"Rashid MH, et al. Critical immunosuppressive effect of MDSC\u2013derived exosomes in the tumor microenvironment. Oncol Rep. 2021;45:1171\u201381.","journal-title":"Oncol Rep"},{"key":"2165_CR563","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1182\/blood.V128.22.3690.3690","volume":"128","author":"T Tsubaki","year":"2016","unstructured":"Tsubaki T, et al. Elucidation of tumor-promoting effects of Novel Adherent Immature Myeloid cells in Tumor. Blood. 2016;128:3690\u20133690.","journal-title":"Blood"},{"key":"2165_CR564","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/cac2.12496","volume":"44","author":"O Safak","year":"2024","unstructured":"Safak O, et al. Dynamics and cytokinic regulation of immune cell infiltration in genetically engineered mouse models of pancreatic cancer dictate the sensitivity to immunotherapy. Cancer Commun. 2024;44:178\u201382.","journal-title":"Cancer Commun"},{"key":"2165_CR565","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12967-022-03649-4","volume":"20","author":"G Zhang","year":"2022","unstructured":"Zhang G, et al. Loss of endothelial EMCN drives tumor lung metastasis through the premetastatic niche. J Translational Med. 2022;20:446.","journal-title":"J Translational Med"},{"key":"2165_CR566","doi-asserted-by":"crossref","unstructured":"Su M-T, Kumata S, Endo S, Okada Y, Takai T. LILRB4 promotes tumor metastasis by regulating MDSCs and inhibiting miR-1 family miRNAs. Oncoimmunology. 2022;11(1):2060907.","DOI":"10.1080\/2162402X.2022.2060907"},{"key":"2165_CR567","first-page":"A50","volume":"8","author":"C Pilard","year":"2020","unstructured":"Pilard C, et al. P08.03 combining PD-1\/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy. J Immunother Cancer. 2020;8:A50\u20131.","journal-title":"J Immunother Cancer"},{"key":"2165_CR568","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.mehy.2016.05.022","volume":"93","author":"X Wang","year":"2016","unstructured":"Wang X, et al. CTC immune escape mediated by PD-L1. Med Hypotheses. 2016;93:138\u20139.","journal-title":"Med Hypotheses"},{"key":"2165_CR569","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40425-017-0308-4","volume":"5","author":"SM Steggerda","year":"2017","unstructured":"Steggerda SM, et al. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment. J Immunother Cancer. 2017;5:101.","journal-title":"J Immunother Cancer"},{"key":"2165_CR570","doi-asserted-by":"publisher","first-page":"106777","DOI":"10.1016\/j.phrs.2023.106777","volume":"191","author":"X Zhang","year":"2023","unstructured":"Zhang X, et al. Research progress on the interaction between oxidative stress and platelets: another avenue for cancer? Pharmacol Res. 2023;191:106777.","journal-title":"Pharmacol Res"},{"key":"2165_CR571","doi-asserted-by":"publisher","first-page":"2301455","DOI":"10.1002\/adma.202301455","volume":"35","author":"L Yang","year":"2023","unstructured":"Yang L, et al. Tumor-specific Peroxynitrite overproduction disrupts metabolic homeostasis for sensitizing Melanoma Immunotherapy. Adv Mater. 2023;35:2301455.","journal-title":"Adv Mater"},{"key":"2165_CR572","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jconrel.2016.12.012","volume":"246","author":"F Jadidi-Niaragh","year":"2017","unstructured":"Jadidi-Niaragh F, et al. CD73 specific siRNA loaded Chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice. J Controlled Release. 2017;246:46\u201359.","journal-title":"J Controlled Release"},{"key":"2165_CR573","first-page":"A827","volume":"9","author":"H Lu","year":"2021","unstructured":"Lu H, et al. 792 creating an immune-favorable tumor microenvironment by a novel anti-CD39\/TGF\u03b2-Trap bispecific antibody. J Immunother Cancer. 2021;9:A827\u2013827.","journal-title":"J Immunother Cancer"},{"key":"2165_CR574","doi-asserted-by":"publisher","first-page":"14522","DOI":"10.1021\/acsnano.1c04068","volume":"15","author":"M Jiang","year":"2021","unstructured":"Jiang M, et al. Dual inhibition of endoplasmic reticulum stress and oxidation stress manipulates the polarization of macrophages under Hypoxia to Sensitize Immunotherapy. ACS Nano. 2021;15:14522\u201334.","journal-title":"ACS Nano"},{"key":"2165_CR575","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1021\/acs.chemrestox.8b00148","volume":"31","author":"Y Wang","year":"2018","unstructured":"Wang Y, et al. Polychlorinated Biphenyl Quinones promotes breast Cancer metastasis through reactive oxygen species-mediated nuclear factor \u03baB-Matrix Metalloproteinase Signaling. Chem Res Toxicol. 2018;31:954\u201363.","journal-title":"Chem Res Toxicol"},{"key":"2165_CR576","doi-asserted-by":"publisher","first-page":"e002115","DOI":"10.1136\/jitc-2020-002115","volume":"9","author":"N Yamashita","year":"2021","unstructured":"Yamashita N, et al. MUC1-C integrates activation of the IFN-\u03b3 pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer. J Immunother Cancer. 2021;9:e002115.","journal-title":"J Immunother Cancer"},{"key":"2165_CR577","doi-asserted-by":"crossref","unstructured":"Purbey PK, et al. Opposing tumor-cell-intrinsic and -extrinsic roles of the IRF1 transcription factor in antitumor immunity. Cell Rep. 2024;43(6):114289.","DOI":"10.1016\/j.celrep.2024.114289"},{"key":"2165_CR578","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40364-024-00605-w","volume":"12","author":"L Dai","year":"2024","unstructured":"Dai L, et al. Single-cell and spatial transcriptomics reveal a high glycolysis B cell and tumor-associated macrophages cluster correlated with poor prognosis and exhausted immune microenvironment in diffuse large B-cell lymphoma. Biomark Res. 2024;12:58.","journal-title":"Biomark Res"},{"key":"2165_CR579","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/cac2.12407","volume":"43","author":"S Keelan","year":"2023","unstructured":"Keelan S, et al. Dynamic epi-transcriptomic landscape mapping with disease progression in estrogen receptor-positive breast cancer. Cancer Commun. 2023;43:615\u20139.","journal-title":"Cancer Commun"},{"key":"2165_CR580","first-page":"A117","volume":"8","author":"C Eberle","year":"2020","unstructured":"Eberle C, Rowe J, Fiore A, Mihalek R, Festin S. 199 enhanced immune responses in human breast and colon cancer following checkpoint therapy in a CD34\u2009<\u2009sup>+\u2009stem cell humanized NCG (HuCD34NCG) mouse model. J Immunother Cancer. 2020;8:A117\u2013117.","journal-title":"J Immunother Cancer"},{"key":"2165_CR581","doi-asserted-by":"publisher","first-page":"4494","DOI":"10.1158\/1078-0432.CCR-22-0543","volume":"28","author":"P Gazinska","year":"2022","unstructured":"Gazinska P, et al. Dynamic changes in the NK-, Neutrophil-, and B-cell immunophenotypes relevant in high metastatic risk Post Neoadjuvant chemotherapy\u2013resistant early breast cancers. Clin Cancer Res. 2022;28:4494\u2013508.","journal-title":"Clin Cancer Res"},{"key":"2165_CR582","doi-asserted-by":"crossref","unstructured":"Tokumaru Y, et al. Abstract 2697: Prognostic significance of intratumoral neutrophil lymphocyte ratio (NLR) in breast cancer patients. Cancer Res. 2021;81(13_Supplement):2697.","DOI":"10.1158\/1538-7445.AM2021-2697"},{"key":"2165_CR583","first-page":"A623","volume":"9","author":"MG Han","year":"2021","unstructured":"Han MG, Jang BS, Kang MH, Na D, Kim IA. 593 PI3K\u03b3\u03b4 inhibitor combined with radiation enhances the antitumor immune effect of PD-1 blockade in syngenic murine breast cancer model and humanized patient-derived xenograft model. J Immunother Cancer. 2021;9:A623\u2013623.","journal-title":"J Immunother Cancer"},{"key":"2165_CR584","doi-asserted-by":"crossref","unstructured":"Mori H, et al. Abstract PD1-04: Estrogen-mediated mechanisms in estrogen receptor-positive breast cancer at the single cell level. Cancer Res. 2022;82(4_Supplement):PD1\u201304.","DOI":"10.1158\/1538-7445.SABCS21-PD1-04"},{"key":"2165_CR585","doi-asserted-by":"publisher","first-page":"e1013","DOI":"10.1002\/ctm2.1013","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang X, et al. MTHFR inhibits TRC8-mediated HMOX1 ubiquitination and regulates ferroptosis in ovarian cancer. Clin Translational Med. 2022;12:e1013.","journal-title":"Clin Translational Med"},{"key":"2165_CR586","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/cac2.12276","volume":"42","author":"C Lee","year":"2022","unstructured":"Lee C, et al. Combination of anti-PD-L1 antibody with peptide MEL-dKLA targeting M2 tumor-associated macrophages suppresses breast cancer metastasis. Cancer Commun. 2022;42:345\u20139.","journal-title":"Cancer Commun"},{"key":"2165_CR587","doi-asserted-by":"publisher","first-page":"eadd5204","DOI":"10.1126\/sciimmunol.add5204","volume":"8","author":"Z Gong","year":"2023","unstructured":"Gong Z, et al. Immunosuppressive reprogramming of neutrophils by lung mesenchymal cells promotes breast cancer metastasis. Sci Immunol. 2023;8:eadd5204.","journal-title":"Sci Immunol"},{"key":"2165_CR588","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/ncb3578","volume":"19","author":"DF Quail","year":"2017","unstructured":"Quail DF, et al. Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF. Nat Cell Biol. 2017;19:974\u201387.","journal-title":"Nat Cell Biol"},{"key":"2165_CR589","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41392-023-01542-0","volume":"8","author":"T Ma","year":"2023","unstructured":"Ma T, et al. Chronic pulmonary bacterial infection facilitates breast cancer lung metastasis by recruiting tumor-promoting MHCIIhi neutrophils. Signal Transduct Target Therapy. 2023;8:296.","journal-title":"Signal Transduct Target Therapy"},{"key":"2165_CR590","doi-asserted-by":"publisher","first-page":"e006589","DOI":"10.1136\/jitc-2022-006589","volume":"11","author":"V Cardot-Ruffino","year":"2023","unstructured":"Cardot-Ruffino V, et al. G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans. J Immunother Cancer. 2023;11:e006589.","journal-title":"J Immunother Cancer"},{"key":"2165_CR591","doi-asserted-by":"publisher","first-page":"e0166553","DOI":"10.1371\/journal.pone.0166553","volume":"11","author":"KM Henkels","year":"2016","unstructured":"Henkels KM, Muppani NR, Gomez-Cambronero J. PLD-Specific small-molecule inhibitors decrease Tumor-Associated macrophages and neutrophils infiltration in breast tumors and lung and liver metastases. PLoS ONE. 2016;11:e0166553.","journal-title":"PLoS ONE"},{"key":"2165_CR592","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/cac2.12228","volume":"42","author":"G Yuan","year":"2022","unstructured":"Yuan G, Huang Y, Yang S-t, Ng A, Yang S. RGS12 inhibits the progression and metastasis of multiple myeloma by driving M1 macrophage polarization and activation in the bone marrow microenvironment. Cancer Commun. 2022;42:60\u20134.","journal-title":"Cancer Commun"},{"key":"2165_CR593","doi-asserted-by":"publisher","first-page":"e0304194","DOI":"10.1371\/journal.pone.0304194","volume":"19","author":"E Tsutsumi","year":"2024","unstructured":"Tsutsumi E, Macy AM, LoBello J, Hastings KT, Kim S. Tumor immune microenvironment permissive to metastatic progression of ING4-deficient breast cancer. PLoS ONE. 2024;19:e0304194.","journal-title":"PLoS ONE"},{"key":"2165_CR594","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1038\/s41598-023-50062-y","volume":"14","author":"T Oba","year":"2024","unstructured":"Oba T, Long MD, Ito K-i, Ito F. Clinical and immunological relevance of SLAMF6 expression in the tumor microenvironment of breast cancer and melanoma. Sci Rep. 2024;14:2394.","journal-title":"Sci Rep"},{"key":"2165_CR595","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41590-022-01384-y","volume":"24","author":"AA Saadey","year":"2023","unstructured":"Saadey AA, et al. Rebalancing TGF\u03b21\/BMP signals in exhausted T cells unlocks responsiveness to immune checkpoint blockade therapy. Nat Immunol. 2023;24:280\u201394.","journal-title":"Nat Immunol"},{"key":"2165_CR596","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1158\/2326-6066.CIR-20-0736","volume":"10","author":"A Somasundaram","year":"2022","unstructured":"Somasundaram A, et al. Systemic Immune Dysfunction in Cancer patients driven by IL6 induction of LAG3 in Peripheral CD8\u2009+\u2009T cells. Cancer Immunol Res. 2022;10:885\u201399.","journal-title":"Cancer Immunol Res"},{"key":"2165_CR597","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","volume":"54","author":"S Xu","year":"2021","unstructured":"Xu S, et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8\u2009+\u2009T cells in tumors. Immunity. 2021;54:1561\u2013e15771567.","journal-title":"Immunity"},{"key":"2165_CR598","doi-asserted-by":"publisher","first-page":"e13041","DOI":"10.1200\/JCO.2021.39.15_suppl.e13041","volume":"39","author":"IA Kim","year":"2021","unstructured":"Kim IA, Han MG, Jang BS, Kang MH. PI3K\u03b3\u03b4 inhibitor combined radiation enhances the antitumor immune effect of PD-1 blockade in syngenic triple negative breast cancer models. J Clin Oncol. 2021;39:e13041\u201313041.","journal-title":"J Clin Oncol"},{"key":"2165_CR599","doi-asserted-by":"crossref","unstructured":"Kim JY, et al. Abstract 1666: Tumor-specificity of tumor-infiltrating CD8\u2009+\u2009t cells determines the potential of immune checkpoint inhibitors in breast cancer. Cancer Res. 2021;81(13_Supplement):1666.","DOI":"10.1158\/1538-7445.AM2021-1666"},{"key":"2165_CR600","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41420-024-01910-x","volume":"10","author":"A Affinito","year":"2024","unstructured":"Affinito A, et al. MCT4-driven CAF-mediated metabolic reprogramming in breast cancer microenvironment is a vulnerability targetable by miR-425-5p. Cell Death Discovery. 2024;10:140.","journal-title":"Cell Death Discovery"},{"key":"2165_CR601","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature14492","volume":"522","author":"TR Cox","year":"2015","unstructured":"Cox TR, et al. RETRACTED ARTICLE: the hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. Nature. 2015;522:106\u201310.","journal-title":"Nature"},{"key":"2165_CR602","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41368-023-00236-1","volume":"15","author":"X Liu","year":"2023","unstructured":"Liu X, et al. Carcinoma-associated fibroblast-derived lysyl oxidase-rich extracellular vesicles mediate collagen crosslinking and promote epithelial-mesenchymal transition via p-FAK\/p-paxillin\/YAP signaling. Int J Oral Sci. 2023;15:32.","journal-title":"Int J Oral Sci"},{"key":"2165_CR603","first-page":"963","volume":"57","author":"M Relf","year":"1997","unstructured":"Relf M, et al. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res. 1997;57:963\u20139.","journal-title":"Cancer Res"},{"key":"2165_CR604","doi-asserted-by":"publisher","first-page":"150142","DOI":"10.1016\/j.bbrc.2024.150142","volume":"720","author":"SK Gurung","year":"2024","unstructured":"Gurung SK, Shevde LA, Rao SS. Laminin I mediates resistance to lapatinib in HER2-positive brain metastatic breast cancer cells in vitro. Biochem Biophys Res Commun. 2024;720:150142.","journal-title":"Biochem Biophys Res Commun"},{"key":"2165_CR605","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino A, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527:329\u201335.","journal-title":"Nature"},{"key":"2165_CR606","doi-asserted-by":"publisher","first-page":"110413","DOI":"10.1016\/j.intimp.2023.110413","volume":"121","author":"X Li","year":"2023","unstructured":"Li X, et al. All-trans-retinoic acid inhibits hepatocellular carcinoma progression by targeting myeloid-derived suppressor cells and inhibiting angiogenesis. Int Immunopharmacol. 2023;121:110413.","journal-title":"Int Immunopharmacol"},{"key":"2165_CR607","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1164\/rccm.200903-0322OC","volume":"180","author":"H Tanjore","year":"2009","unstructured":"Tanjore H, et al. Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am J Respir Crit Care Med. 2009;180:657\u201365.","journal-title":"Am J Respir Crit Care Med"},{"key":"2165_CR608","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1136\/gutjnl-2020-323014","volume":"71","author":"Z Xie","year":"2022","unstructured":"Xie Z, et al. Exosome-delivered CD44v6\/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment. Gut. 2022;71:568\u201379.","journal-title":"Gut"},{"key":"2165_CR609","doi-asserted-by":"publisher","first-page":"158","DOI":"10.18632\/oncoscience.381","volume":"4","author":"S Ishihara","year":"2017","unstructured":"Ishihara S, Ponik SM, Haga H. Mesenchymal stem cells in breast cancer: response to chemical and mechanical stimuli. Oncoscience. 2017;4:158\u20139.","journal-title":"Oncoscience"},{"key":"2165_CR610","doi-asserted-by":"publisher","first-page":"5529","DOI":"10.4049\/jimmunol.1403215","volume":"194","author":"SK Sharma","year":"2015","unstructured":"Sharma SK, et al. Pulmonary alveolar macrophages contribute to the premetastatic niche by suppressing antitumor T cell responses in the lungs. J Immunol. 2015;194:5529\u201338.","journal-title":"J Immunol"},{"key":"2165_CR611","doi-asserted-by":"crossref","unstructured":"Altea-Manzano P, et al. A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-\u03baB signaling. Nat Cancer. 2023;4(3):344\u201364.","DOI":"10.1038\/s43018-023-00513-2"},{"key":"2165_CR612","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.immuni.2022.07.001","volume":"55","author":"Z Gong","year":"2022","unstructured":"Gong Z, et al. Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment. Immunity. 2022;55:1483\u2013e15001489.","journal-title":"Immunity"},{"key":"2165_CR613","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1158\/0008-5472.CAN-13-0109","volume":"73","author":"A Natsume","year":"2013","unstructured":"Natsume A, et al. Chromatin Regulator PRC2 is a Key Regulator of Epigenetic plasticity in Glioblastoma. Cancer Res. 2013;73:4559\u201370.","journal-title":"Cancer Res"},{"key":"2165_CR614","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1158\/1541-7786.MCR-22-0451","volume":"21","author":"JM Buschhaus","year":"2023","unstructured":"Buschhaus JM, et al. Bone marrow mesenchymal stem cells induce metabolic plasticity in Estrogen receptor\u2013positive breast Cancer. Mol Cancer Res. 2023;21:458\u201371.","journal-title":"Mol Cancer Res"},{"key":"2165_CR615","doi-asserted-by":"publisher","first-page":"104683","DOI":"10.1016\/j.phrs.2020.104683","volume":"153","author":"KGK Deepak","year":"2020","unstructured":"Deepak KGK, et al. Tumor microenvironment: challenges and opportunities in targeting metastasis of triple negative breast cancer. Pharmacol Res. 2020;153:104683.","journal-title":"Pharmacol Res"},{"key":"2165_CR616","doi-asserted-by":"publisher","first-page":"7419","DOI":"10.3390\/ijms23137419","volume":"23","author":"V Jacquier","year":"2022","unstructured":"Jacquier V, Gitenay D, Cavaill\u00e8s V, Teyssier C. The transcription coregulator RIP140 inhibits Cancer Cell Proliferation by targeting the pentose phosphate pathway. Int J Mol Sci. 2022;23:7419.","journal-title":"Int J Mol Sci"},{"key":"2165_CR617","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12943-017-0742-4","volume":"16","author":"Q Liu","year":"2017","unstructured":"Liu Q, et al. Factors involved in cancer metastasis: a better understanding to seed and soil hypothesis. Mol Cancer. 2017;16:176.","journal-title":"Mol Cancer"},{"key":"2165_CR618","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10238-006-0117-4","volume":"6","author":"D Ribatti","year":"2006","unstructured":"Ribatti D, Mangialardi G, Vacca A. Stephen Paget and the \u2018seed and soil\u2019 theory of metastatic dissemination. Clin Experimental Med. 2006;6:145\u20139.","journal-title":"Clin Experimental Med"},{"key":"2165_CR619","first-page":"39","volume":"207","author":"EC Lien","year":"2016","unstructured":"Lien EC, Lyssiotis CA, Cantley LC. Metabolic reprogramming by the PI3K-Akt-mTOR pathway in Cancer. Recent Results cancer Res Fortschr Der Krebsforschung Progres dans les recherches sur le cancer. 2016;207:39\u201372.","journal-title":"Recent Results cancer Res Fortschr Der Krebsforschung Progres dans les recherches sur le cancer"},{"key":"2165_CR620","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12964-022-00989-y","volume":"20","author":"E Corrales","year":"2022","unstructured":"Corrales E, et al. PI3K\/AKT signaling allows for MAPK\/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma. Cell Communication Signaling: CCS. 2022;20:187.","journal-title":"Cell Communication Signaling: CCS"},{"key":"2165_CR621","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12967-020-02237-8","volume":"18","author":"J Chen","year":"2020","unstructured":"Chen J, et al. Metabolic classification of circulating tumor cells as a biomarker for metastasis and prognosis in breast cancer. J Translational Med. 2020;18:59.","journal-title":"J Translational Med"},{"key":"2165_CR622","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13046-018-0789-0","volume":"37","author":"J Chen","year":"2018","unstructured":"Chen J, et al. Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer. J Experimental Clin cancer Research: CR. 2018;37:127.","journal-title":"J Experimental Clin cancer Research: CR"},{"key":"2165_CR623","doi-asserted-by":"crossref","unstructured":"Radhakrishnan V, Kaifi JT, Suvilesh KN. Circulating Tumor Cells: How Far Have We Come with Mining These Seeds of Metastasis? Cancers (Basel). 2024;16(4):816.","DOI":"10.3390\/cancers16040816"},{"key":"2165_CR624","doi-asserted-by":"crossref","unstructured":"Salu P, Reindl KM. Advancements in circulating Tumor Cell Research: bridging Biology and clinical applications. Cancers (Basel). 2024;16(6):1213.","DOI":"10.3390\/cancers16061213"},{"key":"2165_CR625","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13578-022-00898-0","volume":"12","author":"J Wilting","year":"2022","unstructured":"Wilting J, Becker J. The lymphatic vascular system: much more than just a sewer. Cell Bioscience. 2022;12:157.","journal-title":"Cell Bioscience"},{"key":"2165_CR626","doi-asserted-by":"crossref","unstructured":"Fujimoto N, Dieterich LC. Mechanisms and clinical significance of Tumor Lymphatic Invasion. Cells. 2021;10(10):2585.","DOI":"10.3390\/cells10102585"},{"key":"2165_CR627","doi-asserted-by":"publisher","first-page":"672195","DOI":"10.3389\/fonc.2021.672195","volume":"11","author":"F Chemi","year":"2021","unstructured":"Chemi F, et al. Early dissemination of circulating Tumor cells: Biological and clinical insights. Front Oncol. 2021;11:672195.","journal-title":"Front Oncol"},{"key":"2165_CR628","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12943-021-01347-1","volume":"20","author":"MP Ward","year":"2021","unstructured":"Ward MP, et al. Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell? Mol Cancer. 2021;20:59.","journal-title":"Mol Cancer"},{"key":"2165_CR629","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10585-021-10120-z","volume":"39","author":"SP Leong","year":"2022","unstructured":"Leong SP, Naxerova K, Keller L, Pantel K, Witte M. Molecular mechanisms of cancer metastasis via the lymphatic versus the blood vessels. Clin Exp Metastasis. 2022;39:159\u201379.","journal-title":"Clin Exp Metastasis"},{"key":"2165_CR630","doi-asserted-by":"crossref","unstructured":"Genna A, et al. EMT-Associated Heterogeneity in circulating Tumor cells: Sticky friends on the Road to Metastasis. Cancers (Basel). 2020;12(6):1632.","DOI":"10.3390\/cancers12061632"},{"key":"2165_CR631","doi-asserted-by":"crossref","unstructured":"Xu Z, et al. Fluid shear stress regulates the survival of circulating tumor cells via nuclear expansion. J Cell Sci. 2022;135(10):jcs259586.","DOI":"10.1242\/jcs.259586"},{"key":"2165_CR632","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","volume":"15","author":"Y Huang","year":"2022","unstructured":"Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol. 2022;15:129.","journal-title":"J Hematol Oncol"},{"key":"2165_CR633","doi-asserted-by":"crossref","unstructured":"Tang Y, Durand S, Dalle S, Caramel J. EMT-Inducing transcription factors, drivers of Melanoma phenotype switching, and resistance to treatment. Cancers (Basel). 2020;12(8):2154.","DOI":"10.3390\/cancers12082154"},{"key":"2165_CR634","doi-asserted-by":"crossref","unstructured":"Sun Y et al. Platelet-mediated circulating tumor cell evasion from natural killer cell killing through immune checkpoint CD155-TIGIT. Hepatology (Baltimore, Md.) (2024).","DOI":"10.1097\/HEP.0000000000000934"},{"key":"2165_CR635","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12943-023-01748-4","volume":"22","author":"B Wu","year":"2023","unstructured":"Wu B, Shi X, Jiang M, Liu H. Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment. Mol Cancer. 2023;22:38.","journal-title":"Mol Cancer"},{"key":"2165_CR636","doi-asserted-by":"crossref","unstructured":"Aramini B, et al. Dissecting Tumor Growth: the role of Cancer Stem cells in Drug Resistance and Recurrence. Cancers (Basel). 2022;14(4):976.","DOI":"10.3390\/cancers14040976"},{"key":"2165_CR637","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12935-023-02992-w","volume":"23","author":"S Safaei","year":"2023","unstructured":"Safaei S, et al. Tumor matrix stiffness provides fertile soil for cancer stem cells. Cancer Cell Int. 2023;23:143.","journal-title":"Cancer Cell Int"},{"key":"2165_CR638","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-3-031-12974-2_4","volume":"1393","author":"SM Afify","year":"2022","unstructured":"Afify SM, et al. Functional and molecular characters of Cancer Stem cells through development to establishment. Adv Exp Med Biol. 2022;1393:83\u2013101.","journal-title":"Adv Exp Med Biol"},{"key":"2165_CR639","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12032-022-01801-0","volume":"39","author":"K Mortezaee","year":"2022","unstructured":"Mortezaee K, Majidpoor J, Kharazinejad E. Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updated. Med Oncol (Northwood Lond Engl). 2022;39:193.","journal-title":"Med Oncol (Northwood Lond Engl)"},{"key":"2165_CR640","doi-asserted-by":"crossref","unstructured":"Youssef G, et al. Disseminating cells in human oral tumours possess an EMT cancer stem cell marker profile that is predictive of metastasis in image-based machine learning. Elife. 2023;12:e90298.","DOI":"10.7554\/eLife.90298"},{"key":"2165_CR641","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10585-021-10102-1","volume":"38","author":"JA Mosier","year":"2021","unstructured":"Mosier JA, Schwager SC, Boyajian DA, Reinhart-King CA. Cancer cell metabolic plasticity in migration and metastasis. Clin Exp Metastasis. 2021;38:343\u201359.","journal-title":"Clin Exp Metastasis"},{"key":"2165_CR642","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41586-019-0977-x","volume":"568","author":"I Elia","year":"2019","unstructured":"Elia I, et al. Breast cancer cells rely on environmental pyruvate to shape the metastatic niche. Nature. 2019;568:117\u201321.","journal-title":"Nature"},{"key":"2165_CR643","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41586-022-04758-2","volume":"605","author":"M Rossi","year":"2022","unstructured":"Rossi M, et al. PHGDH heterogeneity potentiates cancer cell dissemination and metastasis. Nature. 2022;605:747\u201353.","journal-title":"Nature"},{"key":"2165_CR644","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/ng.3753","volume":"49","author":"OG McDonald","year":"2017","unstructured":"McDonald OG, et al. Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis. Nat Genet. 2017;49:367\u201376.","journal-title":"Nat Genet"},{"key":"2165_CR645","doi-asserted-by":"crossref","unstructured":"Ahamed A, Hosea R, Wu S, Kasim V. The emerging roles of the Metabolic Regulator G6PD in human cancers. Int J Mol Sci. 2023;24(24):17238.","DOI":"10.3390\/ijms242417238"},{"key":"2165_CR646","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","volume":"21","author":"PS Ward","year":"2012","unstructured":"Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell. 2012;21:297\u2013308.","journal-title":"Cancer Cell"},{"key":"2165_CR647","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.bbadis.2016.11.021","volume":"1863","author":"P Phannasil","year":"2017","unstructured":"Phannasil P, et al. Mass spectrometry analysis shows the biosynthetic pathways supported by pyruvate carboxylase in highly invasive breast cancer cells. Biochim et Biophys acta Mol Basis Disease. 2017;1863:537\u201351.","journal-title":"Biochim et Biophys acta Mol Basis Disease"},{"key":"2165_CR648","doi-asserted-by":"publisher","first-page":"8335","DOI":"10.3892\/mmr.2017.7637","volume":"16","author":"J Zhao","year":"2017","unstructured":"Zhao J, et al. LDHA promotes tumor metastasis by facilitating epithelial\u2013mesenchymal transition in renal cell carcinoma. Mol Med Rep. 2017;16:8335\u201344.","journal-title":"Mol Med Rep"},{"key":"2165_CR649","doi-asserted-by":"crossref","unstructured":"Liu S, et al. Hsp90 Promotes Gastric Cancer Cell Metastasis and Stemness by Regulating the Regional Distribution of Glycolysis-Related Metabolic Enzymes in the Cytoplasm. Adv Sci (Weinh). 2024;11(33):e2310109.","DOI":"10.1002\/advs.202310109"},{"key":"2165_CR650","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature19353","volume":"537","author":"M Sciacovelli","year":"2016","unstructured":"Sciacovelli M, et al. Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition. Nature. 2016;537:544\u20137.","journal-title":"Nature"},{"key":"2165_CR651","doi-asserted-by":"publisher","first-page":"eabh2443","DOI":"10.1126\/sciadv.abh2443","volume":"7","author":"SY Loo","year":"2021","unstructured":"Loo SY, et al. Fatty acid oxidation is a druggable gateway regulating cellular plasticity for driving metastasis in breast cancer. Sci Adv. 2021;7:eabh2443.","journal-title":"Sci Adv"},{"key":"2165_CR652","first-page":"e2308945","volume":"11","author":"R Lu","year":"2024","unstructured":"Lu R, et al. Loss of OVOL2 in Triple-negative breast Cancer promotes fatty acid oxidation fueling stemness characteristics. Advanced science (Weinheim. Baden-Wurttemberg Germany). 2024;11:e2308945.","journal-title":"Baden-Wurttemberg Germany)"},{"key":"2165_CR653","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/ncb3039","volume":"16","author":"VS LeBleu","year":"2014","unstructured":"LeBleu VS, et al. PGC-1\u03b1 mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat Cell Biol. 2014;16:992\u20131003.","journal-title":"Nat Cell Biol"},{"key":"2165_CR654","doi-asserted-by":"publisher","first-page":"216724","DOI":"10.1016\/j.canlet.2024.216724","volume":"587","author":"D Murthy","year":"2024","unstructured":"Murthy D, et al. CD24 negativity reprograms mitochondrial metabolism to PPAR\u03b1 and NF-\u03baB-driven fatty acid \u03b2-oxidation in triple-negative breast cancer. Cancer Lett. 2024;587:216724.","journal-title":"Cancer Lett"},{"key":"2165_CR655","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/cac2.12247","volume":"42","author":"D Wu","year":"2022","unstructured":"Wu D, et al. Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1. Cancer Commun (London England). 2022;42:37\u201355.","journal-title":"Cancer Commun (London England)"},{"key":"2165_CR656","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.cmet.2023.12.003","volume":"36","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, et al. Metabolic switch regulates lineage plasticity and induces synthetic lethality in triple-negative breast cancer. Cell Metabol. 2024;36:193\u2013e208198.","journal-title":"Cell Metabol"},{"key":"2165_CR657","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1038\/s41467-019-10592-4","volume":"10","author":"A van Weverwijk","year":"2019","unstructured":"van Weverwijk A, et al. Metabolic adaptability in metastatic breast cancer by AKR1B10-dependent balancing of glycolysis and fatty acid oxidation. Nat Commun. 2019;10:2698.","journal-title":"Nat Commun"},{"key":"2165_CR658","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1038\/s41467-022-32101-w","volume":"13","author":"Y Tan","year":"2022","unstructured":"Tan Y, et al. Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells. Nat Commun. 2022;13:4554.","journal-title":"Nat Commun"},{"key":"2165_CR659","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12929-024-01013-w","volume":"31","author":"S Xu","year":"2024","unstructured":"Xu S, et al. Metabolism-regulating non-coding RNAs in breast cancer: roles, mechanisms and clinical applications. J Biomed Sci. 2024;31:25.","journal-title":"J Biomed Sci"},{"key":"2165_CR660","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00018-015-2070-4","volume":"73","author":"Z Li","year":"2016","unstructured":"Li Z, Zhang H. Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol Life Sci. 2016;73:377\u201392.","journal-title":"Cell Mol Life Sci"},{"key":"2165_CR661","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12964-023-01449-x","volume":"22","author":"X Li","year":"2024","unstructured":"Li X, et al. Glutamine addiction in tumor cell: oncogene regulation and clinical treatment. Cell Communication Signaling: CCS. 2024;22:12.","journal-title":"Cell Communication Signaling: CCS"},{"key":"2165_CR662","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1007\/s13277-013-0819-7","volume":"34","author":"S Kim","year":"2013","unstructured":"Kim S, Jung WH, Koo JS. The expression of glutamine-metabolism-related proteins in breast phyllodes tumors. Tumour Biology: J Int Soc Oncodevelopmental Biology Med. 2013;34:2683\u20139.","journal-title":"Tumour Biology: J Int Soc Oncodevelopmental Biology Med"},{"key":"2165_CR663","doi-asserted-by":"crossref","unstructured":"Marini C, et al. Fundamental role of Pentose Phosphate Pathway within the endoplasmic reticulum in glutamine addiction of Triple-negative breast Cancer cells. Antioxidants (Basel). 2022;12(1):43.","DOI":"10.3390\/antiox12010043"},{"key":"2165_CR664","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/j.molcel.2022.03.016","volume":"82","author":"B Jiang","year":"2022","unstructured":"Jiang B, et al. Filamentous GLS1 promotes ROS-induced apoptosis upon glutamine deprivation via insufficient asparagine synthesis. Mol Cell. 2022;82:1821\u2013e18351826.","journal-title":"Mol Cell"},{"key":"2165_CR665","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/s41589-022-01154-9","volume":"19","author":"VH Villar","year":"2023","unstructured":"Villar VH, et al. Hepatic glutamine synthetase controls N(5)-methylglutamine in homeostasis and cancer. Nat Chem Biol. 2023;19:292\u2013300.","journal-title":"Nat Chem Biol"},{"key":"2165_CR666","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41586-020-2857-9","volume":"587","author":"M Shang","year":"2020","unstructured":"Shang M, et al. Macrophage-derived glutamine boosts satellite cells and muscle regeneration. Nature. 2020;587:626\u201331.","journal-title":"Nature"},{"key":"2165_CR667","doi-asserted-by":"publisher","first-page":"114083","DOI":"10.1016\/j.ab.2020.114083","volume":"644","author":"T Dorai","year":"2022","unstructured":"Dorai T, Pinto JT, Denton TT, Krasnikov BF, Cooper AJL. The metabolic importance of the glutaminase II pathway in normal and cancerous cells. Anal Biochem. 2022;644:114083.","journal-title":"Anal Biochem"},{"key":"2165_CR668","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cmet.2019.11.020","volume":"31","author":"HC Yoo","year":"2020","unstructured":"Yoo HC, et al. A variant of SLC1A5 is a mitochondrial glutamine transporter for metabolic reprogramming in Cancer cells. Cell Metabol. 2020;31:267\u2013e283212.","journal-title":"Cell Metabol"},{"key":"2165_CR669","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41586-023-06299-8","volume":"620","author":"C Guo","year":"2023","unstructured":"Guo C, et al. SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity. Nature. 2023;620:200\u20138.","journal-title":"Nature"},{"key":"2165_CR670","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41568-020-00320-2","volume":"21","author":"G Bergers","year":"2021","unstructured":"Bergers G, Fendt SM. The metabolism of cancer cells during metastasis. Nat Rev Cancer. 2021;21:162\u201380.","journal-title":"Nat Rev Cancer"},{"key":"2165_CR671","first-page":"677","volume":"35","author":"K Sugano","year":"2015","unstructured":"Sugano K, et al. Expression of xCT as a predictor of disease recurrence in patients with colorectal cancer. Anticancer Res. 2015;35:677\u201382.","journal-title":"Anticancer Res"},{"key":"2165_CR672","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.molcel.2017.11.025","volume":"69","author":"L Jin","year":"2018","unstructured":"Jin L, et al. The PLAG1-GDH1 Axis promotes Anoikis Resistance and Tumor Metastasis through CamKK2-AMPK Signaling in LKB1-Deficient Lung Cancer. Mol Cell. 2018;69:87\u2013e9987.","journal-title":"Mol Cell"},{"key":"2165_CR673","doi-asserted-by":"crossref","unstructured":"Zhang Y, et al. Cul4A-DDB1-mediated monoubiquitination of phosphoglycerate dehydrogenase promotes colorectal cancer metastasis via increased S-adenosylmethionine. J Clin Invest. 2021;131(21):e146187.","DOI":"10.1172\/JCI146187"},{"key":"2165_CR674","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1158\/2159-8290.CD-19-1228","volume":"10","author":"B Ngo","year":"2020","unstructured":"Ngo B, et al. Limited Environmental Serine and Glycine Confer Brain Metastasis sensitivity to PHGDH Inhibition. Cancer Discov. 2020;10:1352\u201373.","journal-title":"Cancer Discov"},{"key":"2165_CR675","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1158\/0008-5472.CAN-23-1788","volume":"84","author":"S Saha","year":"2024","unstructured":"Saha S, et al. Serine depletion promotes Antitumor Immunity by activating mitochondrial DNA-Mediated cGAS-STING signaling. Cancer Res. 2024;84:2645\u201359.","journal-title":"Cancer Res"},{"key":"2165_CR676","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12943-021-01412-9","volume":"20","author":"X Liu","year":"2021","unstructured":"Liu X, et al. CircMYH9 drives colorectal cancer growth by regulating serine metabolism and redox homeostasis in a p53-dependent manner. Mol Cancer. 2021;20:114.","journal-title":"Mol Cancer"},{"key":"2165_CR677","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40364-023-00487-4","volume":"11","author":"W Sun","year":"2023","unstructured":"Sun W, et al. Targeting serine-glycine-one-carbon metabolism as a vulnerability in cancers. Biomark Res. 2023;11:48.","journal-title":"Biomark Res"},{"key":"2165_CR678","doi-asserted-by":"publisher","first-page":"19740","DOI":"10.1074\/jbc.RA119.011519","volume":"294","author":"K Masui","year":"2019","unstructured":"Masui K, et al. mTORC2 links growth factor signaling with epigenetic regulation of iron metabolism in glioblastoma. J Biol Chem. 2019;294:19740\u201351.","journal-title":"J Biol Chem"},{"key":"2165_CR679","doi-asserted-by":"publisher","first-page":"106827","DOI":"10.1016\/j.isci.2023.106827","volume":"26","author":"J He","year":"2023","unstructured":"He J, et al. Reprogramming of iron metabolism confers ferroptosis resistance in ECM-detached cells. iScience. 2023;26:106827.","journal-title":"iScience"},{"key":"2165_CR680","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1038\/s41467-023-37871-5","volume":"14","author":"XY He","year":"2023","unstructured":"He XY, et al. LncRNA modulates Hippo-YAP signaling to reprogram iron metabolism. Nat Commun. 2023;14:2253.","journal-title":"Nat Commun"},{"key":"2165_CR681","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/s41557-020-0513-5","volume":"12","author":"S M\u00fcller","year":"2020","unstructured":"M\u00fcller S, et al. CD44 regulates epigenetic plasticity by mediating iron endocytosis. Nat Chem. 2020;12:929\u201338.","journal-title":"Nat Chem"},{"key":"2165_CR682","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/1878-0261.12494","volume":"13","author":"SI Mohammed","year":"2019","unstructured":"Mohammed SI, Torres-Luquis O, Walls E, Lloyd F. Lymph-circulating tumor cells show distinct properties to blood-circulating tumor cells and are efficient metastatic precursors. Mol Oncol. 2019;13:1400\u201318.","journal-title":"Mol Oncol"},{"key":"2165_CR683","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fonc.2018.00036","volume":"8","author":"D Jones","year":"2018","unstructured":"Jones D, Pereira ER, Padera TP. Growth and Immune Evasion of Lymph Node Metastasis. Front Oncol. 2018;8:36.","journal-title":"Front Oncol"},{"key":"2165_CR684","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1158\/2159-8290.CD-RW2022-092","volume":"12","author":"Lymph Node Metastasis","year":"2022","unstructured":"Lymph Node Metastasis. Induces Immune Tolerance and Distant Metastasis. Cancer Discov. 2022;12:1610.","journal-title":"Cancer Discov"},{"key":"2165_CR685","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1126\/science.aav0173","volume":"363","author":"CK Lee","year":"2019","unstructured":"Lee CK, et al. Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation. Sci (New York N Y). 2019;363:644\u20139.","journal-title":"Sci (New York N Y)"},{"key":"2165_CR686","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1186\/s12885-023-11055-2","volume":"23","author":"D Tian","year":"2023","unstructured":"Tian D, et al. Pararespiratory and paradigestive lymph node metastases in esophageal squamous cell carcinoma: predicting survival and refining the N staging system. BMC Cancer. 2023;23:695.","journal-title":"BMC Cancer"},{"key":"2165_CR687","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","volume":"585","author":"JM Ubellacker","year":"2020","unstructured":"Ubellacker JM, et al. Lymph protects metastasizing melanoma cells from ferroptosis. Nature. 2020;585:113\u20138.","journal-title":"Nature"},{"key":"2165_CR688","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12943-020-1138-4","volume":"19","author":"X Li","year":"2020","unstructured":"Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer. Mol Cancer. 2020;19:12.","journal-title":"Mol Cancer"},{"key":"2165_CR689","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/bcr2149","volume":"10","author":"G Kallergi","year":"2008","unstructured":"Kallergi G, et al. Phosphorylated EGFR and PI3K\/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients. Breast cancer Research: BCR. 2008;10:R80.","journal-title":"Breast cancer Research: BCR"},{"key":"2165_CR690","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12943-024-01934-y","volume":"23","author":"J Liu","year":"2024","unstructured":"Liu J, et al. Selective autophagy in cancer: mechanisms, therapeutic implications, and future perspectives. Mol Cancer. 2024;23:22.","journal-title":"Mol Cancer"},{"key":"2165_CR691","doi-asserted-by":"crossref","unstructured":"Torres-L\u00f3pez L, Dobrovinskaya O. Dissecting the Role of Autophagy-Related Proteins in Cancer Metabolism and Plasticity. Cells. 2023;12(20):2486.","DOI":"10.3390\/cells12202486"},{"key":"2165_CR692","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1158\/0008-5472.CAN-16-2976","volume":"77","author":"B Ruprecht","year":"2017","unstructured":"Ruprecht B, et al. Lapatinib Resistance in breast Cancer cells is accompanied by phosphorylation-mediated reprogramming of Glycolysis. Cancer Res. 2017;77:1842\u201353.","journal-title":"Cancer Res"},{"key":"2165_CR693","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","volume":"631","author":"H Chen","year":"2024","unstructured":"Chen H, et al. NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature. 2024;631:663\u20139.","journal-title":"Nature"},{"key":"2165_CR694","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1016\/j.celrep.2019.11.008","volume":"29","author":"WW Feng","year":"2019","unstructured":"Feng WW, et al. CD36-Mediated metabolic rewiring of breast Cancer cells promotes resistance to HER2-Targeted therapies. Cell Rep. 2019;29:3405\u2013e34203405.","journal-title":"Cell Rep"},{"key":"2165_CR695","doi-asserted-by":"crossref","unstructured":"Wei Z, et al. MIER2\/PGC1A elicits sunitinib resistance via lipid metabolism in renal cell carcinoma. J Adv Res. 2024:S2090-1232(24)00177-2.","DOI":"10.1016\/j.jare.2024.04.032"},{"key":"2165_CR696","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1053\/j.gastro.2022.11.014","volume":"164","author":"S Solanki","year":"2023","unstructured":"Solanki S, et al. Dysregulated amino acid sensing drives colorectal Cancer growth and metabolic reprogramming leading to Chemoresistance. Gastroenterology. 2023;164:376\u2013e391313.","journal-title":"Gastroenterology"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-024-02165-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-024-02165-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-024-02165-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T20:02:36Z","timestamp":1732219356000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-024-02165-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":696,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2165"],"URL":"https:\/\/doi.org\/10.1186\/s12943-024-02165-x","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"261"}}